| Keywords
|
|
[186]
|
-omics
|
|
|
| 2026 |
|
2026 AB0001
|
GENE EXPRESSION PROFILING OF JAK INHIBITOR THERAPY: NEURO-METABOLIC AND INFLAMMATORY IMPLICATIONS IN AUTOIMMUNE RHEUMATIC DISEASES – A PILOT STUDY,
E. Modzelewska, K. Palej, S. Stanczyk, J. Laszuk, B. Stypińska, M. Stasiek, A. Felis-Giemza, A. Wajda
|
|
2026 AB0002
|
CLUSTER MEDICINE: LEVERAGING GENETICS TO IDENTIFY SHARED BIOLOGICAL PATHWAYS ACROSS IMMUNE-MEDIATED INFLAMMATORY DISEASES,
T. Raisi, D. Plant, M. Buch, A. Morris, J. Bowes
|
|
2026 AB0006
|
AN EXPLORATORY PROTEOMIC STUDY TO IDENTIFY BIOMARKERS PREDICTING RESPONSE TO ANTI-TNF THERAPY IN INFLAMMATORY RHEUMATIC DISEASES,
R. Rodríguez-Mauriz, L. Lourido, P. Domínguez-Guerrero, L. Ramudo-Cela, N. Oreiro, T. Cerdó, C. Lopez-Pedrera, L. Margusino-Framiñan, F. J. Blanco, C. Ruiz-Romero
|
|
2026 AB0012
|
IMPACT OF HLA EVOLUTIONARY DIVERGENCE ON PEPTIDE PRESENTATION AND PATHOGEN MIMICRY IN THE PATHOGENESIS OF SLE,
R. Domínguez Rodríguez, E. Carnero-Montoro, P. Cytometry Consortium, R. Díaz Peña, M. Alarcon-Riquelme, G. Barturen
|
|
2026 AB0046
|
LIPIDOMIC CHANGES ASSOCIATED TO HEPATIC STEATOSIS AND FIBROSIS IN INFLAMMATORY ARTHRITIS,
M. Ruiz-Ponce, A. M. Barranco, E. Martin-Salazar, L. Romero-Zurita, M. D. López-Montilla, M. L. Ladehesa-Pineda, C. Perez-Sanchez, M. C. Ábalos-Aguilera, D. Ruiz-Vilchez, P. Ortiz-Buitrago, C. Ferreira, D. Corona-Mata, M. Casares-Jimenez, C. Lopez-Pedrera, E. Collantes-Estevez, C. López-Medina, A. Escudero-Contreras, I Arias-de la Rosa, N. Barbarroja
|
|
2026 AB0050
|
HISTOPATHOLOGICAL AND TRANSCRIPTIONAL ANALYSIS OF PATIENTS WITH MYOSITIS AND POSITIVE U1RNP-ANTIBODIES: EXPLORING THE FIELD OF OVERLAP-MYOSITIS,
M. T. Holzer, A. Schänzer, S. Léonard-Louis, O. Benveniste, Y. Allenbach, U. Schneider, R. Biesen, U. Müller-Ladner, D. Lemmer, I. Kötter, T. B. Huber, J. Prudlo, M. Krusche, C. Preuße, W. Stenzel
|
|
2026 AB0057
|
DISPARATE PERIPHERY AND LUNG IMMUNE MICROENVIRONMENTS INDUCED MONOCYTE-MACROPHAGE ACTIVATION AS A KEY FACTOR IN ANTI-SYNTHETASE SYNDROME-ASSOCIATED INTERSTITIAL LUNG DISEASE,
K. Su, J. He, Y. Zhou, J. Huang
|
|
2026 AB0065
|
IDENTIFICATION OF UPREGULATED MIRNAS IN INFLAMED SYNOVIAL FIBROBLASTS AND MACROPHAGES IN OSTEOARTHRITIS BY INTEGRATING IN SILICO AND IN VITRO ANALYSES,
J. Veldman, R. Frei, A. Hegger, E. Farrell, A. Lolli, G van Osch
|
|
2026 AB0067
|
METABOLOMIC PROFILING OF SERUM BILE ACIDS IDENTIFIES GLCA-3S AS A MARKER OF EROSIVE HAND OSTEOARTHRITIS: DATA FROM THE DIGICOD COHORT,
M. Binvignat, A. Desmons, P. Krasniqi, C. Albalaa, A. Lefevre, A. Courties, A. Latourte, M. Kloppenburg, E. Mariotti-Ferrandiz, H. Sokol, F. Berenbaum, D. Rainteau, A. Lamaziere, J. Sellam
|
|
2026 AB0068
|
MACHINE LEARNING-BASED PLASMA PROTEOMICS IDENTIFIES TWO NOVEL ENDOTYPES IN KNEE OSTEOARTHRITIS: PLATELET-DRIVEN AND IMMUNE-DRIVEN,
P. Quaranta, P. Fernández Puente, D. Fernandez-Edreira, J. Linares-Blanco, S. Gonzalez-Carro, L. Lourido, C. Ruiz-Romero, N. Oreiro, M. Silva-Díaz, A. Soto-Gonzalez, M. Crespo, J. L. Diaz Diaz, E. Miguez-Rey, A Mena de Cea, F. J. Blanco, V. Calamia
|
|
2026 AB0070
|
GENETIC INTEGRATION OF MITOCHONDRIAL AND NUCLEAR VARIANTS IMPROVES PREDICTION OF METABOLIC SYNDROME–RELATED KNEE OSTEOARTHRITIS,
J. Vázquez-García, A. Morano Torres, L. Martínez-Sotodosos, D. Noriega, S. Relaño-Fernandez, N. Oreiro, F. J. Blanco, I. Rego-Perez
|
|
2026 AB0083
|
URINE AND PLASMA METABOLOMIC PROFILING TO PREDICT DULOXETINE RESPONSE IN FIBROMYALGIA: AN EXPLORATORY PILOT STUDY,
O. D. Argyropoulou, I. Tsartsitalidis, M. I. Magkaki, D. Benaki, E. Mikros, M. N. Manoussakis
|
|
2026 AB0084
|
IMMUNOMETABOLIC REMODELING ASSOCIATED WITH CLINICAL AND INFLAMMATORY RESPONSE TO ANTI-TNF THERAPY IN PSORIATIC ARTHRITIS,
E. Martin-Salazar, I. Arias-de la Rosa, M. Ruiz-Ponce, A. M. Barranco, M. Á. Puche-Larrubia, P. Ortiz-Buitrago, M. D. López Montilla, C. Perez-Sanchez, L. Romero-Zurita, E. Moreno-Caño, R. Ortega-Castro, J. Calvo-Gutiérrez, M. C. Ábalos-Aguilera, D. Ruíz-Vilchez, C. Lopez-Pedrera, A. Escudero-Contreras, E. Collantes-Estevez, C. López-Medina, N. Barbarroja
|
|
2026 AB0092
|
UNRAVELING SEX-SPECIFIC WEIGHTED GENETIC MARKERS AND PATHWAYS IN PSORIATIC ARTHRITIS,
K. Healey, Q. Li, I. Jurisica, D. Gladman, V. Chandran, L. Eder, P. Rahman
|
|
2026 AB0101
|
TRANSCRIPTOMIC AND CHROMATIN ACCESSIBILITY PROFILING OF PERIPHERAL BLOOD MONOCYTES IN RHEUMATOID ARTHRITIS FLARE AND REMISSION,
A. Melville, K. Woolcock, F. Rayner, A. McGucken, A. E. Anderson, A. Filer, I. B. McInnes, K. Raza, A. Pratt, K. F. Baker, J. Isaacs, S. Siebert, C. S. Goodyear
|
|
2026 AB0104
|
THE KRENN INDEX IDENTIFIES AN AGGRESSIVE SYNOVITIS PHENOTYPE IN EARLY RHEUMATOID ARTHRITIS: CLINICAL, ULTRASOUND, HISTOLOGICAL, AND SERUM PROTEOMIC CHARACTERIZATION WITH PROGNOSTIC IMPLICATIONS,
S. Corrales-Díaz Flores, A. Cid-Chaves, J. Osuna, C. Perez-Sanchez, C. Merlo-Ruiz, M. C. Ábalos-Aguilera, N. Barbarroja, F. Leiva-Cepas, A. Escudero-Contreras, C. Lopez-Pedrera, C. Aranda-Valera
|
|
2026 AB0109
|
A GLYCOLYTIC GATE IN BONA FIDE RECENT THYMIC EMIGRANTS COUPLES THYMIC OUTPUT TO BLOOD–SYNOVIUM INFLAMMATION ACROSS PRE-CLINICAL AND ESTABLISHED RHEUMATOID ARTHRITIS,
Z. Yang, R. Song, M. Souto-Carneiro
|
|
2026 AB0111
|
LEVERAGING SINGLE-CELL TRANSCRIPTOMICS AT DIAGNOSIS FOR PREDICTIVE BIOMARKER DISCOVERY IN RHEUMATOID ARTHRITIS,
J. Vencic, S. Roux, M. Scott, H. Allard-Chamard
|
|
2026 AB0114
|
SUBSET SPECIFIC LFA-1 ACTIVATION UNCOVERS FUNCTIONALITY OF NK CELLS EXPANDED IN RHEUMATOID ARTHRITIS REMISSION,
C. Coyle, M. Ma, R. Koechl, E. Perucha, A. Cope
|
|
2026 AB0116
|
BIOINFORMATICS AND ARTIFICIAL INTELLIGENCE-INTEGRATED IDENTIFICATION AND EXPERIMENTAL VALIDATION OF RKIP AS A NOVEL THERAPEUTIC TARGET IN RHEUMATOID ARTHRITIS,
H. S. Noh, S. Kim, H. Lim, H. Lee, M. J. Pyo, H. M. Jeon, M. Kim, S. J. Buu, W. Yoon, Y. H. Cheon, S. I. Lee
|
|
2026 AB0123
|
CHARACTERIZING THE ALDH4A1/ANTI-ALDH4A1 AXIS IN INFLAMMATORY ARTHRITIS - A NOVEL PLAYER AND CLINICAL BIOMARKER OF ATHEROSCLEROSIS ACROSS ARTHRITIS STAGES,
D. Miranda-Prieto, M. Alperi-López, Á. I. Pérez-Álvarez, R. Coras, S. Alonso-Castro, N. Amigó, M. Guma, A. Suárez, J. Rodríguez-Carrio
|
|
2026 AB0124
|
CYTOKINE PROFILES AND SINGLE-CELL TRANSCRIPTOMIC ANALYSIS OF SYNOVIAL FLUID: CHARACTERIZATION AND STRATIFICATION OF RHEUMATOID ARTHRITIS,
M. Lesturgie Talarek, F. Carbone, V. Gonzalez, A. Schvartz, S. Hecquet, F. Oudart, M. Thomas, R. D’Alessandro, Y. Allanore, M. Ménager, J. Avouac
|
|
2026 AB0128
|
A MOLECULAR TREATMENT RESPONSE SIGNATURE IMPROVES EFFICACY OF T-CELL THERAPY IN RHEUMATOID ARTHRITIS,
K. Qu, L. Zhang, A. Wong, A. Jones, S. Guardiano, C. Younger, R. Seeto, R. Phan
|
|
2026 AB0130
|
SYNOVIAL TRANSCRIPTOMIC PROFILING REVEALS BIOLOGICAL HETEROGENEITY IN ACPA-POSITIVE AND ACPA-NEGATIVE RHEUMATOID ARTHRITIS: RESULTS FROM THE PATHOBIOLOGY OF EARLY ARTHRITIS COHORT (PEAC),
J. Perera, A. Nerviani, C. Cubuk, R. Lau, E. Sciacca, F. Rivellese, M. A. Boutet, M. Lewis, C. Pitzalis
|
|
2026 AB0131
|
PLASMA BIOMARKERS PREDICTING DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS IN PATIENTS,
K. Mocová, J. Baloun, A. Prokopcova, K. Brabnikova Maresova, H. Mann, J. Vencovský, K. Pavelka, L. Šenolt
|
|
2026 AB0138
|
COMPARTMENT-DERIVED SECRETED PROTEIN SIGNATURES DEFINE CLINICAL RESPONSE TO METHOTREXATE IN EARLY RHEUMATOID ARTHRITIS,
S. Corrales-Díaz Flores, C. Perez-Sanchez, C. Merlo-Ruiz, R. Ortega-Castro, J. Calvo, M. L. Ladehesa-Pineda, L. Muñoz-Barrera, L. Formanti Alonso, D. Ruiz-Vilchez, M. Á. Aguirre-Zamorano, N. Barbarroja, T. Cerdó, M. Alarcon-Riquelme, C. Aranda-Valera, A. Escudero-Contreras, C. Lopez-Pedrera
|
|
2026 AB0140
|
TEMPORAL DYNAMICS OF INFLAMMATORY PROTEINS IN THE PRE-SYMPTOMATIC PHASE OF RHEUMATOID ARTHRITIS RELATED TO SEROCONVERSION,
A. Ahlsved, A. Lundquist, K. Lejon, S. Rantapää Dahlqvist, M. Brink
|
|
2026 AB0149
|
CLINICALLY RELEVANT MEMORY B-CELL SUBSETS IN EARLY RHEUMATOID ARTHRITIS,
I. Gjertsson, P. Haase, K. Grimstad, S. McGrath, M. Leu Agelii, C. Jonsson, A. K. H. Ekwall, I. L. Mårtensson
|
|
2026 AB0152
|
NON-INVASIVE IDENTIFICATION OF SYNOVIAL PATHOTYPES IN RHEUMATOID ARTHRITIS USING CELLULAR DECONVOLUTION OF PERIPHERAL BLOOD RNA,
C. Taylor, A. Kerschbaumer, A. Moore, P. Khatri
|
|
2026 AB0159
|
TRANSCRIPTIONAL MAPPING OF RHEUMATOID ARTHRITIS HETEROGENEITY: METABOLIC REWIRING AND TRANSPOSABLE ELEMENTS AS KEY DRIVERS OF TREATMENT PHENOTYPES,
O. Katsouli, M. Pouliou, V. Lainis, A. P. Dekastros, A. Manoudakis, G. Vatsellas, M. Agelopoulos, P. G. Vlachoyiannopoulos
|
|
2026 AB0166
|
GRANZYME K DEFINES A DISTINCT CYTOTOXIC CD4 T CELL STATE WITH ALTERED DIFFERENTIATION IN RHEUMATOID ARTHRITIS,
P. Nguyen, J. Wiegand, L. Braune, F. Beck, T. Hagemann, K. Rothe, U. Wagner
|
|
2026 AB0178
|
SINGLE-CELL MAPPING OF SYNOVIAL FLUID AND BLOOD IMMUNE LANDSCAPES IN IMMUNE CHECKPOINT INHIBITOR-INDUCED RHEUMATOID ARTHRITIS,
S. Ghannoum, M. Liapi, M. Sijbranda, V. Malmström, K. Chemin, K. Chatzidionysiou
|
|
2026 AB0182
|
HUMORAL RESPONSES AGAINST HDL ARE LINKED TO UNFAVORABLE LIPOPROTEIN, LIPID, AND PROTEOMIC SIGNATURES IN SJÖGREN DISEASE – A MULTI-PLATFORM APPROACH,
S. Suárez, D. Miranda-Prieto, P. López, A. Alunno, Á. I. Pérez-Álvarez, N. Amigó, A. Martínez-Zapico, A. Suárez, J. Rodríguez-Carrio
|
|
2026 AB0200
|
FUNCTIONAL CHARACTERISATION OF HEALTH-ASSOCIATED GUT BACTERIA IN ANKYLOSING SPONDYLITIS: LINKING THE ROLE OF MICROBIAL METABOLITES TO EPITHELIAL BARRIER INTEGRITY AND IMMUNE REGULATION IN HOMEOSTASIS AND INFLAMMATION,
J. Jimenez Loayza, P. O Cuiv, G. Tyson, T. Kenna
|
|
2026 AB0206
|
INTEGRATED METABOLOMIC ANALYSIS OF SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS REVEALS SHARED AND DISTINCT PATHWAYS,
E. Martin-Salazar, C. López-Medina, M. Á. Puche-Larrubia, P. Ortiz-Buitrago, M. D. López Montilla, C. Perez-Sanchez, I. Arias-de la Rosa, M. Ruiz-Ponce, L. Romero-Zurita, A. M. Barranco, E. Moreno-Caño, R. Ortega-Castro, J. Calvo-Gutiérrez, M. C. Ábalos-Aguilera, D. Ruíz-Vilchez, C. Lopez-Pedrera, A. Escudero-Contreras, E. Collantes-Estevez, N. Barbarroja
|
|
2026 AB0211
|
CIRCULATING MicroRNA-mRNA SIGNATURES AS ORGAN-SPECIFIC BIOMARKERS OF DISEASE FLARE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: AN INTEGRATED SMALL RNA-SEQ AND TRANSCRIPTOMIC ANALYSIS,
A. Karmakar, A. Nayek, U. Kumar, V. Bolar Suryakanth, V. Ravindran, S. P. Nagaraju, S. Prabhu, M. M. Prabhu, S. Karmakar
|
|
2026 AB0212
|
MULTI-OMICS MAPPING OF MATERNAL-FETAL INTERFACE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN EARLY PREGNANCY,
J. Ye, J. Wu
|
|
2026 AB0213
|
PROTEOMIC PROFILING OF LOW LUPUS DISEASE ACTIVITY AND REMISSION IN SYSTEMIC LUPUS ERYTHEMATOSUS,
R. Abida, C. Pericleous, A. Rahman, T. McDonnell, C. Wincup
|
|
2026 AB0214
|
AltraFlowSOM: A SEMISUPERVISED FRAMEWORK FOR SCALABLE PHENOTYPING OF IMAGING MASS CYTOMETRY DATA,
A. Anilkumar Rekha, P. E. Jouve, S. Hillion, E. Bettacchioli, C. Le Dantec
|
|
2026 AB0222
|
MENDELIAN RANDOMIZATION AND TRANSCRIPTOMICS REVEAL THAT RNASET2 DYSFUNCTION IN IMMUNE CELLS INCREASES THE RISK OF SYSTEMIC LUPUS ERYTHEMATOSUS,
L. Chen, W. Tang
|
|
2026 AB0228
|
SINGLE-CELL TRANSCRIPTIONAL AND TCR REPERTOIRE PROFILING REVEALS DYNAMIC ALTERATIONS OF T AND NK CELLS DURING SYSTEMIC LUPUS ERYTHEMATOSUS DEVELOPMENT,
X. Han, R. Yao, S. Jin, R. Liang, H. Xu, Y. Zhu, Y. Su
|
|
2026 AB0245
|
SINGLE-CELL IMMUNOLOGICAL PROFILING DECIPHERS NOVEL PATHWAYS OF PROGRESSION FROM ANA+ AT-RISK STAGE TO SYSTEMIC LUPUS ERYTHEMATOSUS,
A. Psarras, L. Tamon, S. Arocha, M. Attar, K. Argoud, M. Y. Md Yusof, R. J. M. Bashford-Rogers, A. Clarke, E. M. Vital
|
|
2026 AB0247
|
UNTARGETED SERUM PROTEOMICS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS REVEALS MOLECULAR PATHWAYS ASSOCIATED WITH ETHNICITY AND DISEASE PHENOTYPES,
L. Eades, H. Valipour Kahrood, J. Steele, J. Kent, A. R. Kitching, R. Schittenhelm, R. Kandane-Rathnayake, A. Hoi, E. Morand, F. Vincent
|
|
2026 AB0257
|
N-LACTOYL AMINO ACIDS AS METABOLIC INDICATORS OF FIBROSIS IN SYSTEMIC SCLEROSIS SKIN: AN INTEGRATED METABOLOMIC-TRANSCRIPTOMIC STUDY,
A. Ravaei, Y. Zhang, C. Överdahl, R. Pullerits, O. Distler, C. Maglio
|
|
2026 AB0258
|
MOBILE GENES (TRANSPOSONS) EXPRESSION IN FIBROBLASTS FROM SKIN BIOPSIES OF PATIENTS WITH SYSTEMIC SCLEROSIS,
D. Bleck, T. Filla, K. Drechsel, P. Li, M. V. Napoli, P. Bearzi, E. Pachera, O. Distler, A. Pezone, E. V. Avvedimento, N. Del Papa, R. De Angelis, J. Distler, A. Gabrielli
|
|
2026 AB0259
|
PLASMA METABOLOMIC PROFILING IDENTIFIES CIRCULATING BIOMARKERS OF SYSTEMIC SCLEROSIS AND LUNG INVOLVEMENT,
C. Överdahl, A. Orlando, R. Giacomelli, R. Pullerits, Y. Zhang, C. Maglio
|
|
2026 AB0261
|
MESENCHYMAL STROMAL CELLS FUEL IMMUNOMETABOLISM REPROGRAMMING OF TYPE 2 CONVENTIONAL DENDRITIC CELLS TO ALLEVIATE SYSTEMIC SCLEROSIS,
Z. Wang, D. Wang
|
|
2026 AB0263
|
SEX-BIASED FIBROBLAST SUBPOPULATIONS AND TRANSCRIPTIONAL PROGRAMS REVEAL MECHANISMS OF SKIN LESION DEVELOPMENT IN SYSTEMIC SCLEROSIS,
C. Khantham, I. Rodriguez-Martin, M. Kerick, G. Villanueva-Martin, J. L. Callejas, A. Guillen-Del-Castillo, C. P. Simeón-Aznar, R. Ruiz-Villaverde, E. Andrés-León, J. Martin, M. Acosta-Herrera
|
|
2026 AB0266
|
GENOME-WIDE ASSOCIATION STUDY IDENTIFIES GENETIC RISK LOCI ASSOCIATED WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE,
C. Rosa-Baez, C. Rangel-Peláez, I. Rodriguez-Martin, G. Borrego-Yaniz, M. Kerick, A. Guillen-Del-Castillo, C. P. Simeón-Aznar, J. L. Callejas, A. Voskuyl, A. Kreuter, O. Distler, I. SSc Group, S. M. Proudman, M. Nikpour, A. Scleroderma Interest Group (ASIG), N. Hunzelmann, G. Moroncini, A. Gabrielli, M. Dapas, J. K. de Vries-Bouwstra, A. L. Herrick, Y. Allanore, L. Beretta, M. D. Mayes, C. Denton, S. Assassi, J. Martin, M. Acosta-Herrera
|
|
2026 AB0267
|
ANALYSIS OF mRNA AND microRNA CHANGES ASSOCIATED WITH UPPER GASTROINTESTINAL FEATURES OF SYSTEMIC SCLEROSIS: A PILOT STUDY,
N. Martis, M. Isola, J. Mille, L. Guardini, H. Cadis, C. Scribe, E. Bazin, T. Nerson, V. Queyrel, S. Patouraux, F. Burel-Vandenbos, G. Vanbiervliet, J. Fassy, M. Truchi, K. Lebrigand, G. Vassaux, B. Mari
|
|
2026 AB0275
|
NETWORK ANALYSIS ON TRANSCRIPTOME STUDIES OF LARGE- AND SMALL-VESSEL VASCULITIS HIGHLIGHTS SYK AND CD247 AS HIGHLY CONNECTED HUB GENES IN GIANT CELL ARTERITIS,
I. Lindquist, M. Friedman
|
|
2026 AB0468
|
A SYTEMATIC LITERATURE REVIEW OF LIPIDOMIC BIOMARKERS IN INFLAMMATORY ARTHRITIS,
H. Canagarajah, F. Mills-Baker, J. K. Singh, J. Bluett
|
|
2026 AB0503
|
68Ga-FAPI-04 PET/CT: A NEW HORIZON FOR EVALUATING PULMONARY INVOLVEMENT IN MDA5+ DERMATOMYOSITIS,
Y. Li, Y. Wu, L Zhang, C. Tan, Y. Liu
|
|
2026 AB0780
|
HIGH-DIMENSIONAL LONGITUDINAL IMMUNE PROFILING MAPS THE IMMUNE LANDSCAPE OF TNF INHIBITOR RESPONSE IN RHEUMATOID ARTHRITIS,
L. Cao, H. Zhu, R. Li, H. Ye, Z. Li
|
|
2026 AB0860
|
METABOLOMICS REVEALS METABOLIC MARKERS FOR INDIVIDUALS IN RHEUMATOID ARTHRITIS ASSOCIATED INTERSTITIAL LUNG DISEASE,
Y. Zhang, Z. Lai, F. Wang, R. Li, C. Li
|
|
2026 AB0921
|
PERFORMANCE OF CLINICALLY VALIDATED MOLECULAR SIGNATURE RESPONSE CLASSIFIER ACROSS MULTIPLE SEQUENCING PLATFORMS AND CLINICAL WORKFLOWS,
A. Jones, C. Younger, R. Hui, B. Feleke, R. Seeto, R. Phan
|
|
2026 AB1081
|
DISEASE-ACTIVITY-DEPENDENT COMPLEMENT-COAGULATION INTERACTIONS AND PERSISTENT PLATELET ACTIVATION IN EARLY SLE,
M. C. L. Larsen, F. Demir, H. Z. Langkilde, P. Linge, E. Grenmyr, E. M. Hauge, A. Voss, M. M. Rinschen, A. Bengtsson, J. B. Larsen, A. Troldborg
|
|
2026 AB1091
|
CEREBROSPINAL FLUID PROTEOME REVEALS NEW BIOMARKERS DIFFERENTIATING CENTRAL NPSLE AND CENTRAL NERVOUS SYSTEM INFECTION,
J. Xu, P. Yang
|
|
2026 AB1120
|
ENVUDEUCITINIB, AN ALLOSTERIC TYK2 INHIBITOR, INHIBITS SLE-RELEVANT TYPE I IFN BIOMARKERS IN SKIN USING SPATIAL TRANSCRIPTOMICS,
N. Narayan, J. Hoffman, C. L. Langrish, R. Punwaney, P. R. Corpuz Jr, N. E. Vlahakis, M. Tilley
|
|
2026 AB1164
|
BEYOND POSITIVITY: PROTEOMIC AND CLINICAL DIFFERENCES IN SLE DEFINED BY ANTI-dsDNA DETECTION METHOD,
I. Gómez-García, S. Dans-Caballero, C. Perez-Sanchez, A. Escudero-Contreras, R. Ortega-Castro, M. Á. Aguirre-Zamorano, C. Lopez-Pedrera
|
|
2026 AB1165
|
TARGETED SERUM LIPIDOMIC PROFILING IN SYSTEMIC LUPUS ERYTHEMATOSUS AND LUPUS NEPHRITIS,
M. Skacelova, R. Masar, D. Friedecky, M. Kadláčková, M. Dudkova, P. Horak
|
|
2026 AB1191
|
SYSTEMIC ALTERATION OF TRYPTOPHAN METABOLISM IS INDEPENDENT OF TYPE I INTERFERON SIGNATURE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS,
Y. J. Huang, L. Tapeng, M. Yang, C. M. Bottomley, J. Peters, C. Frezza, J. Behmoaras, M. Pickering, M. Botto
|
|
2026 OP004
|
MULTI-OMICS ANALYSIS ELUCIDATES THE TRAJECTORY OF PROGRESSION FROM THE ANTIBODY-POSITIVE PHASE TO ESTABLISHED SYSTEMIC SCLEROSIS,
H. Yin, F. Wu, C. Jia, W. LIN, Z. Zhao, D. ZHE, Y. Sun, C. Wei, X. Liu, L. Lu
|
|
2026 OP006
|
LUPUS NEPHRITIS HISTOLOGICAL ACTIVITY AND RESPONSE ARE LINKED TO SPECIFIC IMMUNE, METABOLIC, AND REMODELING PATHWAYS: A PER-PROTOCOL KIDNEY BIOPSY STUDY.,
A. Fava, C. Y. Lee, R. Lu, C. Guthridge, R. Chou, D. Nikolopoulos, J. Lindblom, F. Tamirou, J. A. James, M. Petri, J. M. Guthridge, F. Houssiau, I. Parodis
|
|
2026 OP009
|
METABOLIC REMODELING OF SALIVARY GLAND EPITHELIUM LINKS MITOCHONDRIAL DYSFUNCTION TO CHRONIC INFLAMMATION IN SJÖGREN’S DISEASE,
S. Colafrancesco, E. Pontarini, E. Simoncelli, G. Cavallaro, M. Certo, C. Mauro, S. Nayar, J. D. Turner, C. Barbati, D. Stefanoni, F. Sacco, L. Perfetto, C. Montesano, M. Sergi, F. Conti, C. F. Selmi, E. Gremese, C. Pitzalis, R. Priori, M. Bombardieri
|
|
2026 OP015
|
CHARACTERIZATION OF GIANT MULTINUCLEATED CELLS PHENOTYPE AND FORMATION IN GOUTY TOPHUS,
C. Leroy, A. Dupont, M. Zarka, N. Pham, H.D.Q Nguyen, A. Latourte, T. Bardin, P. Richette, H. K. Ea
|
|
2026 OP0151
|
SINGLE-CELL ANALYSIS OF INTERFERON BLOCKADE UNCOVERS B CELL REPERTOIRE REMODELING IN SYSTEMIC LUPUS ERYTHEMATOSUS,
K. Terada, Y. Tsuchida, T. S. Ushijima, Y. Suwa, K. Saegusa, S. Yamada, M. Ota, T. Okamura, K. Fujio
|
|
2026 OP0155
|
EARLY DISRUPTION OF B CELL TOLERANCE PATHWAYS AND IMMUNE REGULATORY CIRCUITS IN PRECLINICAL SYSTEMIC AUTOIMMUNE DISEASE,
A. Bylinska, M. Smith, R. Lu, C. Wagner, B. Jones, M. C. Marlin, C. Guthridge, C. Wright, S. Macwana, W. DeJager, M. Beel, C. J. Lessard, C. Arriens, T. Aberle, J. Merrill, J. M. Guthridge, J. A. James
|
|
2026 OP0159
|
MULTIMODAL ANALYSIS IDENTIFIES ALTERED BRAIN CONNECTIVITY SIGNATURE AND RELATED PSYCHOLOGICAL AND MOLECULAR PATTERNS IN DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS,
L. Gunkl-Tóth, G. Orsi, N. Császár-Nagy, L. Duzsik, G. Mátay, K. Csókási, G. Sütő, G. Kumánovics, S. Takács, Z. Vidnyánszky, J. Kun, K. Takács-Lovász, A. Pintér, P. Királyhidi, G. Schett, G. Nagy, Z. Helyes
|
|
2026 OP0165
|
INTEGRATED GENOMICS AND CROSS-TISSUE SINGLE-CELL TRANSCRIPTOMICS DEFINE MONOCYTE-DRIVEN TISSUE INJURY IN MYOSITIS,
S. Izuka, T. Komai, I. Ueda, M. Fujimoto, H. Fukui, M. Takeshita, N. Umezawa, S. Yasuda, Y. Kondo, I. Matsumoto, M. Yasuda, Y. Fujieda, T. Iwasaki, A. Morinobu, T. Kawamoto, M. Matsushita, N. Tamura, H. Nakajima, K. Yoshida, T. Isozaki, N. Yajima, A. Yoshida, T. Gono, M. Kuwana, M. Ueno, Y. Tanaka, K. Sakurai, K. Kawahata, Y. Kamata, K. Sato, T. Mimura, A. Suzuki, Y. Kochi, K. Yamamoto, H. Yuki, T. Itamiya, M. Ota, T. Okamura, K. Fujio
|
|
2026 OP017
|
INSULIN INHIBITS INFLAMMATION AND EPIGENETICALLY SUPPORTS T CELL PHENOTYPE TRANSITION IN RHEUMATOID ARTHRITIS,
V. Chandrasekaran, M. Erlandsson, D. Svensson, E. Malmhäll-Bah, G. Katona, R. Pullerits, M. I. Bokarewa
|
|
2026 OP0189
|
HIGH-RESOLUTION SPATIAL MAPPING OF THE JIA SYNOVIUM UNCOVERS DISEASE-RELEVANT CELLULAR LANDSCAPE AND NICHE,
J. Inamo, R. Fierkens, M. R. CLay, A. H. Jonsson, C. Lin, K. Hayes, N. Rogers, H. Leach, K. Yomogida
|
|
2026 OP0257
|
SPATIAL TRANSCRIPTOMICS REVEALS MECHANISM OF AUTOIMMUNITY DRIVEN BY INTERNALIZED AUTOANTIBODIES,
I. Pinal-Fernandez, K. Pak, M. Casal-Dominguez, S. Muñoz-Braceras, G. Wigerblad, S. Del Orso, F. Naz, S. Islam, G. Gutierrez-Cruz, T. B. Kinder, S. A. Ogbonnaya-Whittlesey, A. Fernández-Codina, M. Giannini, B. Ellezam, G. Laverny, V. Gilbart, O. Landon-Cardinal, M. Hudson, Y. troyanov, D. Randazzo, A. Kenea, A. Matas-García, G. Garrabou, I. Aldecoa-Ansorregui, A. Gil, E. Trallero-Araguás, M. Milone, T. Liewluck, E. Naddaf, G. Espinosa, C. P. Simeón-Aznar, A. Guillen-Del-Castillo, C. Preuße, F. Kleefeld, N. Bublitz, W. Stenzel, A. Meyer, J. Pope, A. Selva-O’Callaghan, J. Milisenda, A. Mammen
|
|
2026 OP0258
|
LONGITUDINAL SERUM PROTEOMIC SIGNATURES ASSOCIATED WITH DURABLE REMISSION VERSUS RELAPSE AFTER CAR-T THERAPY IN AUTOIMMUNE DISEASES,
F. Iwata, P. G. Gavin, D. M. Nöthling, K. Anoshkin, L. Bucci, P. Garantziotis, S. Clarke, N. Ferrari, C. Tur, M. Hagen, A. Wirsching, T. Rothe, S. Kretschmann, S. Völkl, M. Aigner, F. Müller, A. Mackensen, A. Bozec, G. Schett, R. Grieshaber-Bouyer
|
|
2026 OP0259
|
SHARED AND DISEASE-SPECIFIC MOLECULAR SIGNATURES IN RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS REVEALED BY MULTI-OMICS INTEGRATION,
I. Sanchez-Pareja, C. Perez-Sanchez, D. Toro-Domínguez, M. Á. Aguirre-Zamorano, E. Moreno-Caño, L. Formanti Alonso, R. Ortega-Castro, C. Aranda-Valera, M. L. Ladehesa-Pineda, J. Calvo-Gutiérrez, D. Ruiz-Vilchez, C. Merlo, N. Barbarroja, M. Alarcon-Riquelme, A. Escudero-Contreras, C. Lopez-Pedrera, T. Cerdó
|
|
2026 OP0262
|
IMMUNOMETABOLIC CHANGES ASSOCIATED WITH SUSTAINED REMISSION IN PATIENTS WITH cSLE AND JDM TREATED WITH ANTI-CD19 CAR T CELLS,
E. Marasco, A. Ariolli, N. de Franco, R. Nicolai, C. Bracaglia, S. Barresi, M. Becilli, P. Merli, M. I. Petrone, F. del Bufalo, M. Algeri, M. G. Cefalo, F. Locatelli, F. de Benedetti
|
|
2026 OP0264
|
MULTI-TISSUE TRANSCRIPTOMICS ANALYSIS OF EARLY CTD-ILD REVEALS CONSISTENT MOLECULAR SIGNATURES POINTING TO INTERFERON RESPONSE MECHANISMS,
P. Stauffer, V. Palchevskiy, L. Much, P. P. Diep, M. M. Aabel, N. Moe, T. Gaisl, C. Steinack, S. Lari, E. Pachera, Ø. Molberg, O. Distler, S. S. Weigt, J. Belperio, A. M. Hoffmann-Vold
|
|
2026 OP0266
|
SINGLE-CELL PROFILING OF SKIN AND SYNOVIAL FIBROBLASTS IDENTIFIES OPPOSING IFN ALPHA/BETA PATHWAY REGULATION IN PSORIASIS WITH ARTHRALGIA AND PSORIATIC ARTHRITIS.,
A. Khmelevskaia, L. A. Coletto, D. Somma, S. Alivernini, M. Kurowska-Stolarska, C. Ospelt, R. Micheroli
|
|
2026 OP0268
|
A T CELL-DRIVEN CCL20+ MACROPHAGE CIRCUIT DRIVES TNF PATHOLOGY AND Th17 Cell Recruitment In Axial Spondyloarthritis Synovium,
J. Zhao, F. Liu, J. Li, H. Shi, C. Worth, L. Jiang, D. Simone, F. Penkava, A. Chan, L. Duan, P. Bowness, L. Chen
|
|
2026 OP0277
|
RECENT THYMIC EMIGRANTS DEFINE A THERAPEUTICALLY MODIFIABLE IMMUNOMETABOLIC STATE IN RHEUMATOID ARTHRITIS,
Z. Yang, P. Pietzcker, F. V. Kraus, J. Lu, R. Song, L. V. Klotz, K. Gente, R. A. Carvalho, H. M. Lorenz, M. Souto-Carneiro
|
|
2026 OP0279
|
GENETIC RISK VARIANTS REVEAL CYTOKINE-RESPONSIVE MODULES DRIVING PATHOGENIC PROGRAMS IN RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLASTS,
E. Ezen, A. Khmelevskaia, M. Lugar, C. Ospelt
|
|
2026 OP0280
|
POPULATION-SCALE T-CELL RECEPTOR SEQUENCING IN RHEUMATOID ARTHRITIS CONTROLS HLA POLYMORHISM AND IDENTIFIES DISEASE-ASSOCIATED CLONOTYPES,
T. Nishino, T. Arakawa, R. Sasai, K. Asahara, H. Inokuchi, N. Itokawa, M. Yamaguchi, M. Endo, S. Noma, T. Kawashima, H. Hatano, M. Nakano, M. Kono, B. Natsumoto, K. Matsuda, Y. Momozawa, K. Ishigaki
|
|
2026 OP0284
|
SINGLE-CELL TRANSCRIPTOMIC AND PROTEOMIC PROFILING HIGHLIGHTS THE ROLE OF GZMK+ CD8+ T CELLS IN SEVERE VASCULAR BEHÇET’S SYNDROME,
J. Li, S. Jin, T. Liu, Z. Li
|
|
2026 OP0287
|
SINGLE-CELL ANALYSIS REVEALS GLYCOSYLATION-DYSREGULATED NAÏVE B CELLS IN IgA VASCULITIS,
J. C. Batista-Liz, M. Sebastián Mora-Gil, E. Troendle, O. Cappa, M. T. Leonardo Cabello, A. C. Peñalba Citores, L. Martín-Penagos, L. Gabrie, R. Gálvez-Sánchez, J. L. Callejas, D. de Argila, E. Vicente-Rabaneda, S. Castañeda, D. Simpson, R. Blanco, V. Pulito-Cueto, R. López-Mejías
|
|
2026 OP0291
|
ESTRADIOL FACILITATES URATE EXCRETION BY REDUCING GLUT9 EXPRESSION VIA ERΒ/TMEM106B/PI3K/AKT1 PATHWAY IN RENAL TUBULAR EPITHELIAL CELLS,
L. Haijun, X. Zizi, Y. Liu, K. Long, L. Nemin, W. Xiaomin
|
|
2026 OP0305
|
MULTIORGAN SINGLE-CELL PROFILING IDENTIFIES SHARED INTERFERON AND ALTERNATIVE COMPLEMENT ACTIVATION ACROSS TISSUES IN SYSTEMIC SCLEROSIS.,
C. Iperi, C. Geiss, P. Stauffer, A. M. Hoffmann-Vold, O. Distler, C. Ospelt, M. Elhai
|
|
2026 OP0306
|
LONGITUDINAL MULTI-OMIC ANALYSIS OF CD19 CAR-T CELL THERAPY IN SYSTEMIC SCLEROSIS DEMONSTRATES COORDINATED IMMUNE AND STROMAL MODULATION,
H. Yin, Z. Zhao, C. Jia, W. LIN, F. Wu, D. Zhe, X. Liu, L. Lu
|
|
2026 OP0307
|
HUMAN LUNG ORGANOIDS AS A MODEL OF SSc-ILD,
R. Neelagar, X. Hong, H. Qi, Y. Xiao, Y. N. Li, M. Regensburger, F. Marxreiter, T. Filla, A. H. Györfi, J. Adjaye, J. Winkler, J. Distler, A. E. Matei
|
|
2026 OP0309
|
SINGLE-CELL PROFILING IDENTIFIES PDE4B AS A DISEASE-RELEVANT TARGET IN SYSTEMIC SCLEROSIS ACROSS TISSUES AND CELL SUBSETS,
A. Hofman, P. Bearzi, L. Much, M. Asadikorayem, A. Laimbacher, H. Jarnagin, Z. Gong, M. Whitfield, S. Assassi, A. M. Hoffmann-Vold, M. O. Becker, E. Pachera, O. Distler
|
|
2026 OP0326
|
BONE MARROW SINGLE-CELL MULTIOMICS SHEDS LIGHT ON THE ETIOLOGY OF SCHNITZLER SYNDROME,
S. Riescher, Y. Le Bris, E. Douillard, M. Devic, M. Cherkaoui, S. Barbarot, F. Magrangeas, S. Minvielle, E. Letouze, A. Néel
|
|
2026 OP0350
|
NEUROIMAGING SIGNATURES OF RHEUMATOID ARTHRITIS IN THE UK BIOBANK WITH ONGOING MECHANISTIC PROFILING IN A CIA RAT MODEL,
Z. Dai, Y. Duan, X. Yue, G. Chen, S. Qiu
|
|
2026 OP036
|
NETWORK ANALYSIS OF THE SERUM PROTEOME IN A PROSPECTIVE COHORT OF IMMUNE CHECKPOINT INHIBITOR RECIPIENTS HIGHLIGHTS INTERFERON-γ AS A PIVOTAL MEDIATOR OF IMMUNE-RELATED ADVERSE EVENTS,
J. Berry, K. Williams, A. Gault, L. Hogarth, A. Degnan, J. Diboll, I. Wilson, A. E. Anderson, R. Plummer, A. Pratt
|
|
2026 OP037
|
IMMUNE EXHAUSTION PROTECTS AGAINST CHECKPOINT INHIBITOR TOXICITY CAUSED BY ACTIVATION AND MIGRATION OF CYTOTOXIC T-CELLS TO SYNOVIAL TISSUE,
A. K. McLean, A. Thomson, J. D. Turner, K. Williams, A. C. Gault, A. Degnan, J. Berry, L. Hogarth, J. Diboll, I. Nicorescu, L. J. Jones, G. Merces, A. Teodosio, B. Hunter, I. Wilson, A. Bridgewood, L. J. Brown-Schofield, J. Nsengimana, S. Jariwala, Q. An, L. Pallan, B. A. Fisher, J. Coxhead, R. Hussain, M. Magid-Slav, D. McDonald, S. Siebert, A. Filby, A. P. Croft, J. Isaacs, G. Reynolds, R. Plummer, C. Hilkens, D. F. Tough, A. E. Anderson, A. Filer, A. Pratt
|
|
2026 OP038
|
PLASMA PROTEOMIC PROFILE OF RHEUMATOID ARTHRITIS: INSIGHTS INTO SHARED INFLAMMATORY PATHWAYS WITH PSORIATIC ARTHRITIS,
M. Kyriakidi, E. K. Vetsika, G. E. Fragoulis, M. G. Tektonidou, P. P. Sfikakis
|
|
2026 OP043
|
TRANSCRIPTOMIC PROFILES DIFFERENTIATE RESOLVING FROM CHRONIC REACTIVE ARTHRITIS,
A. Agarwal, P. Dhanekula, S. Verma, S. R. Nayak, P. Mruthyunjaya, P. Padhan, A. R. K. Patro, R. Misra, S. Ahmed
|
|
2026 OP047
|
CIRCULATING PROTEOMIC BIOMARKERS PREDICT FLARE DURING BIOLOGIC TAPERING IN RHEUMATOID ARTHRITIS,
L. Lourido, P. Quaranta, V. Calamia, P. Fernández-Puente, R. Paz González, P. Domínguez-Guerrero, V. Balboa-Barreiro, D. Noriega, A. Galindo, B. Acasuso, N. Oreiro, R. Rojo, F. J. Blanco, C. Ruiz-Romero
|
|
2026 OP048
|
EX VIVO IMMUNE-DERIVED MOLECULAR SIGNATURES OF JAK AND TNF INHIBITORS PREDICT TREATMENT RESPONSE IN BIOLOGIC- AND TARGETED SYNTHETIC DMARD-NAÏVE RHEUMATOID ARTHRITIS PATIENTS,
S. Corrales-Díaz Flores, C. Perez-Sanchez, T. Cerdó, R. Ortega-Castro, J. Calvo, M. L. Ladehesa-Pineda, C. Merlo-Ruiz, L. Muñoz-Barrera, I. Sanchez-Pareja, M. C. Ábalos-Aguilera, D. Ruiz-Vilchez, N. Barbarroja, M. Á. Aguirre-Zamorano, B. Malvar-Fernández, S. García, C. Aranda-Valera, M. Alarcon-Riquelme, A. Escudero-Contreras, C. Lopez-Pedrera
|
|
2026 OP096
|
GENOME-WIDE METHYLATION PROFILING IDENTIFIES EPIGENETIC SIGNATURES OF PAIN, FATIGUE, AND HEALTH SCORES IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS,
A. Camponeschi, A. Ravaei, T. Fatima, C. Wincup, A. Rudin, J. Bjersing, C. Maglio
|
|
2026 OP097
|
BASELINE PROTEOMIC PROFILING IDENTIFIES A SUBCLINICAL INFLAMMATORY-ORGAN DAMAGE STATE PRECEDING DISEASE WORSENING IN SYSTEMIC LUPUS ERYTHEMATOSUS,
L. Formanti Alonso, C. Perez-Sanchez, R. Ortega-Castro, I. Gómez-García, P. Seguí Azpilcueta, C. Merlo-Ruiz, M. C. Ábalos-Aguilera, N. Barbarroja, T. Cerdó, A. Escudero-Contreras, M. Á. Aguirre-Zamorano, C. Lopez-Pedrera
|
|
2026 POS0010
|
SINGLE-CELL RNA SEQUENCING OF SKIN TISSUE REVEALS PROMINENT FIBROBLAST–T CELL CROSSTALK IN PRE-STAGES OF SYSTEMIC SCLEROSIS,
L. Li, E. Pachera, R. Dobrota, S. Muraru, K. Buerki, C. Mihai, M. Elhai, L. Much, A. Hofman, P. Bearzi, S. Xu, M. Venables, M. Asadikorayem, P. Stauffer, A. M. Hoffmann-Vold, O. Distler
|
|
2026 POS0011
|
MULTI-OMICS REVEALS A VASCULAR-IMMUNE NICHE CHARACTERIZING REGRESSIVE SKIN FIBROSIS IN SYSTEMIC SCLEROSIS,
A. Hofman, A. Khmelevskaia, P. Bearzi, C. Bruni, L. Much, M. Asadikorayem, B. Burja, L. Li, K. Buerki, M. Elhai, C. Mihai, R. Dobrota, S. Muraru, P. Stauffer, A. M. Hoffmann-Vold, M. O. Becker, E. Pachera, O. Distler
|
|
2026 POS0012
|
SPATIAL TRANSCRIPTOMICS IDENTIFIES PHENOTYPIC SHIFTS IN FIBROBLASTS UPON CD19-CAR T-CELL THERAPY IN SYSTEMIC SCLEROSIS SKIN,
M. Xu, A. Rius Rigau, S. Chenguiti Fakhouri, J. Auth, P. Garantziotis, Z. Liu, M. K. Selvaraju, M. G. Raimondo, C. Tur, T. Filla, F. Müller, A. Wirsching, M. Hagen, P. Gupta, A. Bozec, A. Mackensen, J. Distler, G. Schett, Y. N. Li, C. Bergmann
|
|
2026 POS0013
|
HIGH-DEFINITION SPATIAL TRANSCRIPTOMICS REVEALS ALTERED T CELL STATES AND EPITHELIAL STRESS RESPONSES IN THE SMALL INTESTINE OF SYSTEMIC SCLEROSIS PATIENTS,
L. Much, E. Pachera, H. Fretheim, K. E. Lundin, A. Hofman, Ø. Midtvedt, E. Bækkevold, L. Aabakken, L. Li, P. Stauffer, M. Asadikorayem, S. Xu, B. Burja, M. Scharl, C. Mihai, Ø. Molberg, O. Distler, A. M. Hoffmann-Vold
|
|
2026 POS0014
|
NICHE-SPECIFIC PHENOTYPES OF IMMUNE CELLS IN IMMUNE CELL AGGREGATES IN SYSTEMIC SCLEROSIS SKIN,
D. Bleck, K. Drechsel, T. Filla, Y. N. Li, A. E. Matei, A. H. Györfi, J. Distler
|
|
2026 POS0016
|
SPATIAL PROFILING OF SCLERODERMA RENAL CRISIS REVEALS FIBROTIC REMODELING AND COMPLEMENT ACTIVATION IN THE KIDNEY,
Z. Li, C. Li, L. Zheng, F. Qin, H. Zou, H. Mo, S. Liu, M. Liang
|
|
2026 POS0017
|
DISTINCT HLA RISK LANDSCAPES IN FEMALE AND MALE PATIENTS WITH SYSTEMIC SCLEROSIS,
I. Rodriguez-Martin, M. Kerick, C. Rangel-Peláez, C. Rosa-Baez, G. Borrego-Yaniz, L. Ortiz-Fernández, A. Guillen-Del-Castillo, C. P. Simeón-Aznar, J. L. Callejas, O. Distler, I. S Sc Group, P. Clinical Consortium, S. M. Proudman, M. Nikpour, A. Scleroderma Interest Group (ASIG), N. Hunzelmann, J. K. de Vries-Bouwstra, A. L. Herrick, Y. Allanore, M. Alarcon-Riquelme, L. Beretta, S. Assassi, C. P. Denton, M. D. Mayes, J. Martin, M. Acosta-Herrera
|
|
2026 POS0038
|
THE SINGLE-CELL MULTI-OMIC PROFILING OF PLACENTAL TROPHOBLAST DIFFERENTIATION IN OBSTETRIC ANTIPHOSPHOLIPID SYNDROME,
R. Gao, G. Ma, H. Liu, R. Cai, L. Qin
|
|
2026 POS0082
|
CYTOMETRY BY TIME OF FLIGHT (CyTOF) IDENTIFIES SEXUAL DIMORPHISM IN MONOCYTE POPULATIONS IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHROPATHY (AxSpA),
C. Worth, F. Liu, D. Ahern, A. Chan, F. Penkava, L. Chen, N. Yager, A. Ridley, H. Al Mossawi, P. Bowness
|
|
2026 POS0083
|
PERIPHERAL IMMUNE-CELL SIGNATURES PREDICT CLINICAL RESPONSE IN PSORIATIC ARTHRITIS: INTEGRATED FLOW CYTOMETRY AND SINGLE-CELL RNA SEQUENCING FROM THE COLIPSO COHORT,
S. Gunawardana, L. James, C. Diamond, A. Andersson, J. Li, S. Arocha, M. Attar, H. Al Mossawi, H. Thomaides Brears, L. C. Coates, A. Clarke
|
|
2026 POS0084
|
AXIAL–PERIPHERAL IMMUNE DIVERGENCE AT HUMAN ENTHESEAL SITES REVEALED BY SINGLE-CELL TRANSCRIPTOMICS,
T. Macleod, M. Harland, C. Wong, K. Abacar, Y. Hamid, A. S. Rao, A. Khan, P. Loughenbury, V. Borse, C. MacEachern, A. P. Van den Heuvel, W. Chen, A. Altaie, D. McGonagle
|
|
2026 POS0092
|
DEFINING THE IMMUNOMETABOLIC LANDSCAPE OF HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH) USING INTEGRATED MULTI-OMICS,
A. Oppong, A. Holloway, T. McDonnell, R. Wilson, B. Carpenter, G. Robinson, J. Manson, E. Jury
|
|
2026 POS0097
|
THE POTENTIAL OF ALBUMIN-FUSED IL-10 AS A THERAPEUTIC AGENT FOR MACROPHAGE ACTIVATION SYNDROME,
W. Fujii, H. Sofue, E. Yuba, J. Ishihara, K. Baßler, A. Hasegawa, T. Hiyama, S. Komatsu, K. Nakamura, T. Miyao, A. Tanaka, S. Arai, R. Maezawa, M. Arima, Y. Kawahito, K. Ikeda
|
|
2026 POS0115
|
LOW-LEVEL MYD88 SOMATIC MOSAICISM IN PATIENTS WITH SCHNITZLER SYNDROME,
W. Roosens, A. Betrains, J. Vande Velde, M. Aertgeerts, B. Dewaele, S. Vander Borght, L. Michaux, J. Cools, S. Savic, A. Janssens, S. Vanderschueren, J. Demeulemeester, R. Schrijvers
|
|
2026 POS0130
|
CHIDAMIDE REPROGRAMS THE GATA1-HES1 DYSREGULATION TO RESTORE MEGAKARYOPOIESIS IN SLE-ASSOCIATED IMMUNE THROMBOCYTOPENIA,
Y. Hou, Z. Yang, M. Zhou, X. Tang, X. Feng, L. Sun
|
|
2026 POS0131
|
ULTRASENSITIVE DIGITAL ELISA–BASED INTERFERON PROFILING INTEGRATED WITH LARGE-SCALE PROTEOMICS REVEALS IMMUNE CELL–CYTOKINE/CHEMOKINE DYNAMICS IN SYSTEMIC LUPUS ERYTHEMATOSUS,
T. Abe, T. Itamiya, Y. Tsuchida, H. Tsuchiya, H. Shoda, M. Ota, T. Okamura, K. Fujio
|
|
2026 POS0151
|
A PRE-TRAINED MODEL TRAIN INCORPORATING A MILLION-SCALE MULTI-OMICS DATA MATRIX FOR COMPREHENSIVE RHEUMATOID ARTHRITIS MANAGEMENT,
Y. Zhou, M. Tang, J. Huang, C. Jian, T. Wang, J. Wu, W. Dang, F. Zeng
|
|
2026 POS0172
|
PERIPHERAL BLOOD SINGLE-CELL PROGRAMS MIRROR SYNOVIAL INFLAMMATORY NETWORKS AND TRACK CTLA-4–Ig–MEDIATED MODULATION IN RHEUMATOID ARTHRITIS,
J. R. Wang, H. H. Chen, T. M. Ko
|
|
2026 POS0176
|
UNSUPERVISED MULTI-OMICS ANALYSIS REVEALS DISTINCT MOLECULAR PROGRAMMES ASSOCIATED WITH PROGRESSION TO RHEUMATOID ARTHRITIS IN CCP-POSITIVE AT-RISK INDIVIDUALS,
L. Chang, F. Tariq, A. Azeem, D. Clayton, K. Flack, T. Young, A. Ibbotson, A. Martinez Rodriguez, S. Lara Reyna, A. Aman, E. Cross, L. Duquenne, A. Di Matteo, P. Emery, K. Mankia, S. Savic
|
|
2026 POS0206
|
INTEGRATION OF SYNOVIAL PATHOTYPES AND SERUM PROTEOMIC MODULES REVEALS DIFFERENTIAL CLINICAL PROFILES AND TREATMENT RESPONSE IN EARLY RHEUMATOID ARTHRITIS,
S. Corrales-Díaz Flores, J. Osuna, A. Cid-Chaves, C. Perez-Sanchez, C. Merlo-Ruiz, R. Ortega-Castro, J. Calvo, M. L. Ladehesa-Pineda, D. Ruiz-Vilchez, N. Barbarroja, F. Leiva-Cepas, M. Alarcon-Riquelme, C. Lopez-Pedrera, C. Aranda-Valera, A. Escudero-Contreras
|
|
2026 POS0209
|
DigiTREAT: A DIGITAL TWIN FRAMEWORK FOR RHEUMATOID ARTHRITIS INTEGRATING A MULTICELLULAR AGENT-BASED SYNOVIAL MODEL WITH EXPERIMENTAL AND CLINICAL DATA TO PREDICT RESPONSE TO BIOLOGICS,
E. Mages, S. Bitoun, M. A. Mendoza-Parra, A. Niarakis
|
|
2026 POS0271
|
IL6+ FIBROBLASTS DRIVE THE PATHOLOGICAL REMODELING OF TAKAYASU ARTERITIS VESSELS THROUGH A NON-CANONICAL FGF7–FGFR1 AXIS,
C. Wang, N gao, L. Pan, T. Li
|
|
2026 POS0273
|
GENETIC BIOMARKERS OF CLINICAL MANIFESTATIONS OF GIANT CELL ARTERITIS DEFINE FOUR CLINICALLY-RELEVANT GENETIC SUBGROUPS,
G. Borrego-Yaniz, V. Fuentes-Moreno, L. Ortiz-Fernández, J. Hernández-Rodríguez, S. Mackie, A. Vaglio, S. Castañeda, R. Solans-Laqué, J. Mestre Torres, N. Khalidi, C. Langford, S. R. Ytterberg, L. Beretta, M. Govoni, G. Emmi, M. A. Cimmino, T. Witte, T. Neumann, J. Holle, V. Schönau, G. Pugnet, T. Papo, J. Haroche, A. Mahr, L. Mouthon, Ø. Molberg, A. Diamantopoulos, A. Voskuyl, T. Daikeler, C. Berger, E. Molloy, Y. van Sleen, L. Sorensen, R. Luqmani, S. GCA Group, U. G. Consortium, V. C. Research Consortium, N. Ortego-Centeno, E. Brouwer, P. Lamprecht, S. Klapa, C. Salvarani, P. Merkel, M. C. Cid, M. Iles, M. Á. González-Gay, A. Morgan, J. Martin, A. Márquez
|
|
2026 POS0277
|
RELATIONSHIPS BETWEEN HOST AND GUT MICROBIOME IN BEHÇET’S SYNDROME: RESULTS OF THE BEHCETBIOT MATCHED CASE-CONTROL STUDY.,
M. Joubert, R. Bonnet, G. Kvedaraviciute, E. Billard, N. Tchitchek, B. Bonnet, D. Bouvier, C. Chevarin, H. Lobbes, A. Tournadre, D. Saadoun, M. André
|
|
2026 POS0293
|
DIFFERENTIAL MOLECULAR PROFILES IN PSORIATIC ARTHRITIS: THE POTENTIAL OF METABOLOMICS TO PREDICT TREATMENT OUTCOMES,
M. L. M. Bentvelzen, W. Yang, Y. Zhang, A. Kindt, A. C. Harms, J. Spierings, A. Herman, S. C. Mooij, L. G. Schipper, H. E. Vonkeman, S vreugdenhil, S. C. Mastbergen, T. Hankemeier, P. Welsing
|
|
2026 POS0314
|
PERIPHERAL LYMPHOPENIA IN SJÖGREN’S DISEASE IS DRIVEN BY TYPE I INTERFERON–MEDIATED DISRUPTION OF THE IL-7/IL-7R SIGNALING AXIS,
P. Javorova, E. Zuegner, M. Rados, M. Reisch, C. Magnes, J. Thiel, J. Fessler, M. Stradner
|
|
2026 POS0315
|
MINOR SALIVARY GLAND PROTEOMICS REVEALS DISTINCT CLINICAL AND MOLECULAR SUBGROUPS IN SJÖGREN’S DISEASE,
N. Štucin, M. Brunner, K. P. Pirkmajer, A. Hočevar, J. Pižem, B. Maurer, S. Čučnik, P. Zigon, K. Klein
|
|
2026 POS0318
|
PAROTID TRANSCRIPTOMICS REVEALS MODULATION OF GENE EXPRESSION LINKED TO SALIVARY FUNCTION AND INFLAMMATION IN SJÖGREN’S DISEASE FOLLOWING LEFLUNOMIDE AND HYDROXYCHLOROQUINE COMBINATION TREATMENT,
W. Y. Wong, H. Leavis, C. Bekker, S. Nayar, V. Baloche, J. van Roon
|
|
2026 POS0319
|
CELLULAR AND TRANSCRIPTIONAL DIFFERENCES ACROSS EARLY SJÖGREN’S DISEASE SUBPHENOTYPES,
M. Radziszewski, J. Li, S. Yao, C. Pritchett Frazee, M. M. Wiley, K. L. Tessneer, M. C. Marlin, M. Smith, K. Wei, S. Raychaudhuri, M. Brenner, L. Tsoi, J. E. Gudjonsson, N. Hacohen, U. Deshmukh, S. Kovats, J. A. James, R. H. Scofield, A. Rasmussen, S. Shiboski, B. Khatri, A. Baer, A. D. Farris, C. Shiboski, J. M. Guthridge, B. M. Warner, C. J. Lessard
|
|
2026 POS0320
|
MOLECULAR CHARACTERIZATION OF ANTI-Ro POSITIVE AND NEGATIVE SJÖGREN’S DISEASE WITH SINGLE CELL RNA SEQUENCING OF PERIPHERAL BLOOD,
J. Li, B. Khatri, S. Yao, M. Radziszewski, C. Pritchett Frazee, M. M. Wiley, K. L. Tessneer, C. Lawrence, H. Christakos, C. Lopez-Davis, T. C. Taylor, M. L. Joachims, A. Rasmussen, R. H. Scofield, B. M. Warner, J. A. James, J. M. Guthridge, A. D. Farris, C. J. Lessard
|
|
2026 POS0348
|
SYNOVIAL LINING FIBROBLAST MOLECULAR ENDOTYPES RELATE TO DIVERGENT PHENOTYPES IN RHEUMATOID AND PSORIATIC ARTHRITIS,
S. Law, C. Cohen, S. Snelling, P. Hulley, J. Mimpen
|
|
2026 POS0350
|
DIFFERENTIAL INFLAMMATORY SIGNATURES ACROSS MIS-C, KAWASAKI DISEASE, AND STILL DISEASE.,
T. Pidkova, V. Urrea, R. Pino, M. Vidal, R. Aguilar, G. Moncunill, C. Dobano, B. Clotet, J. Antón, C. Fortuny, J. Blanco, B. Trinité
|
|
2026 POS0353
|
CHARACTERIZATION OF AZD0120, A BCMA/CD19 DUAL-TARGETING AUTOLOGOUS CAR T-CELL THERAPY GENERATED FROM PBMCs OF PATIENTS WITH RHEUMATOLOGIC DISEASE,
R. Ma, F. Eng, N. Ferrari, P. Gavin, N. Hamada, M. Shen, N. Abutaleb, L. Clarke, Y. Ikeda, L. Cao, C. Kuhn
|
|
2026 POS0359
|
CD19 CAR T-CELL THERAPY FOR DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS: LONG-TERM FOLLOW-UP,
X. xu, C. Guo, Z. Chen
|
|
2026 POS0369
|
CHARACTERIZATION OF BLOOD MOLECULAR SIGNATURE OF OSTEOPOROSIS IN SYSTEMIC MASTOCYTOSIS,
Y. Degboé, M. Galindo, L. Basso, M. Zahm, A. Ruyssen-Witrand, B. Razat, N. Gaudenzio, C. Bulai Livideanu
|
|
2026 POS0384
|
A NOVEL PATHOGENIC MECHANISM IN ANTIPHOSPHOLIPID SYNDROME INVOLVING HEPATIC, AUTOIMMUNE AND METABOLIC PATHWAYS,
B. Vellón-García, S. Corrales-Díaz Flores, G. D. García-Delgado, M. Á. Aguirre-Zamorano, I. Sanchez-Pareja, L. Muñoz-Barrera, T. Cerdó, P. Seguí Azpilcueta, C. Merlo, M. D. C. Abalos-Aguilera, N. Barbarroja, R. Ortega-Castro, J. A. González-Reyes, A. Escudero-Contreras, C. Lopez-Pedrera, J. M. Villalba, C. Perez-Sanchez
|
|
2026 POS0388
|
MULTI-OMICS PROFILING REVEALS SELECTIVE CD16+ NK-CELL COLLAPSE AND TNF-DRIVEN APOPTOTIC REWIRING DURING FAMILIAL MEDITERRANEAN FEVER FLARES,
Z. Zhou, M. Veyssiere, O. Ozisik, E. Camenen, K. Laskari, V. Soumelis, T. Henry, I. Koné-Paut, S. Georgin-Lavialle
|
|
2026 POS0393
|
FIBROBLAST ACTIVATION BY IFN-I-PRIMED KERATINOCYTES BRIDGES UVB-INDUCED EPIDERMAL INJURY TO MMP9+ MYELOID CELL RECRUITMENT AND T CELL CYTOTOXICITY IN SKIN LUPUS AND DERMATOMYOSITIS,
K. Afshari, Y. Wang, N. Haddadi, C. Salomão Lopes, C. H. L. Eng, L. M. Whiteman, N. Martinez, P. Kyawe, K. S. Anufrieva, K. Wei, K. Frieda, R. Vleugels, J. Harris, S. Gallucci, M. Garber, M. Rashighi
|
|
2026 POS0394
|
NOVEL GENETIC RISK FACTORS FOR SYSTEMIC SCLEROSIS-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION,
C. Rangel-Peláez, C. Rosa-Baez, I. Rodriguez-Martin, M. Kerick, A. Guillen-Del-Castillo, C. P. Simeón-Aznar, J. L. Callejas, A. Voskuyl, A. Kreuter, O. Distler I. SSc Group, S. M. Proudman, M. Nikpour A. Scleroderma Interest Group (ASIG), N. Hunzelmann, G. Moroncini, A. Gabrielli, J. Distler, J. K. de Vries-Bouwstra, A. L. Herrick, Y. Allanore, L. Beretta, B. Skaug, S. Assassi, C. P. Denton, J. Martin, L. Ortiz-Fernández, M. Acosta-Herrera
|
|
2026 POS0396
|
CHEMOKINE-MEDIATED IMMUNE CELL TRAFFICKING CHARACTERIZES ACTIVE SYSTEMIC SCLEROSIS: INSIGHTS FROM HIGH-DIMENSIONAL IMMUNE PROFILING,
M. Noviani, A. Chia, A. Lajam, P. Kumar, V. R. Chellamuthu, K. Nay Yaung, M. Wasser, J. G. Yeo, J. Behmoaras, E. Petretto, A. Low, S. Albani
|
|
2026 POS0398
|
MICROVASCULOPATHY-RELATED HEMORRHAGIC TISSUE DEPOSITION OF IRON IN THE PATHOGENESIS OF SYSTEMIC SCLEROSIS,
N. Vlachogiannis, A. P. Avdi, A. Galani, K. Verrou, E. Zormpas, S. Panopoulos, V. Poulia, C. Mavragani, M. G. Tektonidou, S. Mavrogeni, L. A. Moulopoulos, P. P. Sfikakis
|
|
2026 POS0400
|
AVACOPAN-TARGET C5AR1 IS INCREASED IN CRESCENTIC GLOMERULI IN ANCA VASCULITIS KIDNEY BIOPSIES,
M. Barkhuizen, K. Schreiter, H. Schebet, B. Tampe, M. Zeisberg, R. Oliveira Vidal, M. Zheng, I. Komarov, B. Seip, J. Schoening, V. Poondi Krishnan, H. Stark, K. Thanamit, P. Skroblin, U. Andag
|
|
2026 POS0577
|
DISTINCT SERUM PROTEOMIC SIGNATURES ASSOCIATED WITH GASTROINTESTINAL SYMPTOM SEVERITY IN SYSTEMIC SCLEROSIS,
A. Makol, T. Guedens, E. Jessen, E. Lesmana, J. Pedelty, M. Breen-Lyles, A. Edwinson, M. Grover
|
|
2026 POS0672
|
SINGLE-CELL AND SPATIAL TRANSCRIPTOMIC PROFILING REVEALS SYSTEMIC AND TISSUE IMMUNE REMODELING IN SLE TREATED WITH ANIFROLUMAB,
I. Martínez-Garcia, P. Nubiola-Rivera, T. Moline, M. Royo, A. D. Ulloa-Navas, B. Ferrer, G. Aparicio, C. Solé-Marcé, J. Cortés-Hernández
|
|
2026 POS0678
|
COMPARISON OF MOLECULAR RESPONSES TO AUTOLOGOUS AND ALLOGENEIC CD19 CAR-T CELL THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS,
E. Maestri, H. McCann, H. Zheng, A. Kerschbaumer, A. Moore, P. J. Utz, P. Khatri
|
|
2026 POS0697
|
PATHWAY-BASED MOLECULAR STRATIFICATION IDENTIFIES PATIENT SUBGROUPS WITH DIFFERENTIAL IN-SILICO RESPONSE RATES TO BIOLOGIC THERAPIES IN SYSTEMIC LUPUS ERYTHEMATOSUS,
A. Brescia Zapata, M. Rivas-Torrubia, P. cytometry consortium, I. Parodis, M. Alarcon-Riquelme, G. Barturen
|
|
2026 POS0748
|
SINGLE‑CELL TRANSCRIPTOMICS, IMMUNE AND METABOLIC PROFILING REVEAL MONOCYTE AND T‑CELL ALTERATIONS IN FAMILIAL MEDITERRANEAN FEVER,
L. Merlo Pich, T. Schlüter, R. Deniz, M. Ozturk, M. Bruno, Y. Negishi, S. S. Ekmekci, N. Abaci, M. Mhlanga, A. Ziogas, L. Joosten, A. Gul, M. Netea
|
|
2026 POS0750
|
MULTI-OMICS STRATIFICATION OF FMF ATTACKS DISTINGUISHES BI-ALLELIC FROM HETEROZYGOUS PATIENTS THROUGH IL-18/S100 BIOMARKERS,
Z. Zhou, M. Veyssiere, O. Ozisik, E. Camenen, K. Laskari, V. Soumelis, T. Henry, I. Koné-Paut, S. Georgin-Lavialle
|
|
2026 POS0752
|
METABOLOMIC ANALYSIS REVEALED CHARACTERISTIC INFLAMMATORY AND NON-INFLAMMATORY PAIN SIGNATURES IN INFLAMMATORY ARTHRITIS,
L. Gunkl-Tóth, N. Szentes, V. Tékus, B. Fülöp, É. Borbély, Á. Horváth, K. Takács-Lovász, J. Kun, G. Karvaly, R. Farkas, G. Nagy, Z. Helyes
|
|
2026 POS0754
|
LONGITUDINAL SERUM PROTEOMICS REVEALS COMPLEMENT PATHWAY DIVERSITY IN RHEUMATOID ARTHRITIS,
B. Marchand, N. Carrier, E. Beaulieu, D. Lévesque, B. Ramanathan, F. M. Boisvert, S. Roux, J. Marrugo, G. Boire, H. Allard-Chamard
|
|
2026 POS0759
|
FLIPPING THE SWITCH: COMPLEMENT ACTIVATION IN STILL’S DISEASE,
F. Huijsmans, A. Bodelón de Frutos, G. Rogani, L. Siebers, J. F. Swart, S. Benseler, R. Yeung, S. Vastert, J. van Loosdregt
|
|
2026 POS0771
|
BEYOND NLRP3: EXPANDING THE SPECTRUM OF NLR-ASSOCIATED AUTOINFLAMMATORY DISEASES,
R. Deniz, C. Tansu Yavuz, A. Aydin Gümüş, L. Yilmaz Çelik, P. Ercoşkun, A. Gul, C. Bes
|
|
2026 POS0772
|
CLINICAL AND PHENOTYPIC DIFFERENCES BETWEEN MEFV-POSITIVE AND MEFV-NEGATIVE FAMILIAL MEDITERRANEAN FEVER: ARE THEY REALLY THE SAME?,
R. Deniz, H. K. Yerisenoglu Demir, M. Günaydin, A. Gül, C. Bes
|
|
2026 POS0827
|
DISENTANGLING CAUSALITY AND PLEIOTROPY BETWEEN OSTEOPOROSIS AND ANKYLOSING SPONDYLITIS USING GENOME-WIDE GENETIC ANALYSES,
S. S. Zhao, N. Harvey, B. Nam, Z. Li, L. A. Bradbury, L. S. Gensler, P. B. Wordsworth, M. Ward, M. H. Weisman, T. Learch, J. D. Reveille, T. H. Kim, M. Brown
|
|
2026 POS0833
|
CIRCULATING IL-17A ACCUMULATION REFLECTS EFFECTIVE TARGET BLOCKADE WITH SECUKINUMAB IN SPONDYLOARTHRITIS,
A. Llamas Urbano, J. M. Martínez-Moreno, L. Romero Zurita, Y. Hanaee, A. Escudero-Contreras, P. Blake, K. Rawson, J. J. Silva Torres, E. Collantes-Estevez, N. Barbarroja, C. López-Medina, C. Perez-Sanchez
|
|
2026 POS0835
|
LOW-DOSE INTERLEUKIN-2 PROMOTES REGULATORY T CELL ACTIVITY AND MONOCYTES ANTI-INFLAMMATORY REPROGRAMMING IN SYSTEMIC LUPUS ERYTHEMATOSUS,
M. X. Liu, T. Gao, Y. X. Wang, C. Wang, J. Luo, S. X. Zhang
|
|
2026 POS0888
|
IDENTIFICATION OF SEX-DIFFERENTIATED CLINICAL-MOLECULAR CARDIOVASCULAR RISK SIGNATURES IN RHEUMATOID ARTHRITIS PATIENTS,
T. Cerdó, C. Perez-Sanchez, R. Ortega-Castro, C. Aranda-Valera, J. Calvo-Gutiérrez, P. Seguí Azpilcueta, L. Formanti Alonso, C. Merlo-Ruiz, M. C. Ábalos-Aguilera, N. Barbarroja, M. Vinaixa, M. Rojas Torres, N. Amigó, C. Molina Lopez, J. Marrugat, I. Pineda-Torra, A. Escudero-Contreras, C. Lopez-Pedrera
|
|
2026 POS0889
|
LARGE-SCALE MULTICOHORT BLOOD TRANSCRIPTOMIC ANALYSIS IDENTIFIES A DIAGNOSTIC RHEUMATOID ARTHRITIS SIGNATURE ASSOCIATED WITH DISEASE ACTIVITY,
A. Kerschbaumer, A. Moore, E. Maestri, H. McCann, A. Ganesan, H. Zheng, W. Robinson, P. Khatri
|
|
2026 POS0893
|
THE USE OF ARTIFICIAL INTELLIGENCE IN RHEUMATOID ARTHRITIS DIAGNOSIS: A SCOPING REVIEW,
M. Moreira, M. Pacheco, D. Geada, N. Delgado, A. F. Águeda, M. Guerra, J. Rodrigues, R. Pinheiro Torres, M. Oliveira
|
|
2026 POS0895
|
INTEGRATED LIPIDOMIC, PROTEOMIC AND HEPATIC FUNCTIONAL PROFILING REVEALS A REVERSIBLE INFLAMMATORY-METABOLIC AXIS IN RHEUMATOID ARTHRITIS,
L. Muñoz-Barrera, C. Perez-Sanchez, R. Ortega-Castro, S. Corrales-Díaz Flores, T. Cerdó, J. Calvo, M. C. Ábalos-Aguilera, D. Ruiz-Vilchez, P. Seguí Azpilcueta, C. Merlo-Ruiz, J. J. Pérez Venegas, D. Ruiz-Montesino, C. M. Romero-Barco, A. Fernández-Nebro, N. Mena-Vázquez, F. J. Godoy Navarrete, A. M. Cabezas Lucena, N. Barbarroja, A. Escudero-Contreras, C. Lopez-Pedrera
|
|
2026 POS0898
|
TARGETING NAD+ METABOLISM IN INFLAMMATORY RHEUMATIC DISEASES: IMPACT OF ANTI-TNF THERAPY AND NAD+ SUPPLEMENTATION,
B. Vellón-García, A. Escudero-Contreras, G. D. García-Delgado, A. Llamas-Urbano, Y. Hanaee, P. Ortiz-Buitrago, C. Merlo, L. Romero-Zurita, M. D. C. Abalos-Aguilera, D. Ruiz-Vilchez, M. Á. Puche-Larrubia, I. Arias-de la Rosa, M. D. López Montilla, E. Collantes-Estevez, C. Aranda-Valera, I. Gómez-García, R. Ortega-Castro, J. Calvo-Gutiérrez, M. L. Ladehesa-Pineda, C. López-Medina, N. Barbarroja, C. Lopez-Pedrera, J. M. Villalba, C. Perez-Sanchez
|
|
2026 POS0908
|
MONOCYTE EPIGENETIC SIGNATURE IN SARCOIDOSIS,
M. Robert, N. Yatim, S. Culina, T. Dott, V. Saint-Andre, S. Schmutz, E. Villain, R. Borie, T. Goulenok, P. A. Juge, A. Mageau, N. Peiffer Smadja, N. Charles, D. Duffy, K. Sacre
|
|
2026 POS0954
|
PERIPHERAL BLOOD TRANSCRIPTOMICS REVEALS INTERFERON-DRIVEN INNATE IMMUNE NETWORKS DISTINGUISHING MDA5-POSITIVE DERMATOMYOSITIS WITHIN IDIOPATHIC INFLAMMATORY MYOPATHIES AND INFORMING RATIONAL THERAPEUTIC TARGETING,
Y. Koyama, Y. Sato, Y. Nakai, Y. Nishiura, K. Shidahara
|
|
2026 POS0956
|
ENHANCED FIBROGENIC PATHWAYS DEFINE SCLEROMYOSITIS WITHIN THE SPECTRUM OF ACR/EULAR MYOSITIS SUBSETS,
M. Giannini, G. Quiring, B. Ellezam, Y. Troyanov, L. Debrut, V. Gilbart, B. Geny, G. Laverny, M. Hudson, O. Landon-Cardinal, A. Meyer
|
|
2026 POS0958
|
NOVEL CANDIDATE BIOMARKERS FOR MONITORING RESPONSE TO JAKi TREATMENT IN IDIOPATHIC INFLAMMATORY MYOPATHY,
L. Tomlinson, S. Sugden, N. Scott, G. I. Rice, M. Christofi, A. Oldroyd, A. Krishan, J. Lilleker, Y. Sylvestre Garcia, A. Snedden, P. Gordon, A. Prabu, S. Tansley, A. Aslam, N. Haupt, H. Alexanderson, I. E. Lundberg, F. McMorrow, H. Chinoy, J. Lamb
|
|
2026 POS0959
|
SPATIAL PROTEOMIC-BASED PHENOTYPING OF MUSCLE STEM CELLS REVEALS HETEROGENEITY OF MUSCLE STEM CELL NICHES AND PERTURBATIONS IN THEIR CELLULAR INTERACTION NETWORKS IN IMMUNE MEDIATED INFLAMMATORY MYOPATHIES,
B. S. Tumerdem, Y. N. Li, T. Filla, R. Schroeder, A. Brunn, A. Micu, A. Stütz, L. M. Lahu, A. Rius Rigau, C. Bergmann, A. E. Matei, J. Distler, A. H. Györfi
|
|
2026 POS0960
|
A MITOCHONDRIAL GENE SIGNATURE TO STRATIFY JUVENILE DERMATOMYOSITIS PATIENT GROUPS FOR MORE TARGETED TREATMENT,
M. Wilkinson, A. E. Syntakas, N. Evans, R. Restuadi, H. Nguyen, M. Kartawinata, D. Cancemi, V. Alexiou, L. Marshall, B. Jebson, E. Ralph, H. Peckham, A. Radziszewska, N. de Gruijter, W. Y. Lin, G. Otto, G. Hall, D. Kelberman, S. Castellano, C. Ciurtin, S. Eaton, C. Deakin, E. Rosser, C. Wallace, L. Wedderburn
|
|
2026 POS0961
|
SPATIAL MAPPING OF DYSREGULATED INTERFERON AND MITOCHONDRIAL PATHWAYS IN JUVENILE DERMATOMYOSITIS MUSCLE TISSUE,
A. E. Syntakas, Y. E. Sanchez-Corrales, T. Xenakis, H. D. Nguyen, C. Papadopoulou, M. Al-Obaidi, C. Pilkington, O. Ogunbiyi, A. Merve, L. Wedderburn, M. Wilkinson
|
|
2026 POS0966
|
SYNOVIAL TISSUE HETEROGENEITY IN RHEUMATOID ARTHRITIS: FROM HISTOLOGICAL PATHOTYPES TO SPATIAL TRANSCRIPTOMICS,
A. Terrett, A. Small, S. W. Wong, C. Altmann, A. McIntyre, K. Bhamidipati, G. Ce, W. Suwakulsiri, M. Smith, S. M. Proudman, K. Wei, R. Thomas, M. D. Wechalekar
|
|
2026 POS0969
|
CAUSAL NETWORKS OFFER INSIGHTS INTO PATHOBIOLOGICAL PATHWAYS TO FLARE IN RHEUMATOID ARTHRITIS: ANALYSIS OF THE BIOLOGICAL FACTORS THAT LIMIT SUSTAINED REMISSION (BIO-FLARE) STUDY,
K. Patasova, J. Sim, G. Smith, F. Rayner, N. Naamane, B. Dyke, A. Melville, S. Kerrigan, A. McGucken, C. D. Buckley, A. Filer, I. B. McInnes, K. Raza, S. Siebert, W. F. Ng, K. F. Baker, A. E. Anderson, J. Isaacs, H. Cordell, A. Pratt
|
|
2026 POS0974
|
MULTI-ANCESTRY GENOME-WIDE ASSOCIATION ANALYSIS OF SJÖGREN’S DISEASE IDENTIFIES NOVEL RISK LOCI,
M. Radziszewski, B. Khatri, P. E. Stuart, A. Rasmussen, K. L. Tessneer, C. Pritchett Frazee, M. T. Patrick, E. Pontarini, M. Bombardieri, M. Rischmueller, M. Kvarnström, T. Witte, H. Bootsma, G. M. Verstappen, F. G. M. Kroese, A. Vissink, S. Pringle, A. Tzioufas, C. Mavragani, A. Baer, M. Alarcon-Riquelme, J. Martin, X. Mariette, G. Nocturne, J. O. Pers, J. E. Gottenberg, W. F. Ng, E. Abner, K. Batool, B. A. Fisher, R. Gordon, G. Hernandez-Molina, A. Y. S. Lee, C. Shiboski, K. E. Taylor, L. Criswell, B. M. Warner, A. D. Farris, J. A. James, R. H. Scofield, J. M. Guthridge, D. J. Wallace M.D., S. Venuturupali, M. T. Brennan, J. Imgenberg-Kreuz, L. Ronnblom, E. Baecklund, M. L. Eloranta, S. J. A. Johnsen, R. Omdal, L. A. Aqrawi, Ø. Palm, J. G. Brun, D. Hammenfors, M. V. Jonsson, S. Appel, S. M. Bucher, H. Forsblad-d’Elia, T. Mandl, P. Eriksson, M. Wahren-Herlenius, J. E. Gudjonsson, L. Tsoi, G. Nordmark, C. J. Lessard
|
|
2026 POS0976
|
SPATIAL TRANSCRIPTOMICS REVEALS GLANDULAR CELL INVOLVMENT IN THE PATHOPHYSIOLOGY OF SJÖGREN’S DISEASE,
S. Yao, M. Radziszewski, J. Li, C. Pritchett Frazee, M. M. Wiley, K. L. Tessneer, M. C. Marlin, M. Smith, K. Wei, S. Raychaudhuri, M. Brenner, L. Tsoi, J. E. Gudjonsson, N. Hacohen, J. A. James, R. H. Scofield, A. Rasmussen, S. Shiboski, B. Khatri, A. Baer, A. D. Farris, C. Shiboski, J. M. Guthridge, B. M. Warner, C. J. Lessard
|
|
2026 POS0979
|
GTPASE-DEPENDENT RNA DECAPPING DRIVES PERSISTENT INFLAMMATION AND RELAPSE SUSCEPTIBILITY IN GIANT CELL ARTERITIS,
R. Gheitasi, S. M. Petzinna, C. J. Bauer, M. Zahmatkesh, V. S. Schäfer
|
|
2026 POS0982
|
SAME, SAME, BUT DIFFERENT - ANCA-ASSOCIATED AND LARGE VESSEL VASCULITIS TRANSCRIPTOMES IN WHOLE BLOOD,
J. Amsler, M. Kreuzer, L. Petelytska, O. Iaremenko, L. Christ, M. Gasser, F. Ryser, A. C. Sarbu, L. Seitz, P. M. Seitz, B. Maurer, K. Klein
|
|
2026 POS0991
|
IDENTIFICATION OF CLONALLY EXPANDED CYTOMEGALOVIRUS-SPECIFIC EFFECTOR MEMORY GZMK+ CD8 T CELLS IN ANCA-ASSOCIATED VASCULITIS,
L. S. van Dam, M. Zhang, J. S. Moon, S. Moutusy, F. Held, S. Parsafar, A. Horomanski, O. Sharpe, J. R van Leeuwen, T. Lanz, C van Kooten, Y. K. O. Teng, W. Robinson
|
|
2026 POS0992
|
EARLY POST-TREATMENT INTERFERON RESPONSES LINKED TO DENDRITIC CELL ACTIVATION ARE ASSOCIATED WITH REDUCED RELAPSE IN ANCA-ASSOCIATED VASCULITIS,
S. Sumitomo, H. Oka, T. Iwasaki, K. Ohmura
|
|
2026 POS1110
|
A MASKED AND TGFβRIII-BIASED αCD3-TGF-β FUSION PROTEIN PROMOTES REGULATORY T CELL INDUCTION AND IMMUNE TOLERANCE,
Y. Kong, P. Chen, G. Lin, X. Chen, J. Mei, B. Hou
|
|
2026 POS1124
|
CNS DISEASES CEREBROSPINAL FLUID SINGLE-CELL ATLAS REVEALS IMMUNE CHARACTERISTICS OF NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS,
X. Wang, S. Zhang, S. Fan, W. Zhang, W. Fang, T. Ma, N. Liang, Y. Wu, S. Yang, C. Xia, Z. Zhao, D. Xu, X. Zeng, J. Zhao, H. Guan, Y. Ding, G. Gao, M. Li
|
|
2026 POS1125
|
CEBPA-DRIVEN ABNORMAL EXPANSION OF BONE MARROW AUTOREACTIVE CD11C+ PRO-B CELLS IN SYSTEMIC LUPUS ERYTHEMATOSUS,
Z. Yang, Y. Hou, X. Tang, X. Feng
|
|
2026 POS1129
|
POLYGENIC BURDEN OF LUPUS ENHANCES TYPE I INTERFERON SIGNALING IN HEALTHY INDIVIDUALS,
H. Inokuchi, M. Nakano, K. Asahara, T. Arakawa, T. Kawashima, N. Takahiro, H. Takahashi, H. Hatano, M. Kono, B. Natsumoto, Y. Kaneko, K. Ishigaki
|
|
2026 POS1132
|
SAFETY, EFFICACY, AND MOLECULAR MECHANISM OF CD3×CD19 T-CELL-ENGAGER THERAPY IN ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: A PHASE I INVESTIGATOR INITIATED TRIAL,
J. Xu, C. Mei, X. Guan, R. Du, B. Wu, D. Wu, M. Li, J. Li, Y. Song, X. Chen, T. R. Katsumoto, X. Yan, E. Meffre, J. Sussman, Q. Guo, H. Chen, V. Kennedy, A. Huang, M. Baker, Q. Li
|
|
2026 POS1133
|
HIGH-THROUGHPUT PROTEOMIC PROFILING REVEALS IL12B AS A DIAGNOSTIC BIOMARKER IN SYSTEMIC LUPUS ERYTHEMATOSUS,
C. Perez-Sanchez, M. Á. Aguirre-Zamorano, T. Cerdó, C. Merlo-Ruiz, L. Formanti Alonso, A. Llamas Urbano, N. Barbarroja, M. L. Ladehesa-Pineda, R. Ortega-Castro, A. Escudero-Contreras, C. Lopez-Pedrera
|
|
2026 POS1136
|
EXPLORING BONE MARROW B CELL RESETTING AFTER CD19/BCMA CART THERAPY IN REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS,
X. Zhang, Z. Zhu, C. Wu, T. Li, Y. Fu, S. Ye, Q. Fu
|
|
2026 POS1143
|
PIRFENIDONE INHIBITS RENAL FIBROSIS IN MURINE LUPUS NEPHRITIS VIA DOWNREGULATING MXRA7: A POTENTIAL THERAPEUTIC STRATEGY,
X. Li, J. Bao, H. Wu, Y. Fan
|
|
2026 POS1148
|
INTEGRATED SPATIAL TRANSCRIPTOMICS AND PROTEOMICS REVEALS ABERRANT LYMPHOID NETWORKS AND STROMAL DAMAGE PATTERNS IN PEDIATRICS LUPUS NEPHRITIS,
N. Hasle, R. C. Reed, G. Schultz, M. Conner, R. Martin, S. W. Jackson
|
|
2026 POS1206
|
COMMON PROTEOMIC BIOMARKERS ASSOCIATED WITH SYSTEMIC SCLEROSIS AND DISTINCT CARDIAC PHENOTYPES,
S. Scholfield, A. I. Mohammed, R. B. Dumitru, F. Del Galdo, L. A. Bissell, R. Shukla, S. Plein, M. Buch
|
|
2026 POS1306
|
PD-L1 RELATED MECHANISMS DISTINGUISH CD4+ T CELLS IN THE PRE-CLINICAL AND EARLY STAGES OF RHEUMATOID ARTHRITIS,
V. Chandrasekaran, M. Erlandsson, R. Modigh, R. Pullerits, M. I. Bokarewa
|
|
|
[161]
|
Adaptive immunity
|
|
|
| 2026 |
|
2026 AB0005
|
DISTINCT IMMUNE PROFILES AFTER IN VITRO AND IN VIVO TREATMENT WITH LLL12B, A PRE-CLINICAL SMALL MOLECULE STAT3 INHIBITOR, IN INFLAMMATORY MYOSITIS, LUPUS, AND HEALTHY CONTROLS,
S. Coss, S. Bruckner, W. Jarjour
|
|
2026 AB0009
|
PRECLINICAL DEVELOPMENT OF A mRNA-ENCODED TRISPECIFIC T CELL ENGAGER FOR PROFOUND B CELL DEPLETION AND IMMUNE RESETTING IN AUTOIMMUNITY,
B. Cao, B. Zhang, S. Yao, Q. Zhang, S. Zhou, L. Zhang, L. Li, C. Ni, J. Zhang, Y. Zhou, X. Ma, X. Zhang, H. Han, W. Xu
|
|
2026 AB0010
|
EVALUATION OF THE POTENT AND SELECTIVE DIHYDROOROTATE DEHYDROGENASE INHIBITOR PTC844 FOR USE IN IMMUNE-MEDIATED DISEASES,
M. Weetall, J. Sheedy, A. Mollin, N. Risher, L. Lee, J. Narasimhan, M. Ma, C. Delagrange, J. Karafilidis, A. Tansy, G. Bernstein, M. Johnston
|
|
2026 AB0012
|
IMPACT OF HLA EVOLUTIONARY DIVERGENCE ON PEPTIDE PRESENTATION AND PATHOGEN MIMICRY IN THE PATHOGENESIS OF SLE,
R. Domínguez Rodríguez, E. Carnero-Montoro, P. Cytometry Consortium, R. Díaz Peña, M. Alarcon-Riquelme, G. Barturen
|
|
2026 AB0016
|
DISTINCT V-DOMAIN IG SUPPRESSOR OF T CELL ACTIVATION (VISTA) EXPRESSION PROFILES ACROSS INFLAMMATORY RHEUMATIC MUSCULOSKELETAL DISEASES: IMPLICATIONS FOR IMMUNE REGULATION AND BIOMARKER POTENTIAL,
I. Roman, B. Lalazi, S. Tsiami, U. Kiltz, L. Ney, X. Baraliakos, C. Schütz
|
|
2026 AB0030
|
IMPACT OF IMMUNOSUPPRESSIVE STRATEGIES AND UBA1 MUTATION GENOTYPES ON DISTRIBUTION AND TRANSCRIPTIONAL LANDSCAPE OF HEMATOPOIETIC CELLS IN VEXAS SYNDROME,
C. Campochiaro, M. Fiumara, L. Alessandrini, G. Bergonzi, E. Cozzo, A. Tomelleri, E. Diral, P. Quaranta, L. Bassoricci, R. Molteni, S. Cenci, A. Aiuti, F. Ciceri, L. Dagna, M. Matucci-Cerinic, S. Scala, L. Naldini, S. Ferrari
|
|
2026 AB0054
|
HISTIDYL-tRNA SYNTHETASE-INDUCED MYOSITIS IS MEDIATED BY MEMBRANOPATHY AND AMELIORATED BY REGULATORY T CELLS,
S. Coss, N. Young, S. Bruckner, B. Zeno, G. Giarrano, H. Bulgart, P. Clemens, J. Paul, C. V. Oddis, N. Weisleder, D. Ascherman, W. Jarjour
|
|
2026 AB0061
|
RECOVERY OF THE TH1 CELL POPULATION IS ASSOCIATED WITH CLINICAL REMISSION OF JUVENILE DERMATOMYOSITIS,
N. Evans, L. Marshall, A. E. Syntakas, B. Jebson, V. Alexiou, M. Kartawinata, C. Ciurtin, A. Radziszewska, H. Peckham, C. Deakin, E. Rosser, M. Wilkinson, L. Wedderburn
|
|
2026 AB0063
|
AN EXTRAFOLLICULAR RESPONSE CHARACTERIZES PATIENTS WITH OLIGOARTICULAR AND POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS AT DISEASE ONSET,
E. Marasco, A. Ariolli, N. De Franco, A. Aquilani, G. Tarantino, M. I. Petrone, R. Nicolai, I. Caiello, S. Magni-Manzoni, F. De Benedetti
|
|
2026 AB0086
|
PERIPHERAL B-CELL IMMUNOPHENOTYPING IDENTIFIES TREATMENT-NAIVE PSORIATIC ARTHRITIS PATIENTS WITH DIFFERENTIAL LIKELIHOOD OF EARLY CLINICAL RESPONSE,
D. Bruno, B. Tolusso, S. Perniola, D. Campobasso, C. Di Mario, S. Alivernini, E. Gremese
|
|
2026 AB0090
|
SELECTIVE IMMUNE REMODELING AND IMMUNOMETABOLIC REPROGRAMMING FOLLOWING ANTI-INTERLEUKIN-17 THERAPY REVEAL A DYSREGULATED INFLAMMATORY RESOLUTION PATHWAY IN PSORIATIC ARTHRITIS,
A Sherri, J. Makowska, J. Sarnik, N. Stocker, A. Lewandowska-Polak, M. Sokolowska
|
|
2026 AB0093
|
IL-17 MEDIATED HOST-GUT MICROBIOTA INTERACTIONS IN PSORIATIC ARTHRITIS,
W. Liu
|
|
2026 AB0103
|
TOLERANCE INDUCTION IN ARTHRITIS BY PLANT-MADE NANOPARTICLES DISPLAYING AN IMMUNODOMINANT PEPTIDE,
L. Avesani, N. Sofat, A. Rosa, A. Raneri, D. Pivotto, R. Zampieri, J. Butler, M. Campolo, E. Esposito
|
|
2026 AB0113
|
FUNCTIONAL PROFILING OF IL-6-DRIVEN JAK-STAT SIGNALLING AS A BASIS FOR PERSONALISED THERAPY IN RHEUMATOID ARTHRITIS,
D. Nagy, B. Horváth, L. Gunkl-Tóth, D. Nemeth, P. Királyhidi, G. Turu, T. Németh, G. Nagy
|
|
2026 AB0117
|
THE EFFICACY OF ABATACEPT IS ASSOCIATED WITH A DECREASE IN CIRCULATING T FOLLICULAR HELPER CELLS IN PATIENTS WITH RHEUMATOID ARTHRITIS,
C. Liaskos, A. Mavropoulos, C. Katsiari, I. Alexiou, D. Bogdanos, L. Sakkas
|
|
2026 AB0118
|
CROSS-REACTIVE GERMLINE-ENCODED B CELL RECEPTORS AS A POTENTIAL SOURCE OF AUTOIMMUNITY IN RHEUMATOID ARTHRITIS,
A. Athanasiadou, S. Kroos, R. van de Wetering, S. Rantapää Dahlqvist, L. Slot, R. Toes, D. van der Woude
|
|
2026 AB0121
|
HIGH DIETARY TRYPTOPHAN RESTORES IMMUNE HOMEOSTASIS AND AMELIORATES ARTHRITIS,
R. Wu, B. Li, X. Zi, C. Wang
|
|
2026 AB0122
|
SYNOVIAL MOLECULAR SIGNATURES AND CLINICAL TRAJECTORIES IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS DEFINE LONG-TERM DISEASE CONTROL AND BIOLOGIC-FREE SURVIVAL AT 5 YEARS.,
F. S. Iaquinta, B. Monosi, S. Kostich, J. Perera, A. Nerviani, C. Pitzalis, F. Rivellese
|
|
2026 AB0124
|
CYTOKINE PROFILES AND SINGLE-CELL TRANSCRIPTOMIC ANALYSIS OF SYNOVIAL FLUID: CHARACTERIZATION AND STRATIFICATION OF RHEUMATOID ARTHRITIS,
M. Lesturgie Talarek, F. Carbone, V. Gonzalez, A. Schvartz, S. Hecquet, F. Oudart, M. Thomas, R. D’Alessandro, Y. Allanore, M. Ménager, J. Avouac
|
|
2026 AB0126
|
CITRULLINATING PAD ENZYMES ARE PRESENT IN MULTIPLE BACTERIA,
A. G van Mourik, R. Carter, V. Derksen, P. Hensbergen, R. Toes, W. K. Smits, D. Mitchell, D van der Woude
|
|
2026 AB0147
|
IMMUNOGENICITY AND SAFETY OF RECOMBINANT ZOSTER VACCINE IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING UPADACITINIB: A PROSPECTIVE, PARALLEL TRIPLE-ARM STUDY (END ZOSTER-J),
R. Watanabe, T. Okano, S. Yamada, R. Kawai, H. Yoshida, H. Fujii, Y. Furusawa, R. Ishihara, M. Katsushima, K. Fukumoto, Y. Yamada, K. Mamoto, M. Hashimoto
|
|
2026 AB0149
|
CLINICALLY RELEVANT MEMORY B-CELL SUBSETS IN EARLY RHEUMATOID ARTHRITIS,
I. Gjertsson, P. Haase, K. Grimstad, S. McGrath, M. Leu Agelii, C. Jonsson, A. K. H. Ekwall, I. L. Mårtensson
|
|
2026 AB0153
|
MULTI-OMICS INTEGRATION STUDY OF SYSTEMIC LUPUS ERYTHEMATOSUS REVEALS MICROBIOTA- AND METABOLITE-DRIVEN IMMUNE DYSREGULATION,
C. Li, P. F. He
|
|
2026 AB0163
|
BIODISTRIBUTION OF RHEUMATOID ARTHRITIS PATIENT-DERIVED ANTI-CITRULLINATED PROTEIN ANTIBODIES AT STEADY STATE AND DURING ARTHRITIS IN MICE,
M. Gomes Afonso, J. Sun, M. Filipovic, T. A. Tran, L. Lu, R. Stålesen, L. Klareskog, V. Malmström, B. Réthi
|
|
2026 AB0166
|
GRANZYME K DEFINES A DISTINCT CYTOTOXIC CD4 T CELL STATE WITH ALTERED DIFFERENTIATION IN RHEUMATOID ARTHRITIS,
P. Nguyen, J. Wiegand, L. Braune, F. Beck, T. Hagemann, K. Rothe, U. Wagner
|
|
2026 AB0167
|
BASELINE INTERFERON AND JAK-STAT TRANSCRIPTOMIC SIGNATURES ASSOCIATED WITH RHEUMATOID ARTHRITIS FLARE AFTER RECOMBINANT ZOSTER VACCINATION: ANCILLARY STUDY OF THE END ZOSTER-J STUDY,
R. Ishihara, R. Watanabe, T. Okano, S. Yamada, T. Iwasaki, Y. Furusawa, M. Katsushima, K. Fukumoto, Y. Yamada, K. Mamoto, M. Hashimoto
|
|
2026 AB0173
|
DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS IS CHARACTERIZED BY ACTIVE SYNOVITIS WITH DISTINCT INNATE AND ADAPTIVE IMMUNE SIGNATURES INDICATIVE OF TRUE BIOLOGICAL REFRACTORINESS,
G. Frazzei, F. S. Iaquinta, F. Abatecola, L. Fossati-Jimack, C. Pitzalis, F. Rivellese
|
|
2026 AB0182
|
HUMORAL RESPONSES AGAINST HDL ARE LINKED TO UNFAVORABLE LIPOPROTEIN, LIPID, AND PROTEOMIC SIGNATURES IN SJÖGREN DISEASE – A MULTI-PLATFORM APPROACH,
S. Suárez, D. Miranda-Prieto, P. López, A. Alunno, Á. I. Pérez-Álvarez, N. Amigó, A. Martínez-Zapico, A. Suárez, J. Rodríguez-Carrio
|
|
2026 AB0188
|
SALIVARY GLAND ANTIBODY-SECRETING CELLS ARE LESS ABUNDANT BUT MORE MATURE IN SJÖGREN’S DISEASE PATIENTS WITH EPITHELIAL HYPERPLASIA AND SEVERE LYMPHOEPITHELIAL LESIONS,
S. C. Liefers, M. S. van Ginkel, G. M. Verstappen, D. Cornec, P. Hémon, H. J. Buikema, S. Pringle, A. Uguen, H. Bootsma, B. van der Vegt, F. G. M. Kroese, T. D. Steinmetz
|
|
2026 AB0189
|
EPITHELIAL–B CELL CROSSTALK MEDIATED BY THE MIF-CD74 AXIS DRIVES B CELL INFILTRATION IN SJÖGREN’S DISEASE,
Y. Zhou, Z. Tan, X. Yuan, X. Sun, N. Xiang, Z. Zhou, Y. Li, L. Wang, X. Li
|
|
2026 AB0198
|
DECIPHERING THE ROLE OF RUNX3 IN HUMAN γδ CELLS,
M. Melchior, D. Venturoli, E. Donckier De Donceel, A. Pedron, M. Nguyen, S. Thomas, V. Acolty, A. Azouz, F. Szymczak, A. Detavernier, K. Venken, D. Elewaut, S. Goriely
|
|
2026 AB0201
|
ASSOCIATION OF GUT-DERIVED SHORT-CHAIN FATTY ACIDS AND SECRETORY IgA WITH DISEASE ACTIVITY IN SPONDYLOARTHRITIS,
C. Romero-Sánchez, A. Ramos-Casallas, J. M. Bello-Gualtero, L. Parra, W. Bautista-Molano, J. De Avila
|
|
2026 AB0204
|
DYNAMICS OF INTERLEUKIN-23/INTERLEUKIN-17 AXIS AND TYPE 1 REGULATORY T CELLS ACROSS DISEASE STAGES IN AXIAL SPONDYLOARTHRITIS,
J. Yeo, M. G. Kim, S. Y. Heo, Y. Yang, K. A. Lee, H. J. Choi, Y. Jung, E. Y. Lee, H. J. Baek
|
|
2026 AB0209
|
MESENCHYMAL STROMAL CELLS RESTORE IMMUNE TOLERANCE THROUGH SUPPRESSION OF MONOCYTE-DERIVED GITRL-DEPENDENT T CELL DYSREGULATION IN LUPUS,
L. Sun, C. Xu, W. Chen
|
|
2026 AB0220
|
FUNCTIONAL AND MOLECULAR CHARACTERIZATION OF CD72-CD95+B CELLS ASSOCIATED WITH DISEASE ACTIVITY AND NEPHRITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS,
K. Wangriatisak, S. Ghannoum, W. Huang, M. Nakazawa, G. Sechi, S. Zachari, C. Grönwall, K. Chemin, I. Gunnarsson, V. Malmström, F. Faustini
|
|
2026 AB0221
|
GUT DYSBIOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS: ROLE IN PATHOGENESIS AND CORRELATION WITH DISEASE ACTIVITY,
S. S. Pattanaik, S. K. Dutta, A. Tripathy, S. Mahapatra, K. Jana, P. Prasad, R. Mishra, R. Tripathy, D. Jena, M. K. Parida, S. R. Tripathy, S. K. Raghav, B. K. Das
|
|
2026 AB0224
|
ALTERED T AND B CELL COMPOSITION IN BLOOD OF PREGNANT WOMEN WITH SLE EXPERIENCING PREGNANCY COMPLICATIONS,
W. Dankers, A. Parra Sanchez, S. A. Germe, D. Biskop, K. Veeneman, A. O’Byrne, J. van Ruitenbeek, G. Shbli, L. Kolk, M. van Gaal, M. de Boer, L. van Baarsen, I. E. M. Bultink
|
|
2026 AB0229
|
THE RNA-BINDING PROTEIN BTG1 EXACERBATES LUPUS NEPHRITIS BY DRIVING THE ABNORMAL DIFFERENTIATION OF Th17 CELLS,
M. Zhang, Y. Jia, J. Deng, M. Sun, H. Dai, C. Lan
|
|
2026 AB0233
|
ROLE OF NUCLEAR RECEPTOR CO-REPRESSOR NCOR1 AND SMRT IN IMMUNE-CELL METABOLISM IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE),
S. S. Pattanaik, A. K. Sahu, A. Tripathy, R. Tripathy, D. Jena, S. R. Tripathy, S. K. Raghav, M. K. Parida, B. K. Das
|
|
2026 AB0234
|
TIM-3 EXPRESSION DEFINES DISTINCT FUNCTIONAL STATES OF CD4+ T CELLS IN EARLY SYSTEMIC LUPUS ERYTHEMATOSUS,
C. Liu, X. Zheng, Z. Xiong, Z. Zong
|
|
2026 AB0244
|
HYDROXYCHLOROQUINE MODULATES THE IMMUNE SYSTEM IN CLINICALLY QUIESCENT PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AFFECTING THE DIFFERENTIATION OF B CELL SUBSETS,
H. Takei, J. Kikuchi, K. Suzuki, H. Fukui, K. Hiramoto, T. Sasaki, M. Akiyama, Y. Kondo, Y. Fujieda, H. Tsujimoto, N. Seki, K. Chiba, Y. Kaneko
|
|
2026 AB0248
|
COMBINED THERAPY OF BELIMUMAB AND FAP INHIBITOR FOR B CELL DEPLETION AND ANTI-FIBROSIS IN LUPUS NEPHRITIS,
H. Cao, J. Lin
|
|
2026 AB0250
|
EXAMINING DOUBLE NEGATIVE CD19+IgD-CD27- T-BET+ B CELLS IN RELATION TO DISEASE IN SLE PREGNANCY: THE BLOOM SLE STUDY (B CELL LINEAGES AND OBSTETRIC OUTCOMES IN MATERNAL SLE),
G. Woodward, B. Goulden, S. N. Luong, T. McDonnell, M. Leandro, V. Reddy, I. Giles
|
|
2026 AB0274
|
PRO-INFLAMMATORY REGULATION OF ENDOTHELIAL VAP-1 EXPRESSION AND MODULATION BY GLUCOCORTICOIDS IN GIANT CELL ARTERITIS,
R. Gheitasi, S. M. Petzinna, A. Aljerf, C. J. Bauer, M. S. Adamson, V. S. Schäfer
|
|
2026 AB0339
|
UTILITY OF CMV T CELL FUNCTIONAL ASSAY IN THE IMMUNOCOMPROMISED COHORT,
S. Z. Xie, J. Zaunders, A. Kelleher, K. Pathmanandavel, S. Le, M. Alves, E. Foley, A. Carr, H. Hu, W. Tong, A. Kane, L. Sedger, S. Breit, W. Sewell
|
|
2026 AB0394
|
MORTALITY AND VAF IN M41-CANONICAL VEXAS SYNDOME IN A MULTI ENTRE STUDY,
M. López I Gómez, P. García-Escudero, B. Magallares López, S. Castañeda, I. Morante Bolado, J. Cerdeña Corrales, C. A. Egües Dubuc, B. Frade-Sosa, I. Carrión-Barberà, D. Reina, A. García Dorta, D. Dios Santos, L. Villalobos-Sánchez, A. Boteanu, A. Mayo-Juanatey, I. Vázquez-Gómez, E. Aurrecoechea, C. Moriano Morales, D. V. Fiallo Suárez, M. Sallés Lizarzaburu, I. Monjo-Henry, E. Enriquez Merayo, C. García Belando, J. Font-Urgelles, F. J. Toyos Sáenz de Miera, C. Merino Argumánez, D. Prieto-Peña, E. Oliver García, Í. J. Rúa-Figueroa, M. Ibañez, R. B. Melero-González, J. A. Miranda Fillloy, M. Rodríguez Laguna, A. Ruiz Román, J. A. Hernandez Beriain, G. Boselli Oporto, D. Gómez Lamas, E. Trallero, E. Riera Alonso, J. Calvo Alén
|
|
2026 AB0399
|
COPA SYNDROME: A SYSTEMATIC LITERATURE REVIEW OF CLINICAL PRESENTATIONS AND TREATMENTS OF REPORTED CASES,
D. Nagra, M. Baghaffar, S. Goh, K. Song, S. Al Masri, M. Jayesinghe, R. Hassan, A. Khan, C. Rosa, S. Banerjee, C. Wincup, A. Mahto, M. Adas, M. Russell, K. Bechman, J. Galloway
|
|
2026 AB0438
|
DIVA: IMMUNE DEFICIENCY AND ANCA-ASSOCIATED VASCULITIS - STUDY OF PROLONGED POST-RITUXIMAB HYPOGAMMAGLOBULINEMIA,
R. Lelong, N. Martin Silva
|
|
2026 AB0439
|
CLINICAL HETEROGENEITY AND AUTOIMMUNE/ AUTOINFLAMMATORY DISORDERS IN PRIMARY IMMUNODEFICIENCY DISEASES: A LARGE RETROSPECTIVE COHORT STUDY,
Y. Chao, H. Xu, R. Li, X. Wang, X. Zhao, X. Lu, L. Zhao
|
|
2026 AB0440
|
FROM GENES TO REMISSION: PATHWAY-ALIGNED PRECISION THERAPY TRANSFORMS OUTCOMES IN CHILDREN WITH MONOGENIC IMMUNE DYSREGULATION DISEASES IN RESOURCE-LIMITED SETTINGS,
D. B. Pandya
|
|
2026 AB0447
|
IMPLEMENTATION OF THE VARICELLA ZOSTER VIRUS VACCINE AND ITS REAL-WORLD EFFECTIVENESS,
L. Mas Sanchez, E. Grau García, P. Muñoz-Martínez, D. Ramos Castro, A. M. Torrat Noves, B. Villanueva Mañes, I. Alcántara Álvarez, M. Simeó Vinaixa, A. Pérez Hurtado, B. Díaz, P. Antón Enguidanos, J. A. Román Ivorra
|
|
2026 AB0612
|
PSYCHOSOCIAL OUTCOMES FOLLOWING IMMUNOSUPPRESSIVE THERAPY IN IDIOPATHIC GRANULOMATOUS MASTITIS,
F. Yildirim, K. Kalkan, G. Akkuzu, D. S. Ozgur, B. Karaalioglu, R. Deniz, G. Guzelant Ozkose, C. Bes
|
|
2026 AB0627
|
INTEGRATING LYMPHOCYTE SUBSETS AND CLINICAL FEATURES: A NOVEL NOMOGRAM PREDICTING REFRACTORY THROMBOCYTOPENIA IN CONNECTIVE TISSUE DISEASES.,
Y. Luo, K. Li, D. Yin, Z. Chen, W. Cai, L. Zhao, Y. Chen, Q. Wang, F. Wang, R. Li, L. CUI, X. Zhang, Y. Cheng
|
|
2026 AB0940
|
CD161+ TREG AS A POTENTIAL BIOMARKER FOR EVALUATING DISEASE ACTIVITY AND TREATMENT EFFICACY IN RHEUMATOID ARTHRITIS,
Z. Song, F. Sun, D. Zhu, X. Sun, Z. Li
|
|
2026 AB0989
|
EXPANSION OF CD226+TIGIT+ MAIT CELLS IDENTIFIES AN ACTIVATED IMMUNE SIGNATURE IN EARLY, TREATMENT-NAÏVE SJÖGREN’S DISEASE,
C. Liu, X. Song, Z. Xiong, H. Luo, B. Yang, Y. Gao
|
|
2026 AB1114
|
Th1/Th2 IMBALANCE AND METABOLIC ABNORMALITIES IN SLE PATIENTS WITH CARDIOVASCULAR COMORBIDITIES,
C. Q. Xue, A. Zhang, Z. Y. Ren, M. Y. Wang, Z. Liang, J. W. Cheng, X. Liu, Q. Y. Su, S. X. Zhang
|
|
2026 AB1143
|
SIROLIMUS MODULATES Treg/Th17 BALANCE AND REDUCES DISEASE ACTIVITY IN TREATING SYSTEMIC LUPUS ERYTHEMATOSUS: A RETROSPECTIVE COHORT STUDY,
Y. L. Duan, Q. Li, Q. Y. Su, S. Zhao, K. Y. Zhang, Y. Y. Wang, H. Z. Du, S. X. Zhang
|
|
2026 AB1155
|
MULTI-PARAMETRIC PROFILING OF ADULT SYSTEMIC LUPUS ERYTHEMATOSUS REVEALS INCREASED BAFF-EXPRESSING CD45RA+ CD8+ T CELLS AND IMMUNE ACTIVATION,
N. K. H. Khoo, K. Nay Yaung, R. Cheong, S. L. Poh, M. Noviani, M. Wasser, T. C. Tan, J. Thumboo, T. Arkachaisri, A. Low, S. Albani, J. G. Yeo
|
|
2026 AB1223
|
SAFETY AND EFFICACY OF CIZUTAMIG, A BCMAxCD3 BISPECIFIC T-CELL ENGAGER, IN SEVERE DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS,
E. Phithak, R. Biesen, E. Siegert, F. N. Albach, P. Wung, K. Song, T. Lu, J. Haddon, P. Krüger, A. Kleyer, M. Dzamukova, A. Sattler, M. Rehm, E. Wiebe, A. Staeck, Q. Cheng, S. Bianco, A. Fleischmann, J. Zernicke, T. Alexander, G. Krönke, D. Simon
|
|
2026 AB1298
|
IMPACT OF ASPIRIN AND STATIN USE ON DISEASE PROGNOSIS IN TAKAYASU ARTERITIS,
F. Yildirim, E. Yildiz Guvercin, D. Temiz Karadag, H. Kocaayan, Ö. Urak, S. Işik, C. Bes, G. Keser, K. Aksu, A. Yazici, A. Cefle, S. Akar, G. Kenar Artin, İ. Sari, F. Onen, A. Omma, N. A. Kanitez
|
|
2026 AB1375-HPR
|
BURDEN OF GOUT ATTRIBUTABLE TO HIGH BODY MASS INDEX IN THE EUROPEAN UNION, 1990-2023: A GLOBAL BURDEN OF DISEASE STUDY 2023 ANALYSIS,
X. Zhang, M. Liu, H. Cheng, H. Wen
|
|
2026 AB1384-HPR
|
TRENDS IN RHEUMATOID ARTHRITIS AMONG ADULTS IN THE UNITED STATES, 2001 TO 2023,
Z. Wang, Y. Lv, J. Kang, J. Geng, Y. Zhao, P. Gao
|
|
2026 LB0004
|
CC312, A NOVEL CD19/CD3/CD28 TRI-SPECIFIC T CELL ENGAGER, DEMONSTRATES SUSTAINED SRI-4 RESPONSES BEYOND ONE YEAR ALONG WITH RAPID AND DEEP B-CELL DEPLETION IN AUTOIMMUNE DISEASES,
Y. Huang, J. Qi, R. Zhang, J. Zhen, X. Zhang, Y. Wei, M. Sun
|
|
2026 OP003
|
MICROENVIRONMENTAL HYPOXIA AND HIF-1α ACTIVITY SEGREGATE ACROSS SKIN, SYNOVIUM AND ENTHESIS IN PSORIATIC DISEASE AND ASSOCIATE WITH COMPARTMENT-SPECIFIC CD8 EXHAUSTION.,
D. Mauro, M. G. Raimondo, A. Ciancio, G. Forte, H. Mohammadian, S. Gandolfo, G. Ilardi, R. Giacca, M. Raimondi, A. Salzillo, K. Ali, G. Cincinelli, A. Parafioriti, R. F. Caporali, A. Ramming, F. Ciccia
|
|
2026 OP006
|
LUPUS NEPHRITIS HISTOLOGICAL ACTIVITY AND RESPONSE ARE LINKED TO SPECIFIC IMMUNE, METABOLIC, AND REMODELING PATHWAYS: A PER-PROTOCOL KIDNEY BIOPSY STUDY.,
A. Fava, C. Y. Lee, R. Lu, C. Guthridge, R. Chou, D. Nikolopoulos, J. Lindblom, F. Tamirou, J. A. James, M. Petri, J. M. Guthridge, F. Houssiau, I. Parodis
|
|
2026 OP009
|
METABOLIC REMODELING OF SALIVARY GLAND EPITHELIUM LINKS MITOCHONDRIAL DYSFUNCTION TO CHRONIC INFLAMMATION IN SJÖGREN’S DISEASE,
S. Colafrancesco, E. Pontarini, E. Simoncelli, G. Cavallaro, M. Certo, C. Mauro, S. Nayar, J. D. Turner, C. Barbati, D. Stefanoni, F. Sacco, L. Perfetto, C. Montesano, M. Sergi, F. Conti, C. F. Selmi, E. Gremese, C. Pitzalis, R. Priori, M. Bombardieri
|
|
2026 OP0151
|
SINGLE-CELL ANALYSIS OF INTERFERON BLOCKADE UNCOVERS B CELL REPERTOIRE REMODELING IN SYSTEMIC LUPUS ERYTHEMATOSUS,
K. Terada, Y. Tsuchida, T. S. Ushijima, Y. Suwa, K. Saegusa, S. Yamada, M. Ota, T. Okamura, K. Fujio
|
|
2026 OP0154
|
OXIDATIVE STRESS–ASSOCIATED PLA2 ACTIVATION DRIVES LYSOPHOSPHOLIPID DYSREGULATION LINKED TO B CELL HYPERACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS,
J. Huang, J. Yang, X. Han
|
|
2026 OP0155
|
EARLY DISRUPTION OF B CELL TOLERANCE PATHWAYS AND IMMUNE REGULATORY CIRCUITS IN PRECLINICAL SYSTEMIC AUTOIMMUNE DISEASE,
A. Bylinska, M. Smith, R. Lu, C. Wagner, B. Jones, M. C. Marlin, C. Guthridge, C. Wright, S. Macwana, W. DeJager, M. Beel, C. J. Lessard, C. Arriens, T. Aberle, J. Merrill, J. M. Guthridge, J. A. James
|
|
2026 OP0156
|
OFF-THE-SHELF DUAL-CAR T-CELL THERAPY: TARGETING B AND T CELLS IN AUTOIMMUNE DISEASE WITHOUT PRECONDITIONING,
N. J. Shiff, M. Jelcic, S. Chandra, S. Shirinbak, B. Groff, A. Williams, A. Gutierrez, M. Meza, B. Gaertner, K. Palomares, L. Campanati, C. Dege, P. F. Tsai, T. Lee, R. Clarke, K. J. Malmberg, M. Mamonkin, B. Valamehr, V. Sandhu, A. Garcia, J. Goodridge, M. Hosking
|
|
2026 OP016
|
FROM HISTOLOGY TO PHENOTYPE: A NATIONAL MULTICENTER STUDY IDENTIFYING SALIVARY GLAND PATHOTYPES IN SJÖGREN’S DISEASE,
S. Colafrancesco, E. Simoncelli, E. Pontarini, N. Foroni, M. Hamed Abdelaziz Hegazi, G. Cavallaro, E. Sciacca, M. Villa, I. Pace, B. Cerbelli, M. G. Pignataro, C. Baldini, V. Donati, O. Berardicurti, A. Marino, F. Pasqualini, C. F. Selmi, E. Gremese, F. Grizzi, R. Giacomelli, F. Conti, C. Pitzalis, M. Bombardieri, R. Priori
|
|
2026 OP0162
|
DIRECT INHIBITION OF SALIVARY GLAND ORGANOID MATURATION BY IGG FROM SJÖGREN DISEASE PATIENTS,
T. D. Steinmetz, A. Wolthuis, T. Yang, J. H. Terpstra, B. Plaat, J. Alberga, F. G. M. Kroese, H. Bootsma, S. Pringle
|
|
2026 OP017
|
INSULIN INHIBITS INFLAMMATION AND EPIGENETICALLY SUPPORTS T CELL PHENOTYPE TRANSITION IN RHEUMATOID ARTHRITIS,
V. Chandrasekaran, M. Erlandsson, D. Svensson, E. Malmhäll-Bah, G. Katona, R. Pullerits, M. I. Bokarewa
|
|
2026 OP0175
|
SPP1+ MACROPHAGES ARE SPECIFICALLY ENRICHED IN ARTHRITIC JOINTS AND ASSOCIATED WITH ABNORMAL BONE METABOLISM IN COLLAGEN-INDUCED ARTHRITIS MICE,
C. He, G. Yin, Q. Xie
|
|
2026 OP0203
|
“IMMUNE DIMMING” WITH LOW-DOSE BLINATUMOMAB REVERSES THE TREATMENT-RESISTANT STATE IN RHEUMATOID ARTHRITIS,
L. Bucci, M. Hagen, S. Boeltz, C. Tur, D. M. Nöthling, T. Dashi, J. Auth, T. Rothe, A. Wirsching, J. Wacker, A. Zoli, A. M. Liphardt, S. Alivernini, L. Munoz, V. Schönau, J. Rech, A. Atzinger, M. A. D’Agostino, A. Bozec, M. Eckstein, M. G. Raimondo, G. Schett, R. Grieshaber-Bouyer
|
|
2026 OP025
|
OPTIMISED ANTIGEN-SPECIFIC IMMUNOTHERAPY LIPOSOMES ENABLE IMMUNE REGULATION AND SUSTAINED DISEASE CONTROL IN EXPERIMENTAL ARTHRITIS,
S. Moonshi, T. Aragao Horoiwa, B. Zeng, N. Fletcher, A. Martyn, N. Pujara, R. Stone, N. Liu, S. Patel, M. Trau, M. Talekar, K. Thurecht, H. Nel, R. Thomas
|
|
2026 OP0258
|
LONGITUDINAL SERUM PROTEOMIC SIGNATURES ASSOCIATED WITH DURABLE REMISSION VERSUS RELAPSE AFTER CAR-T THERAPY IN AUTOIMMUNE DISEASES,
F. Iwata, P. G. Gavin, D. M. Nöthling, K. Anoshkin, L. Bucci, P. Garantziotis, S. Clarke, N. Ferrari, C. Tur, M. Hagen, A. Wirsching, T. Rothe, S. Kretschmann, S. Völkl, M. Aigner, F. Müller, A. Mackensen, A. Bozec, G. Schett, R. Grieshaber-Bouyer
|
|
2026 OP0262
|
IMMUNOMETABOLIC CHANGES ASSOCIATED WITH SUSTAINED REMISSION IN PATIENTS WITH cSLE AND JDM TREATED WITH ANTI-CD19 CAR T CELLS,
E. Marasco, A. Ariolli, N. de Franco, R. Nicolai, C. Bracaglia, S. Barresi, M. Becilli, P. Merli, M. I. Petrone, F. del Bufalo, M. Algeri, M. G. Cefalo, F. Locatelli, F. de Benedetti
|
|
2026 OP0268
|
A T CELL-DRIVEN CCL20+ MACROPHAGE CIRCUIT DRIVES TNF PATHOLOGY AND Th17 Cell Recruitment In Axial Spondyloarthritis Synovium,
J. Zhao, F. Liu, J. Li, H. Shi, C. Worth, L. Jiang, D. Simone, F. Penkava, A. Chan, L. Duan, P. Bowness, L. Chen
|
|
2026 OP0271
|
AN IL-7–DRIVEN GLUCOSE–AIOLOS METABOLIC CIRCUIT LICENSES PATHOGENIC CD8+ T CELLS IN SPONDYLOARTHRITIS,
M. Akiyama, W. Alshehri, M. Koroyasu, T. Kaburaki, K. Yoshimoto, K. Saito, K. Shimanuki, Y. Kaneko
|
|
2026 OP0272
|
NSD1, H3K36me1/2 METHYLTRANSFERASE AS A POTENTIAL THERAPEUTIC TARGET IN TH17 CELL-MEDIATED AUTOINFLAMMATORY DISEASE,
S. E. Wang, D. T. Kim, J. S. Joo, S. H. Lee, J. Chin, S. Jo, J. Y. Hong, T. H. Kim
|
|
2026 OP0273
|
ENRICHMENT OF T PERIPHERAL HELPER CELLS IN BOTH ORGANIZED AND DIFFUSE IMMUNE INFILTRATES IN RA-ILD LUNG EXPLANTS.,
A. Seng, K. Suga, A. Singaraju, B. E. R. Samuel, Y. J. Choi, J. Fert-Bober, J. Giles, T. Parimon, P. Chen, N. Bottini
|
|
2026 OP0276
|
THE EMERGENCE OF DISTINCT CD8+ T CELL EFFECTOR PHENOTYPES IS ASSOCIATED WITH SUBCLINICAL SYNOVITIS WHEN RHEUMATOID ARTHRITIS IS IMMINENT,
K. Abacar, F. Tariq, P. Martin, W. Ye, X. Sun, S. MacKay, D. Muldoon, L. Duquenne, A. Di Matteo, K. Harnden, K. Mbara, M. Menon, H. Al-Mossawi, M. Buch, P. Emery, D. Newton, B. Fairfax, K. Mankia
|
|
2026 OP0280
|
POPULATION-SCALE T-CELL RECEPTOR SEQUENCING IN RHEUMATOID ARTHRITIS CONTROLS HLA POLYMORHISM AND IDENTIFIES DISEASE-ASSOCIATED CLONOTYPES,
T. Nishino, T. Arakawa, R. Sasai, K. Asahara, H. Inokuchi, N. Itokawa, M. Yamaguchi, M. Endo, S. Noma, T. Kawashima, H. Hatano, M. Nakano, M. Kono, B. Natsumoto, K. Matsuda, Y. Momozawa, K. Ishigaki
|
|
2026 OP0281
|
NR2C1 DOWNREGULATION IMPAIRS REGULATORY T CELL DIFFERENTIATION AND CONTRIBUTES TO IMMUNODYSREGULATION IN BEHÇET’S DISEASE,
Y. Liu, J. Wu, X. Yu, X. Wang, H. Chen, W. Zheng
|
|
2026 OP0285
|
GM-CSF- AND IFN-Γ-PRODUCING T CELLS IN POLYMYALGIA RHEUMATICA,
A. Zhang, W. Abdulahad, W. F. Jiemy, R. Reitsema, Y. van Sleen, M. Sandovici, A. Diepstra, T. Kwee, C. Roozendaal, P. Heeringa, E. Brouwer, K. van der Geest
|
|
2026 OP0286
|
B CELL RECEPTOR ISOTYPES OF CIRCULATING PR3-SPECIFIC AUTOREACTIVE B CELLS IN ANCA-ASSOCIATED VASCULITIS,
G. Boscato Sopetto, V. Facchini, R. Corbellari, A. Mattè, I. Pesce, A. Hummel, S. Hillion, M. F. Konig, M. Pandey, G. Grandi, D. Cornec, U. Specks, A. Berti
|
|
2026 OP0306
|
LONGITUDINAL MULTI-OMIC ANALYSIS OF CD19 CAR-T CELL THERAPY IN SYSTEMIC SCLEROSIS DEMONSTRATES COORDINATED IMMUNE AND STROMAL MODULATION,
H. Yin, Z. Zhao, C. Jia, W. LIN, F. Wu, D. Zhe, X. Liu, L. Lu
|
|
2026 OP0309
|
SINGLE-CELL PROFILING IDENTIFIES PDE4B AS A DISEASE-RELEVANT TARGET IN SYSTEMIC SCLEROSIS ACROSS TISSUES AND CELL SUBSETS,
A. Hofman, P. Bearzi, L. Much, M. Asadikorayem, A. Laimbacher, H. Jarnagin, Z. Gong, M. Whitfield, S. Assassi, A. M. Hoffmann-Vold, M. O. Becker, E. Pachera, O. Distler
|
|
2026 OP0322
|
CYTOKINE-DEFINED ENDOTYPES IN ADULT-ONSET STILL’S DISEASE VALIDATED BY INTEGRATED IMMUNE PROFILING WITH IMPLICATIONS FOR TARGETED THERAPY,
R. Guo, X. Liu, L. Gu, L. Lu
|
|
2026 OP0326
|
BONE MARROW SINGLE-CELL MULTIOMICS SHEDS LIGHT ON THE ETIOLOGY OF SCHNITZLER SYNDROME,
S. Riescher, Y. Le Bris, E. Douillard, M. Devic, M. Cherkaoui, S. Barbarot, F. Magrangeas, S. Minvielle, E. Letouze, A. Néel
|
|
2026 OP0333
|
PHENOTYPIC CHANGES OF THE PERIPHERAL B CELL COMPARTMENT PRECEDE THE FIRST CASE OF RELAPSED SLE AFTER CD19 CAR-T CELL THERAPY,
D. M. Nöthling, K. Anoshkin, P. G. Gavin, P. Garantziotis, F. Iwata, L. Bucci, N. Ferrari, S. Clarke, C. Tur, M. Hagen, A. Wirsching, T. Rothe, S. Kretschmann, S. Völkl, M. Aigner, F. Müller, A. Mackensen, A. Bozec, G. Schett, R. Grieshaber-Bouyer
|
|
2026 OP0340
|
SAFETY AND EFFICACY OF DARATUMUMAB IN TREATMENT-REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM THE LONG-TERM EXTENSION OF A PHASE 2 TRIAL,
L. Ostendorf, J. Zernicke, J. Klotsche, A. E. Beenken, R. Biesen, R. Kempkens, Q. Cheng, L. Khodadadi, G. Guerra, F. Heinrich, P. Durek, M. F. Mashreghi, G. R. Burmester, G. Krönke, F. Hiepe, T. Alexander
|
|
2026 OP038
|
PLASMA PROTEOMIC PROFILE OF RHEUMATOID ARTHRITIS: INSIGHTS INTO SHARED INFLAMMATORY PATHWAYS WITH PSORIATIC ARTHRITIS,
M. Kyriakidi, E. K. Vetsika, G. E. Fragoulis, M. G. Tektonidou, P. P. Sfikakis
|
|
2026 OP053
|
T PERIPHERAL HELPER 2 CELLS REFLECT DISEASE ACTIVITY AND PREDICT RELAPSE IN IGG4-RELATED DISEASE,
K. Shimanuki, M. Akiyama, K. Saito, W. Alshehri, T. Maruyama, T. Sasaki, K. Yoshimoto, N. Seki, H. Tsujimoto, K. Chiba, Y. Kaneko
|
|
2026 OP059
|
CD6 AS A DYNAMIC SERUM BIOMARKER OF IMMUNE-RELATED ADVERSE EVENTS, INVOLVED IN JAK/STAT-MEDIATED CD4+ T CELL ACTIVATION,
X. Jiang, C. Jiana, J. Xu, M. Wang, Z. Zhou, X. Si, N. Liang, M. Li, H. Yang
|
|
2026 OP077
|
SAFETY AND EARLY EFFICACY OF RAPCABTAGENE AUTOLEUCEL (YTB323), AN AUTOLOGOUS CD19 DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN SEVERE REFRACTORY IDIOPATHIC INFLAMMATORY MYOPATHIES AND DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS: PRELIMINARY ANALYSIS OF THE OPEN-LABEL AUTOGRAPH-IIM AND -SSC STUDIES,
D. Khanna, X. Andrade-Gonzalez, M. Vercel, M. Lidar, A. Shimoni, A. Pfeil, U. Schnetzke, G. Moroncini, F. Saraceni, Y. Allenbach, S. Choquet, A. Low, Y. Chen, T. Matsushita, A. Yoshida, M. E. Truchetet, E. Forcade, R. Nakashima, Y. Arai, J. Moore, L. Girgis, L. Sanchez Riera, A. Giannelou, Y. Xu, A. Kuznetsova, F. Kawakami, B. Das, C. Y. S. Lee, E. Gatlik, M. Alani, V. Varanasi, S. Diehl, A. Mathur, R. Aggarwal
|
|
2026 POS0010
|
SINGLE-CELL RNA SEQUENCING OF SKIN TISSUE REVEALS PROMINENT FIBROBLAST–T CELL CROSSTALK IN PRE-STAGES OF SYSTEMIC SCLEROSIS,
L. Li, E. Pachera, R. Dobrota, S. Muraru, K. Buerki, C. Mihai, M. Elhai, L. Much, A. Hofman, P. Bearzi, S. Xu, M. Venables, M. Asadikorayem, P. Stauffer, A. M. Hoffmann-Vold, O. Distler
|
|
2026 POS0013
|
HIGH-DEFINITION SPATIAL TRANSCRIPTOMICS REVEALS ALTERED T CELL STATES AND EPITHELIAL STRESS RESPONSES IN THE SMALL INTESTINE OF SYSTEMIC SCLEROSIS PATIENTS,
L. Much, E. Pachera, H. Fretheim, K. E. Lundin, A. Hofman, Ø. Midtvedt, E. Bækkevold, L. Aabakken, L. Li, P. Stauffer, M. Asadikorayem, S. Xu, B. Burja, M. Scharl, C. Mihai, Ø. Molberg, O. Distler, A. M. Hoffmann-Vold
|
|
2026 POS0014
|
NICHE-SPECIFIC PHENOTYPES OF IMMUNE CELLS IN IMMUNE CELL AGGREGATES IN SYSTEMIC SCLEROSIS SKIN,
D. Bleck, K. Drechsel, T. Filla, Y. N. Li, A. E. Matei, A. H. Györfi, J. Distler
|
|
2026 POS0032
|
BASELINE IMMUNITY AND IT´S NATURAL COURSE AGAINST RESPIRATORY SYNCYTIAL VIRUS IN RHEUMATIC PATIENTS WHILE STARTING VACCINATION PROGRAM,
C. Pohl
|
|
2026 POS0035
|
SINGLE CELL RNA SEQUENCING AND AUTOANTIBODY SCREENING REVEAL NOVEL IMMUNE BIOMARKERS IN KNEE JOINT-FLUID FOR EARLY CLINICAL STRATIFICATION OF SEPTIC AND AUTOIMMUNE ARTHRITIS IN CHILDREN,
P. Raj, B. Zhang, C. Zhu, C. Arana, I. Raman, N. Tareen, Y. Pena Lopez, T. Chen, M. Yan, S. Morris, N. Van Oers, L. Hooper, L. Copley
|
|
2026 POS0037
|
ANTIPHOSPHOLIPID ANTIBODY NEGATIVIZATION IS CHARACTERIZED BY RESTORATION OF IMMUNE HOMEOSTASIS AND REVERSAL OF THROMBOGENICITY IN THROMBOTIC PRIMARY ANTIPHOSPHOLIPID SYNDROME,
P. Gaspar, F. Ribeiro, M. M. Santos, B. Filipe, R. Vieira, D. Holdych, S. Pascual, M. Radin, I. Cecchi, A. Barinotti, S. Sciascia, A. R. Cruz-Machado, V. R. Fonseca, A. R. Maceiras, J. E. Fonseca, V. C Romão, L. Graca
|
|
2026 POS0082
|
CYTOMETRY BY TIME OF FLIGHT (CyTOF) IDENTIFIES SEXUAL DIMORPHISM IN MONOCYTE POPULATIONS IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHROPATHY (AxSpA),
C. Worth, F. Liu, D. Ahern, A. Chan, F. Penkava, L. Chen, N. Yager, A. Ridley, H. Al Mossawi, P. Bowness
|
|
2026 POS0084
|
AXIAL–PERIPHERAL IMMUNE DIVERGENCE AT HUMAN ENTHESEAL SITES REVEALED BY SINGLE-CELL TRANSCRIPTOMICS,
T. Macleod, M. Harland, C. Wong, K. Abacar, Y. Hamid, A. S. Rao, A. Khan, P. Loughenbury, V. Borse, C. MacEachern, A. P. Van den Heuvel, W. Chen, A. Altaie, D. McGonagle
|
|
2026 POS0122
|
MISSED RED FLAGS OF MONOGENIC IMMUNE DYSREGULATION: A CASE REPORT OF LATE-ONSET STAT3 GAIN-OF-FUNCTION–RELATED DISEASE,
E. Wiesik-Szewczyk, K. Jahnz-Rozyk
|
|
2026 POS0125
|
MITOCHONDRIAL EXPANSION AND INTERFERON-DRIVEN BIOENERGETIC REPROGRAMMING DEFINE CD4+ T CELL DYSFUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS,
C. Wincup, G. Robinson, M. Wilkinson, A. Rahman
|
|
2026 POS0133
|
DECIPHERING THE ALLEVIATION MECHANISM OF LUPUS NEPHRITIS BY UMBILICAL CORD BLOOD MESENCHYMAL STEM CELLS: TARGETING MiT-TFE/CCL8-MEDIATED CCL8+ MACROPHAGE-CCR5+ NEUTROPHIL CROSSTALK,
L. Sun, Q. Yang, L. Zeng
|
|
2026 POS0208
|
CD8+CCR4+CD25+ T CELLS PREDICT ABATACEPT TREATMENT RESPONSE IN RHEUMATOID ARTHRITIS,
Y. Nagafuchi, S. Yamada, Y. Suwa, M. Ota, H. Hatano, K. Kubo, K. Shimane, K. Setoguchi, T. Azuma, M. Mamura, T. Okamura, K. Sato, K. Ishigaki, K. Fujio
|
|
2026 POS0214
|
BACTEROIDES. sp A1C1 IMPAIRED CLA+Tregs AND EXACERBATED THE DEVELOPMENT OF RHEUMATOID ARTHRITIS VIA MOLECULAR MIMICRY,
D. Zhu, Y. Xie, S. Liu, Y. Li, C. Wei, R. Liang, S. Zang, F. Hu, Z. Li
|
|
2026 POS0256
|
MULTIMODAL PHENOTYPING OF B-CELL DEPLETION AND RECONSTITUTION FOLLOWING CD19 CAR T-CELL THERAPY WITH MIVOCABTAGENE AUTOLEUCEL IN ACPA-POSITIVE, TREATMENT-REFRACTORY, ACTIVE RHEUMATOID ARTHRITIS - DATA FROM THE PHASE 1 OF THE PROSPECTIVE, INTERVENTIONAL COMPARE TRIAL,
T. H. Le, M. Rehm, A. Sattler, A. Wilhelm, A. Fleischmann, S. Bianco, F. N. Albach, E. Wiebe, V. Casteleyn, M. Torgutalp, A. Kleyer, J. Zernicke, D. Borie, M. L. Hütter-Krönke, U. Keller, O. Penack, L. Bullinger, A. Busse, J. Giezen, R. Toes, H. U. Scherer, D. Simon, G. Krönke
|
|
2026 POS0270
|
SINGLE-CELL ANALYSIS REVEALS A HIGHLY CYTOTOXIC CD8+T-CELL SUBSET ASSOCIATED WITH MACROPHAGE INTERACTIONS IN TAKAYASU ARTERITIS,
K. Xu, L. Pan, T. Li
|
|
2026 POS0316
|
AGE-ASSOCIATED B CELLS EXACERBATE PRIMARY SJÖGREN DISEASE THROUGH PROMOTING FOLLICULAR T HELPER CELL DIFFERENTIATION BY OVEREXPRESSING PD-L1,
T. Zhou, Z. Chen, L. Zeng, C. Luo, T. Lyu, H. Chen
|
|
2026 POS0349
|
TARGETING BCMA USING T-CELL ENGAGER BISPECIFICS IN AUTOIMMUNE DISEASES: EXPLORING THE MECHANISM OF CIRCULATING B-CELL DEPLETION AND SOLUBLE BCMA AS A BIOMARKER OF TISSULAR PLASMA CELLS,
J. GAUTHIER, B. Ly, A. Gleizes, Z. Cacan, L. Meudec, R. Belkhir, S. PAVY, J. Henry, R. Seror, T. Lazure, G. Nocturne, S. Hacein Bey, X. Mariette, S. Bitoun
|
|
2026 POS0353
|
CHARACTERIZATION OF AZD0120, A BCMA/CD19 DUAL-TARGETING AUTOLOGOUS CAR T-CELL THERAPY GENERATED FROM PBMCs OF PATIENTS WITH RHEUMATOLOGIC DISEASE,
R. Ma, F. Eng, N. Ferrari, P. Gavin, N. Hamada, M. Shen, N. Abutaleb, L. Clarke, Y. Ikeda, L. Cao, C. Kuhn
|
|
2026 POS0386
|
DECIPHERING PLATELET TRANSCRIPTOMIC PROFILES IN ANTIPHOSPHOLIPID SYNDROME: INSIGHTS INTO THEIR ROLE AS IMMUNOLOGICAL PLAYERS,
Y. Yang, H. Jiang, Z. Tang, C. Yang, T. Liu
|
|
2026 POS0391
|
IN UTERO EXPOSURE TO HIGH PLACENTAL TRANSFER TNF INHIBITORS IS ASSOCIATED WITH DELAYED T CELL MATURATION AND TRANSIENT IL-12/INF-γ IMMUNE PATHWAY DYSFUNCTION IN INFANTS,
Y. Luo, A. Freixedas Raventós, N. Baños, A. Pluma Sanjurjo, G. Argüello, D. Acevedo, S. Rodriguez, R. Castellanos, E. Quesada-Masachs, E. Moreno Ruzafa, G. Yanez, C. Marti-Castellote, A. Deyà-Martínez, A. García-García, M. Torres, E. Ricart, M. Casellas, D. Grados Canovas, M. Juan, A. Esteve-Solé, L. Alsina
|
|
2026 POS0393
|
FIBROBLAST ACTIVATION BY IFN-I-PRIMED KERATINOCYTES BRIDGES UVB-INDUCED EPIDERMAL INJURY TO MMP9+ MYELOID CELL RECRUITMENT AND T CELL CYTOTOXICITY IN SKIN LUPUS AND DERMATOMYOSITIS,
K. Afshari, Y. Wang, N. Haddadi, C. Salomão Lopes, C. H. L. Eng, L. M. Whiteman, N. Martinez, P. Kyawe, K. S. Anufrieva, K. Wei, K. Frieda, R. Vleugels, J. Harris, S. Gallucci, M. Garber, M. Rashighi
|
|
2026 POS0396
|
CHEMOKINE-MEDIATED IMMUNE CELL TRAFFICKING CHARACTERIZES ACTIVE SYSTEMIC SCLEROSIS: INSIGHTS FROM HIGH-DIMENSIONAL IMMUNE PROFILING,
M. Noviani, A. Chia, A. Lajam, P. Kumar, V. R. Chellamuthu, K. Nay Yaung, M. Wasser, J. G. Yeo, J. Behmoaras, E. Petretto, A. Low, S. Albani
|
|
2026 POS0661
|
DELINEATION OF PATHOGENIC IGG4-SECRETING CELLULAR NETWORKS IN IGG4-RELATED DISEASE BY SPATIAL TRANSCRIPTOMIC AND PROTEOMIC PROFILING,
M. G. Kim, H. J. Kim, S. Heo, S. U. Kim, S. Y. Ban, J. H. Moon, S. Cho, J. W. Park, J. E. Park, J. S. Lee, E. Y. Lee
|
|
2026 POS0664
|
DEEP IMMUNOPHENOTYPING REVEALS NOVEL B CELL SUBSETS AND TRAJECTORIES IN IGG4-RELATED DISEASE,
L. Teichert, A. E. Beenken, A. Sattler, H. Hirseland, T. Sempert, L. Ostendorf, S. Ferrara, F. Hiepe, H. Mei, G. Krönke, A. R. Schulz, T. Alexander
|
|
2026 POS0666
|
SEMA4A IS ELEVATED IN PATIENTS WITH PSORIATIC ARTHRITIS AND INDUCES INFLAMMATION IN VITRO AND IN VIVO,
J. Marty, C. Rafael-Vidal, S. Martinez-Ramos, B. Malvar-Fernández, T. Carvalheiro, A. Pinheiro-Lopes, J. N. Pouw, E. F. A. Leijten, S. Vila Garcia, C. Mouriño Rodríguez, N. Pérez Gómez, I. Altabás González, F. J. Maceiras-Pan, D. Fernández Fernández, C. Ventin-Rodriguez, A. Crespo-Golmar, R. Gómez, L. Santiago-Lamelas, R. Diaz-Peña, T. Radstake, J. M. Pego-Reigosa, S. García
|
|
2026 POS0672
|
SINGLE-CELL AND SPATIAL TRANSCRIPTOMIC PROFILING REVEALS SYSTEMIC AND TISSUE IMMUNE REMODELING IN SLE TREATED WITH ANIFROLUMAB,
I. Martínez-Garcia, P. Nubiola-Rivera, T. Moline, M. Royo, A. D. Ulloa-Navas, B. Ferrer, G. Aparicio, C. Solé-Marcé, J. Cortés-Hernández
|
|
2026 POS0673
|
RESTING T REGULATORY CELLS AS BIOMARKERS FOR DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: RESULTS FROM A MONOCENTRIC COHORT,
V. Moretti, A. Asquino, C. Ciancarella, F. Conti, I. Zizzari, F. Ceccarelli
|
|
2026 POS0675
|
DEFICIENCY OF SERUM SHORT-CHAIN FATTY ACIDS IS ASSOCIATED WITH PROMOTING PLASMABLAST DIFFERENTIATION IN SYSTEMIC LUPUS ERYTHEMATOSUS,
R. Kanda, S. Kubo, K. Yamagata, S. Iwata, Y. Todoroki, M. Ueno, A. NAGAYASU, Y. Satoh-Kanda, K. Sonomoto, I. Miyagawa, Y. Tanaka, S. Nakayamada
|
|
2026 POS0679
|
3H-1,2-DITHIOLE-3-THIONE AMELIORATES LUPUS NEPHRITIS IN IMIQUIMOD-INDUCED LUPUS-PRONE MICE VIA MODULATION OF TH1 AND TH17 RESPONSES,
K. C. Wang, M. H. Tai, S. J. Yu
|
|
2026 POS0734-HPR
|
EVALUATING THE CAUSAL ASSOCIATIONS BETWEEN CLONAL HEMATOPOIESIS AND ITS SUBTYPES AND RHEUMATOID ARTHRITIS: A BIDIRECTIONAL MENDELIAN RANDOMIZATION STUDY,
N. Li, R. Wu, Q. Feng, Y. Mu, C. Wang
|
|
2026 POS0738-HPR
|
LONG-TERM TRENDS IN THE BURDEN AND SEX-SPECIFIC PATTERNS OF GOUT IN THE EUROPEAN UNION, 1990–2023: FINDINGS FROM THE GLOBAL BURDEN OF DISEASE STUDY 2023,
X. Wang, K. X. Yao, M. Liu, Y. Yang, H. Wen, H. Cheng
|
|
2026 POS0748
|
SINGLE‑CELL TRANSCRIPTOMICS, IMMUNE AND METABOLIC PROFILING REVEAL MONOCYTE AND T‑CELL ALTERATIONS IN FAMILIAL MEDITERRANEAN FEVER,
L. Merlo Pich, T. Schlüter, R. Deniz, M. Ozturk, M. Bruno, Y. Negishi, S. S. Ekmekci, N. Abaci, M. Mhlanga, A. Ziogas, L. Joosten, A. Gul, M. Netea
|
|
2026 POS0756
|
BREAKING THE CYTOKINE CASCADE: TARGETING INFLAMMATION UPSTREAM WITH SMALL MOLECULES FOR THE TREATMENT OF AUTOIMMUNE DISEASES,
C. Veloso de Simón, M. Kotrulev, A. Briones Contreras, L. Mosquera Ferreiro, S. Carreira Santos, A. Ramírez Iglesias, B. Garcia-Pinel, Y. Lopez-Golan, S. Trincado-Lopez, A. Fuentes Iglesias, D. Guallar, O. J. Cordero, R. Varela-Calvino, P. Brea, M. Loza, E. Sotelo, A. J. Mera-Varela, I. Gomez-Tourino
|
|
2026 POS0773
|
IMP761, A NOVEL IMMUNOSUPPRESSIVE LAG-3 AGONIST ANTIBODY IN THE CLINIC,
F. Triebel, A. Leite Pereira, C. Brignone, S. Winckels
|
|
2026 POS0828
|
THYMIC DOWNREGULATION OF THE IFN/STAT1 PATHWAY PRECEDES TH17 POLARIZATION IN HLA-B27 TRANSGENIC RAT (B27-RAT) MODEL OF SPONDYLOARTHRITIS (SPA),
C. Bonini, E. Cela, B. Cherqaoui, M. Breban, L. M. Araujo
|
|
2026 POS0829
|
HIGH-DIMENSIONAL IMMUNOPHENOTYPING REVEALS DIVERGENT IMMUNE PROFILES IN AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS,
N. Frede, N. Craig-Müller, S. Kohrt, M. T. Bott, U. Salzer, A. Venhoff, J. Thiel, J. Frede, R. Voll, M. Rizzi, R. Lorenzetti, N. Venhoff
|
|
2026 POS0830
|
ALTERED CIRCULATING B-CELL SUBSETS IN AXIAL SPONDYLOARTHRITIS AND THEIR ASSOCIATION WITH ANTI-TNF TREATMENT RESPONSE,
B. Nieto-Carvalhal, M. D. C. Uyaguari Morocho, D. Peiteado, A. Villalba, I. Monjo-Henry, S. García-Carazo, E. De Miguel, M. E. Miranda-Carus
|
|
2026 POS0834
|
NON-LYSOSOMAL TRAFFICKING OF CD71/SIGA COMPLEXES RAISES NEW QUESTIONS ON GUT–ENTHESIS COMMUNICATION IN SPONDYLOARTHRITIS,
J. De Avila, A. Ramos-Casallas, C. Florez, L. Parra, J. M. Bello-Gualtero, C. Romero-Sánchez
|
|
2026 POS0844
|
THE ASSOCIATION OF THE TRIGLYCERIDE-GLUCOSE INDEX WITH DISEASE ACTIVITY AND LYMPHOCYTE-SUBSET PROFILES IN INFLAMMATORY ARTHRITIS,
X. Jiang, Y. X. Guo, Q. Wu, T. Gao, Q. Y. Su, Y. X. Wang, F. LI, S. X. Zhang
|
|
2026 POS0890
|
LOSS OF EXPRESSION OF THE UBIQUITOUS CO-STIMULATORY CD27 AND CCR7 CHARACTERIZES A POPULATION OF RA ASSOCIATED MIGRATORY CD4+ T EFFECTOR CELLS,
L. Braune, H. R. Spatzier, P. Nguyen, A. K. Schierack, R. Scholz, H. Apel, C. Bach, F. Gaunitz, M. Krasselt, O. Seifert, A. M. Glimm, M. Pierer, L. Uhlmann, T. Hagemann, U. Wagner, K. Rothe
|
|
2026 POS0897
|
CIRCULATING TRANSITIONAL B CELLS ARE ELEVATED IN CLINICALLY SUSPECT ARTHRALGIA AND FURTHER EXPAND DURING PROGRESSION TO INFLAMMATORY ARTHRITIS,
B. Nieto-Carvalhal, M. Gutierrez Riart, L. Nuño, A. Villalba, M. Novella-Navarro, I. Monjo-Henry, D. Peiteado, E. De Miguel, M. E. Miranda-Carus
|
|
2026 POS0899
|
AUTOANTIBODIES AGAINST CHEMOKINE RECEPTOR CXCR3 ARE ASSOCIATED WITH DISEASE OUTCOMES AND ATHEROSCLEROSIS RISK ACROSS RHEUMATOID ARTHRITIS STAGES,
D. Miranda-Prieto, M. Alperi-López, Á. I. Pérez-Álvarez, S. Alonso-Castro, G. Riemekasten, A. Suárez, J. Rodríguez-Carrio
|
|
2026 POS0904
|
INVESTIGATING THE IMMUNE SIGNATURE OF INTERSTITIAL LUNG DISEASE ACROSS RHEUMATOID ARTHRITIS,
M. Layeghi, R. Shah, Y. Tan, C. Hayton, M. Buch, M. Menon
|
|
2026 POS0905
|
DEVELOPMENT OF AZD5492, A PIONEERING CD8-GUIDED CD20 T CELL ENGAGER, ADVANCING IN CLINICAL TRIALS FOR AUTOIMMUNE INDICATIONS,
N. Kumar, B. Ursin, K. Golan, Y. Zhang, B. Naiman, Z. Goodwin, A. Qadri, S. Iamsawat, A. Estrada, S. Hawkins, F. Meylan, T. Creigh-pulatmen, A. Lara, N. Jafarzadeh, T. Ciucci, C. Cayatte, D. Close, D. Rowlands, T. Ort
|
|
2026 POS0912
|
REVISITING OSTEOARTHRITIS AS AN INFLAMMATORY DISEASE: CHARACTERIZATION OF SYNOVITIS GRADING AND SYNOVIAL PATHOTYPES IN SURGICAL SPECIMENS,
J. Ciaffi, L. Bianchi, M. Gambarotti, A. Righi, D. Giuggioli, R. F. Caporali, C. Faldini, S. Zaffagnini, T. Huizinga, F. Ursini
|
|
2026 POS0982
|
SAME, SAME, BUT DIFFERENT - ANCA-ASSOCIATED AND LARGE VESSEL VASCULITIS TRANSCRIPTOMES IN WHOLE BLOOD,
J. Amsler, M. Kreuzer, L. Petelytska, O. Iaremenko, L. Christ, M. Gasser, F. Ryser, A. C. Sarbu, L. Seitz, P. M. Seitz, B. Maurer, K. Klein
|
|
2026 POS0984
|
DISSECTING THE IMMUNE RESPONSE THAT UNDERSCORES EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS AND ITS THERAPY,
R. Lorenzetti, C. Aronis, B. Dreo, J. Thiel, M. Villa
|
|
2026 POS0991
|
IDENTIFICATION OF CLONALLY EXPANDED CYTOMEGALOVIRUS-SPECIFIC EFFECTOR MEMORY GZMK+ CD8 T CELLS IN ANCA-ASSOCIATED VASCULITIS,
L. S. van Dam, M. Zhang, J. S. Moon, S. Moutusy, F. Held, S. Parsafar, A. Horomanski, O. Sharpe, J. R van Leeuwen, T. Lanz, C van Kooten, Y. K. O. Teng, W. Robinson
|
|
2026 POS0993
|
STRATIFICATION OF AAV PATIENTS ACCORDING TO PR3-SPECIFIC SERUM IMMUNOGLOBULIN ISOTYPE ASSOCIATES WITH DISEASE ACTIVITY AND CLINICAL MANIFESTATIONS,
V. Facchini, G. Boscato Sopetto, R. Corbellari, N. Jayachamarajapura Onkaramurthy, F. Ravanelli, A. Hummel, M. F. Konig, M. Pandey, D. Cornec, U. Specks, A. Berti
|
|
2026 POS1019
|
CD45RC EXPRESSION CORRELATES WITH LYMPHOCYTIC INFILTRATION IN SALIVARY GLANDS: PROOF-OF-CONCEPT OF THERAPEUTIC AND BIOMARKER POTENTIAL IN SJOGREN’S DISEASE,
J. Deprez, D. Creytens, K. Swinnen, S. Vanhoof, H. Achten, L. H. Ouisse, N. Vimond, C. Guillonneau, R. Van Brempt, I. Peene, D. Elewaut
|
|
2026 POS1023
|
SYNOVIAL CD4+HLADR+ EFFECTORS RESISTANCE TO REGULATION AND INFLAMMATORY METABOLIC REPROGRAMMING IN JUVENILE IDIOPATHIC ARTHRITIS,
J. Y. Leong, P. Kumar, S. H. Tay, G. Mijnheer, A. J. M. Lim, S. Hazirah, J. G. Yeo, A. Consolaro, M. Gattorno, T. Arkachaisri, F. van Wijk, A. Martini, S. Albani
|
|
2026 POS1056
|
CC312, A NOVEL CD19/CD3/CD28 TRI-SPECIFIC T CELL ENGAGER, LEADS TO RAPID AND DEEP B-CELL DEPLETION AND HAS BROAD POTENTIAL FOR DEVELOPMENT IN AUTOIMMUNE DISEASES,
J. Qi, Y. Huang, R. Zhang, J. Zhen, X. Zhang, Y. wei, M. Sun
|
|
2026 POS1115
|
TL1A AND TL1A-DRIVEN INFLAMMATORY PATHWAYS ARE UPREGULATED IN RA, PSA AND AXSPA,
H. Llewellyn, I. S. Jang, A. Baghela, A. Jeon, M. Sze, S. Y. Liu, L. Hegde, M. Tang, J. Woodhouse, E. Munoz
|
|
2026 POS1117
|
THE ACTIVATING LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR A3 (LILRA3) EXHIBITS INHIBITORY EFFECTS ON STIMULATED B CELLS,
J. Grupa, F. Mulenge, C. Ehlers, K. Kniesch, B. Costa, U. Kalinke, T. Witte, T. Graalmann, G. Ahrenstorf
|
|
2026 POS1121
|
DEVELOPING TWO DISTINCT ORGANOID-BASED MODELS TO STUDY FAILING MATERNAL-FETAL TOLERANCE IN SYSTEMIC LUPUS ERYTHEMATOSUS,
W. Dankers, D. Bakkenes, J. van Voorden, S. Boussata, R. Keijser, J. van Ruitenbeek, D. Biskop, M. de Boer, I. E. M. Bultink, G. Afink, L. van Baarsen
|
|
2026 POS1122
|
PRECLINICAL AND TRANSLATIONAL ASSESSMENT OF SMALL MOLECULE IRF5 INHIBITORS IN LUPUS-RELEVANT SYSTEMS,
N. Lewis, G. Zhao, M. Weir, K. Smith, C. Lamarque, N. Perez, H. Sun, G. Harriman, J. Wahle
|
|
2026 POS1127
|
MECHANISTIC AND TRANSLATIONAL PRECLINICAL EVALUATION OF GENSCI136, A LONG-ACTING DUAL BAFF/APRIL INHIBITOR, IN SYSTEMIC LUPUS ERYTHEMATOSUS,
B. Qu, Q. Hao, P. Qi, Y. Chen, J. Wang, Y. Lu, X. liu, H. Wang, D. Ren, L. Dai, J. Cao, G. Xia, H. Zhang, X. Wang, S. Wang, L. Jin
|
|
2026 POS1135
|
A NOVEL MOUSE MODEL OF SYSTEMIC LUPUS ERYTHEMATOSUS FOR EFFICACY EVALUATION OF CD3/BCMA T CELL ENGAGERS,
J. Liang, T. Wang
|
|
2026 POS1142
|
MULTI-DIMENSIONAL ANALYSIS OF THE B CELL COMPARTMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS REVEALS EFFECTOR AND REGULATORY PERTURBATIONS,
R. Cheong, K. Nay Yaung, N. K. H. Khoo, M. Wasser, A. Chia, M. Noviani, T. C. Tan, S. L. Poh, J. Thumboo, T. Arkachaisri, A. Low, S. Albani, J. G. Yeo
|
|
2026 POS1148
|
INTEGRATED SPATIAL TRANSCRIPTOMICS AND PROTEOMICS REVEALS ABERRANT LYMPHOID NETWORKS AND STROMAL DAMAGE PATTERNS IN PEDIATRICS LUPUS NEPHRITIS,
N. Hasle, R. C. Reed, G. Schultz, M. Conner, R. Martin, S. W. Jackson
|
|
2026 POS1161
|
IMMUNOMODULATION WITH ANTI-TNF THERAPY, INTRALIPID INFUSIONS AND CORTICOSTEROIDS IS ASSOCIATED WITH HIGHER LIVE-BIRTH RATES IN WOMEN WITH RECURRENT PREGNANCY LOSS: A LARGE OBSERVATIONAL COHORT STUDY,
N. Abisror, M. Cheloufi, G. Kayem, J. Cohen, C. McAvoy, K. Kolanska, V. Grobost, N. Belhomme, A. Coulomb, M. Devaux, V. Poindron, O. Fain, A. Mekinian
|
|
2026 POS1203
|
LOW-DOSE INTERLEUKIN-2 FOR RECURRENT EARLY PREGNANCY LOSS: A PROOF-OF-CONCEPT STUDY,
A. Mekinian, N. Abisror, C. McAvoy, C. Ribet, R. Lorenzon, E. Vicaut, M. Rosenzwajg, O. Fain, D. Klatzmann
|
|
2026 POS1306
|
PD-L1 RELATED MECHANISMS DISTINGUISH CD4+ T CELLS IN THE PRE-CLINICAL AND EARLY STAGES OF RHEUMATOID ARTHRITIS,
V. Chandrasekaran, M. Erlandsson, R. Modigh, R. Pullerits, M. I. Bokarewa
|
|
2026 POS1311
|
ELEVATED SERUM ANTI-CD27 ANTIBODIES ARE ASSOCIATED WITH DISEASE ACTIVITY AND TREATMENT RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS,
M. Li, Y. Han, Z. Li, Y. Jin, Y. Li, Q. Wang, J. He
|
|
|
[66]
|
Aging
|
|
|
| 2026 |
|
2026 AB0042
|
IMPACT OF AGE ON COMPLICATIONS, TREATMENT TOLERANCE AND MORTALITY IN INFECTIOUS SPONDYLODISCITIS,
S. Boussaid, A. Fayache, B. Kort, K. Zouaoui, S. Rahmouni, S. Rekik, H Sahli
|
|
2026 AB0070
|
GENETIC INTEGRATION OF MITOCHONDRIAL AND NUCLEAR VARIANTS IMPROVES PREDICTION OF METABOLIC SYNDROME–RELATED KNEE OSTEOARTHRITIS,
J. Vázquez-García, A. Morano Torres, L. Martínez-Sotodosos, D. Noriega, S. Relaño-Fernandez, N. Oreiro, F. J. Blanco, I. Rego-Perez
|
|
2026 AB0109
|
A GLYCOLYTIC GATE IN BONA FIDE RECENT THYMIC EMIGRANTS COUPLES THYMIC OUTPUT TO BLOOD–SYNOVIUM INFLAMMATION ACROSS PRE-CLINICAL AND ESTABLISHED RHEUMATOID ARTHRITIS,
Z. Yang, R. Song, M. Souto-Carneiro
|
|
2026 AB0385
|
AGE AT DIAGNOSIS SHAPES FMF PHENOTYPE: CLINICAL, GENETIC AND THERAPEUTIC DIFFERENCES IN A COHORT OF LATE ONSET FAMILIAL MEDITERRANEAN FEVER PATIENTS,
E. Çal, S. Sezer, Z. Karaman Ongun, A. Usta, Ç. Ergül, A. Ilbay, N. Göveç Giynaş, A. Gaydan, E. Uslu, M. E. Yayla, A. Ates, T. M. Tufgay
|
|
2026 AB0541
|
PERFORMANCE OF TRADITIONAL FRACTURE RISK PREDICTORS FOR PREVALENT FRAGILITY FRACTURE IN POST-MENOPAUSAL WOMEN: AN NHS DXA COHORT STUDY,
V. Sahu, M. Bukhari
|
|
2026 AB0551
|
BELIEFS AND KNOWLEDGE ABOUT OSTEOPOROSIS AMONG FRENCH POSTMENOPAUSAL WOMEN ACCORDING TO THEIR BONE STATUS (FRACTURED OR NOT) AND DEMOGRAPHIC CHARACTERISTICS,
H. Boutard, T. Conrozier, A. Lohse
|
|
2026 AB0552
|
IMPACT OF FRAXplus ADJUSTMENTS VERSUS FRAX ON FRACTURE RISK CLASSIFICATION IN THE SWISS OSTEOPOROSIS REGISTRY,
C. Martignoni, O. Lehmann, M. Wenger, S. Oser, M. Toniolo, G. Schmid, U. C. Studer, C. Steiner, H. R. Ziswiler, S. Reichenbach, A. Thoma, H. Johansson, T. Lehmann, E. McCloskey, J. Everts-Graber
|
|
2026 AB0613
|
DAYTIME NAPPING IS ASSOCIATED WITH SKELETAL MUSCLE DEGENERATION: EVIDENCE FROM TWO INDEPENDENT COHORTS,
T. Sha, W. Li, Y. Zhang, J. Xie, N. Lane, C. Li, J. Wei, G. Lei, C. Zeng, H. Wang, Y. Wang
|
|
2026 AB0643
|
ASSOCIATIONS OF AGE, SEX, BMI, AND PHYSICAL ACTIVITY WITH TENDON STIFFNESS MEASURED BY SHEAR WAVE ELASTOGRAPHY,
R. Jari, A. L. Tan, S. Mallett, P. O’Connor, R. J. Wakefield
|
|
2026 AB0654
|
NEUROCOGNITIVE EFFECTS OF LONG-TERM COLCHICINE USE IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER AND GOUT,
R. Deniz, R. Mirza Altintas, A. Kanat, H. İ. Altintaş, C. Bes
|
|
2026 AB0779
|
FRAILTY IN RHEUMATOID ARTHRITIS AND THE GENERAL POPULATION: A COMPARISON OF TWO MEASUREMENT APPROACHES,
S. Truijen, A. Boonen, S. Ramiro, M. van Onna
|
|
2026 AB0808
|
RHEUMATOID SARCOPENIA DRIVES FUNCTIONAL FRAILTY DESPITE REMISSION IN RHEUMATOID ARTHRITIS: A ONE-YEAR PROSPECTIVE COHORT STUDY,
Y. Saito, M. Suzuki, K. Terabe, H. Yamamoto, Y. Saito, T. Sato, S. Asai, S. Imagama
|
|
2026 AB0834
|
THE INTERPLAY OF SYSTEMIC INFLAMMATION AND LDL-CHOLESTEROL ON ARTERIAL STIFFNESS AND HEMODYNAMIC IN RHEUMATOID ARTHRITIS: A MULTIMODAL VASCULAR STUDY,
S. Surya Rini, G. Kambayana, P. K. Kurniari, P. Patriawan, M. D. Ayusta
|
|
2026 AB0847
|
SERIOUS INFECTIONS IN OLDER ADULTS WITH RHEUMATOID ARTHRITIS TREATED WITH DMARDs,
M. Kramer, D. Huschek, P. Herzer, J. Detert, C. Kühne, A. Richter, A. Strangfeld
|
|
2026 AB0893
|
SEX-SPECIFIC PATTERNS OF HEALTH-RELATED QUALITY OF LIFE IN OLDER ADULTS WITH RHEUMATOID ARTHRITIS: A CASE-CONTROL ANALYSIS OF PHYSICAL AND MENTAL HEALTH DOMAINS,
J. M. Nolla, L. Valencia Muntalà, D. Benavent, L. Berbel Arcobe, P. Vidal-Montal, J. Palacios-Olid, M. Roig-Kim, M. Aguilar-Coll, F. J. Narváez Garcia, C. Gómez Vaquero
|
|
2026 AB0896
|
FALL AWARENESS AND ITS DETERMINANTS IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS: A CROSS-SECTIONAL STUDY,
Y. F. Niu, T. Gao, F. P. Lian, X. X. Kang, K. Dong, S. X. Zhang
|
|
2026 AB0907
|
THE IMPACT OF AGE ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS COMPARED TO POPULATION CONTROLS: A CROSS-SECTIONAL ANALYSIS,
S. Truijen, A. Boonen, S. Ramiro, M. van Onna
|
|
2026 AB0939
|
CLINICAL AND FUNCTIONAL IMPLICATIONS OF BDMARD SWITCHING IN ELDERLY RHEUMATOID ARTHRITIS PATIENTS AFTER 1ST BDMARD FAILURE: EVIDENCE FROM AN OVERLAP-WEIGHTED REAL-WORLD ANALYSIS,
S. H. Chang, S. W. Lee, I. Choi, G. G. Song
|
|
2026 AB1127
|
CLINICAL AND HISTOPATHOLOGICAL CHARACTERISTICS OF LATE-ONSET LUPUS NEPHRITIS,
H. Nagaoka, K. Hiramoto, H. Takei, H. Fukui, K. Suzuki, J. Kikuchi, Y. Kaneko
|
|
2026 AB1170
|
AGE AT DISEASE ONSET IS ASSOCIATED WITH THE ANNUAL SDI PROGRESSION RATE IN SYSTEMIC LUPUS ERYTHEMATOSUS,
B. Köksoy, D. Yildirim, I. Karaduman, I. Y. Çakir, E. Eseroglu, B. Karakaya, E. C. Bolek, H. Küçük, B. Göker, M. A. Öztürk, A. Erden
|
|
2026 AB1270
|
SELEXIPAG FOR PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH SYSTEMIC SCLEROSIS: RESULTS FROM THE EUROPEAN SCLERODERMA TRIALS AND RESEARCH GROUP (EUSTAR) DATABASE,
C. Campochiaro, M. G. Lazzaroni, L. Moschetti, G. De Luca, S. Bellando-Randone, E. Zanatta, G. Moroncini, M. De Santis, M. Hughes, J. Jose Alegre Sancho, G. Boleto, P. Airò, F. Del Galdo, M. Kuwana, M. E. Truchetet, M. Matucci-Cerinic, M. Vonk
|
|
2026 AB1306
|
EFFICACY AND SAFETY OF INDUCTION AND TAPERING THERAPY WITH TOFACITINIB AND GLUCOCORTICOID IN PATIENTS WITH POLYMYALGIA RHEUMATICA (ITTG PMR): AN OPEN-LABEL RANDOMIZED CONTROLLED TRIAL,
Y. He, C. Shao, J. Lin, W. Chen
|
|
2026 AB1311
|
COMPARATIVE STUDY OF GLUCOCORTICOID TAPERING TRAJECTORIES BETWEEN CONSEQUENT TWO TREATMENT ERAS IN GIANT CELL ARTERITIS: IMPACT OF AN UPFRONT TOCILIZUMAB STRATEGY IN REAL-WORLD PRACTICE,
A. Mitsui, N. Sugitani, Y. Arinuma, S. Sakakura, T. Shibahara, Y. Nakamura, Y. Tachi, M. Akiyama, Y. Ito, A. Nakajima
|
|
2026 AB1349
|
CLINICAL CHARACTERISTICS AND OUTCOMES OF ELDERLY-ONSET ANCA-ASSOCIATED VASCULITIS: A RETROSPECTIVE COHORT STUDY,
E. Uslu, Z. Karaman Ongun, F. M. Dogan, H. N. Koc Kanik, D. Sahin, S. Sezer, M. E. Yayla, D. Tecer, M. Cinar, A. Ates, T. M. Turgay, S. Yilmaz
|
|
2026 AB1387-HPR
|
MECHANISMS LINKING ORAL HEALTH TO FRAILTY IN RHEUMATOID ARTHRITIS: A STRUCTURAL EQUATION MODELLING STUDY WITH IMPLICATIONS FOR INTEGRATED CARE,
X. Si, Q. Q. Qiao, F. P. Lian, J. Dai
|
|
2026 AB1407-HPR
|
ARE SHORT-TERM BENEFITS OF PLATELET-RICH PLASMA DISTINCT FROM TOPICAL DICLOFENAC IN KNEE OSTEOARTHRITIS? RESULTS FROM A PILOT COMPARATIVE STUDY,
S. Karabörklü Argut, A. Erekdağ, D. Çelik, O. Ergin
|
|
2026 AB1410-HPR
|
VALIDATED TOOLS FOR ASSESSING INTRINSIC CAPACITY AND ITS COMPONENTS WITHIN A POSITIVE AGEING FRAMEWORK: A SCOPING REVIEW,
Y. Henrotin, L. Aguera, G. Briganti, T. Cederholm, D. Diracoglu, G. Franco, A. J. Cruz-Jentoft, K. Piotrowicz, S. Vandenput, S. Duque
|
|
2026 OP0120
|
MOSAIC LOSS OF THE Y CHROMOSOME DIFFERENTIATES GIANT CELL ARTERITIS FROM POLYMYALGIA RHEUMATICA ACROSS THE GCA–PMR SPECTRUM,
S. M. Petzinna, S. M. Kirch, M. S. Adamson, C. J. Bauer, S. Zimmer, R. N. Jamin, V. S. Schäfer
|
|
2026 OP0144-HPR
|
COURSE OF ITCH FROM SYSTEMIC SCLEROSIS ONSET: A SCLERODERMA PATIENT-CENTERED INTERVENTION NETWORK COHORT STUDY,
M. Golberg, C. Dal Santo, M. E. Carrier, L. Kwakkenbos, T. Frech, S. Hoa, E. Netchiporouk, L. Misery, J. A. Lapointe McKenzie, S. Rideout, M. Sauvé, A. Philip, J. Pope, G. Yosipovitch, S. J. Bartlett, B. Chaigne, C. Fortune, A. Gietzen, K. Gottesman, G. Guillot, L. Hummers, A. Lawrie-Jones, V. Malcarne, M. D. Mayes, M. Richard, J. Stempel, R. Wojeck, L. Mouthon, A. Benedetti, B. Thombs
|
|
2026 OP0179
|
EROSIVE HAND OSTEOARTHRITIS IS ASSOCIATED WITH INCREASED RISK OF INCIDENT OSTEOPOROTIC FRACTURES IN POST-MENOPAUSAL WOMEN,
M. Auroux, A. Mercier, A. Piot, B. Merle, M. Proriol, E. Fontanges, F. Duvert, E. Lespessailles, R. Chapurlat
|
|
2026 OP021-PARE
|
“FALL PREVENTION FOR BETTER AGEING” PROJECT FOR ADULTS OVER 65 WHO HAVE RHEUMATIC AND MUSCULOSKELETAL CONDITIONS. PRINCIPAL AUTHOR: MACHI SALAMALIKI-SPANOU,HELLENIC LEAGUE AGAINST RHEUMATISM,
M. Spanou Salamaliki
|
|
2026 OP0243
|
MENOPAUSAL STATUS INFLUENCES DISEASE SEVERITY AND REMISSION IN WOMEN WITH RHEUMATOID ARTHRITIS STARTING BIOLOGIC DMARDs: A REAL-WORLD EVIDENCE STUDY FROM THE MULTICENTER PROSPECTIVE BIOlogic aPUlian REgistry (BIOPURE),
S. Perniola, M. Fornaro, C. Rotondo, G. Carlino, L. Dinoia, S. Lopriore, L. Quarta, L. Santo, A. Semeraro, L. Serafino, F. P. Cantatore, F. Iannone
|
|
2026 OP0246
|
PERIMENOPAUSE IS ASSOCIATED WITH INCREASED DISEASE ACTIVITY IN PSORIATIC ARTHRITIS,
L. Eder, X. Li, S. Koppikar, I. Lega, D. Gladman, V. Chandran, R. Cook
|
|
2026 OP0260
|
ASSOCIATIONS OF CLINICAL BIOMARKER- AND PROTEOMIC-BASED BIOLOGICAL AGING WITH AUTOIMMUNE DISEASE INCIDENCE AND LIFE EXPECTANCY,
M. Song, C. Yun
|
|
2026 OP049
|
SUPERIOR CORRELATION WITH CLINICAL ACTIVITY AND UNIQUE DETECTION PATTERNS: A PROSPECTIVE STUDY OF FAPI VERSUS FDG-PET IN POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS,
W. Chen, X. Han, J. Lin
|
|
2026 OP060
|
DURABLE EFFICACY AT 6 MONTHS USING AN INNOVATIVE INTRA-ARTICULAR APOPTOTIC CELL THERAPY IN KNEE OSTEOARTHRITIS: DATA FROM A PHASE IIA RCT,
P. G. Conaghan, B. Husøy, C. Rovsing, S. L. Boll, L. Groppa, A. Mobasheri, T. Winkler, A. Vishne, A. Shaham, E. Berkman, L. Weinfeld-Bergman, L. Binder, A. R. Bihlet, O. Hershkovitz, E. Galamidi, D. Mevorach, A. Oron
|
|
2026 POS0026
|
RISK OF DIGESTIVE PERFORATION AMONG PATIENTS WITH POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS TREATED WITH ANTI-IL6-RECEPTOR THERAPIES,
B. Chevet, N. Emmanuel, T. Marhadour, A. Tison, B. Quere, D. Cornec, D. Guellec, S. Querellou, A. Saraux, V. Devauchelle-Pensec
|
|
2026 POS0056
|
PLASMA PROTEOMICS IDENTIFIES FABP4 AS A KEY BIOMARKER FOR OBESITY-RELATED KNEE OSTEOARTHRITIS,
Y. Zhao, J. Huang, G. Sun, A. Furey, P. Rahman, G. Zhai
|
|
2026 POS0109
|
WHAT HAPPENS TO PATIENTS WITH FMF AFTER THE AGE OF 50? A RE-EVALUATION OF THE AGING COURSE,
B. Firlatan Yazgan, D. Donmez, M. E. Ozkan, O. A. Ates, T. H. Akbaba, A. I. Bayram, L. Kiliç, Z. Y. Akkaya Ulum, T. Yildirim, U. Kalyoncu, B. Balci Peynircioglu, O. Karadag
|
|
2026 POS0184
|
ASSOCIATIONS OF FRAILTY STATUS AND TRAJECTORIES WITH INCIDENT ARTHRITIS IN OLDER ADULTS: FINDINGS FROM THE HEALTH AND RETIREMENT STUDY AND THE ENGLISH LONGITUDINAL STUDY OF AGEING,
J. Shen, H. Zhang
|
|
2026 POS0235
|
CROSS-SECTIONAL AND LONGITUDINAL ASSOCIATION BETWEEN BIOLOGICAL AGING ACCELERATION AND THE RISK OF OSTEOARTHRITIS: A COHORT STUDY FROM UK BIOBANK,
S. Liu, W. Wang, C. Li, Y. Lai, Z. Zhou, M. Han, Y. Zhang, Y. Zhang, K. Tang, H. Sun, Q. Yang, M. Zeng, T. Fan, Z. A. Li, C. Ding, D. Hunter, Z. Zhu
|
|
2026 POS0269
|
SEQUENTIAL TEMPORAL ARTERY BIOPSIES REVEAL TISSUE-LEVEL PERSISTENCE OF NEUTROPHILIC AND SENESCENT INFLAMMATORY DRIVERS IN GCA PATIENTS FOLLOWING TOCILIZUMAB TREATMENT,
C. Spyropoulos, C. Ricordi, E. Adam, P. Palla, D. Palamidas, L. Chatzis, A. V. Goules, A. Cavazza, S. Croci, C. Salvarani, A. Tzioufas, K. Kambas
|
|
2026 POS0314
|
PERIPHERAL LYMPHOPENIA IN SJÖGREN’S DISEASE IS DRIVEN BY TYPE I INTERFERON–MEDIATED DISRUPTION OF THE IL-7/IL-7R SIGNALING AXIS,
P. Javorova, E. Zuegner, M. Rados, M. Reisch, C. Magnes, J. Thiel, J. Fessler, M. Stradner
|
|
2026 POS0346-HPR
|
IMPROVING ADHERENCE TO FALL PREVENTION EXERCISE IN OLDER ADULTS WITH A HISTORY OF FALLS: A CLUSTER RANDOMISED TRIAL OF BRIEF ACTION PLANNING TRAINING AND DIGITAL SUPPORT FOR PHYSIOTHERAPISTS,
L. Li, H. Xie, N. Lu, J. Davis, M. Oakey, D. Bayraktar, J. Xu, S. Therrien, Y. S. Seo, E. Wang, C. Primeau, J. Ma, J. Mollins, C. Shaw, D. Jehu, T. Liu-Ambrose
|
|
2026 POS0357
|
IDENTIFICATION OF MUSCLE FUNCTIONAL VULNERABILITY PHENOTYPES IN OLDER PATIENTS WITH RHEUMATOID ARTHRITIS USING UNSUPERVISED MACHINE LEARNING,
J. M. Nolla, C. Gómez Vaquero, L. Valencia Muntalà, L. BERBEL ARCOBE, P. Vidal-Montal, L. De Daniel, M. Aguilar-Coll, M. Roig-Kim, F. J. Narváez Garcia, D. Benavent
|
|
2026 POS0360
|
PHYSICAL FUNCTION IN OLDER PEOPLE WITH RHEUMATOID ARTHRITIS AND POPULATION CONTROLS: A CROSS-SECTIONAL STUDY OF SELF-REPORTED AND PERFORMANCE-BASED MEASURES,
S. Truijen, A. Boonen, S. Ramiro, M. van Onna
|
|
2026 POS0362
|
INCIDENCE AND PREDICTORS OF FRAILTY IN RHEUMATOID ARTHRITIS: A POPULATION-BASED COHORT STUDY,
M. Allen, N. Frechette, R. Salama, S. Achenbach, C. S. Crowson, E. Myasoedova
|
|
2026 POS0376
|
IMMUNE RESPONSE TO RECOMBINANT HERPES ZOSTER VACCINE IN PATIENTS WITH INFLAMMATORY RHEUMATIC MUSCULOSKELETAL DISEASES - A PROSPECTIVE LONGITUDINAL STUDY OVER 12 MONTHS,
B. Wilde, E. Steiner, A. Eliakopoulos, D. Chen, I. Andreica, R. stefania, I. gianna, P. Köhler, D. Kiefer, J. Guenzel, P. Sewerin, H. Kavruk, D. Karagkiozidou, J. Braun, R. Brinks, X. Baraliakos, U. Kiltz
|
|
2026 POS0409
|
CLONAL HEMATOPOIESIS AS A SECOND HIT DRIVING ATYPICAL AND SEVERE MANIFESTATIONS IN ADULT FAMILIAL MEDITERRANEAN FEVER,
P. Mertz, K. Olivier, J. Rossignol, L. Savey, M. Delplanque, R. Bourguiba, S. Ardois, Z. Amoura, J. Haroche, P. Seksik, C. Mellaza, S. Berkani, D. Larivière, R. Dhote, S. Trad, G. Leroux, T. A. Szwebel, J. E. Kahn, J. Sellam, F. Chasset, R. Itzykon, O. Hermine, P. Hirsch, S. Georgin-Lavialle
|
|
2026 POS0601
|
CLONAL HEMOPOIESIS OF INDETERMINATE PROGNOSIS AND RELAPSES IN PATIENTS WITH GIANT CELL ARTERITIS,
O. Cellier, P. Hirsch, A. Lejoncour, A. C. Desbois, F. Domont, G. Leroux, G. Maalouf, C. Marques, A. Rigolet, M. Vieira, P. Cacoub, D. Saadoun, A. Mirouse
|
|
2026 POS0610
|
LIFETIME RISK OF MALIGNANCY IN POLYMYALGIA RHEUMATICA: A POPULATION-BASED MATCHED COHORT STUDY FROM SOUTHERN NORWAY,
S. Tengesdal, Ø. Molberg, Ø. Holme, R. Ghiasvand, J. T. Gran, G. Myklebust
|
|
2026 POS0619
|
FRAILTY IN POLYMYALGIA RHEUMATICA: A LONGITUDINAL COHORT STUDY,
P. Harkins, S. Cowley, D. Molloy, D. Kane, R. Conway
|
|
2026 POS0641-HPR
|
PROTEOMIC PROFILING MEDIATES THE ASSOCIATION BETWEEN DEGENERATIVE JOINT DISEASES AND DEMENTIA RISK,
Z. Kang, J. Zhang, Q. Tong, S. M. Dai
|
|
2026 POS0734-HPR
|
EVALUATING THE CAUSAL ASSOCIATIONS BETWEEN CLONAL HEMATOPOIESIS AND ITS SUBTYPES AND RHEUMATOID ARTHRITIS: A BIDIRECTIONAL MENDELIAN RANDOMIZATION STUDY,
N. Li, R. Wu, Q. Feng, Y. Mu, C. Wang
|
|
2026 POS0736-HPR
|
BIOLOGICAL AGE ACCELERATION AS A RISK FACTOR FOR ARTHRITIS: EVIDENCE FROM COLOMBIA,
J. arias, P. Santos-Moreno, M. Zapata-Victoria, J. Vargas, J. C. Rivillas
|
|
2026 POS0763
|
PERIPHERAL BLOOD UBA1 VARIANT ALLELE FREQUENCY PREDICTS POOR OUTCOMES IN VEXAS SYNDROME: A NATIONWIDE PROSPECTIVE STUDY,
Y. Kirino, A. Maeda, H. Nakajima
|
|
2026 POS0856
|
INCLUSION OF OLDER ADULTS IN PHARMACOLOGIC RANDOMIZED CONTROLLED CLINICAL TRIALS OF AUTOIMMUNE RHEUMATIC DISEASES: A SYSTEMATIC REVIEW,
M. Carpio Tumba, R. Lomanto Silva, L. Sung, L. Pedraza, S. Gupta, J. Gwak, A. Mohamadi, D. Louden, R. Stovall, N. Singh, D. Saygin, A. Palmowski, S. Lieber, J. Lee, S. Sattui
|
|
2026 POS0890
|
LOSS OF EXPRESSION OF THE UBIQUITOUS CO-STIMULATORY CD27 AND CCR7 CHARACTERIZES A POPULATION OF RA ASSOCIATED MIGRATORY CD4+ T EFFECTOR CELLS,
L. Braune, H. R. Spatzier, P. Nguyen, A. K. Schierack, R. Scholz, H. Apel, C. Bach, F. Gaunitz, M. Krasselt, O. Seifert, A. M. Glimm, M. Pierer, L. Uhlmann, T. Hagemann, U. Wagner, K. Rothe
|
|
2026 POS0898
|
TARGETING NAD+ METABOLISM IN INFLAMMATORY RHEUMATIC DISEASES: IMPACT OF ANTI-TNF THERAPY AND NAD+ SUPPLEMENTATION,
B. Vellón-García, A. Escudero-Contreras, G. D. García-Delgado, A. Llamas-Urbano, Y. Hanaee, P. Ortiz-Buitrago, C. Merlo, L. Romero-Zurita, M. D. C. Abalos-Aguilera, D. Ruiz-Vilchez, M. Á. Puche-Larrubia, I. Arias-de la Rosa, M. D. López Montilla, E. Collantes-Estevez, C. Aranda-Valera, I. Gómez-García, R. Ortega-Castro, J. Calvo-Gutiérrez, M. L. Ladehesa-Pineda, C. López-Medina, N. Barbarroja, C. Lopez-Pedrera, J. M. Villalba, C. Perez-Sanchez
|
|
2026 POS0914
|
MODERATE-TO-SEVERE DISEASE SEVERITY IS ASSOCIATED WITH HIGHER MOTOR VEHICLE COLLISION RISK IN A COMBINED GROUP OF PEOPLE WITH OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS: DATA FROM THE CANDRIVE OLDER DRIVER STUDY,
C. Godbout, S. Marshall, M. Campbell
|
|
2026 POS1086
|
SYSTEMIC SCLEROSIS IN THE ELDERLY. EVALUATION OF DISEASE MANIFESTATIONS, COMORBIDITIES AND SURVIVAL IN GERIATRIC SYSTEMIC SCLEROSIS,
J. Igweze, A. Omar, M. Movahedi, Z. Ahmad, M. Soowamber, S. R. Johnson
|
|
2026 POS1198
|
ASSOCIATION OF ACCELERATED BIOLOGICAL AGING WITH 20 AUTOIMMUNE DISEASES: INSIGHTS FROM UK BIOBANK PARTICIPANTS,
W. Wang, S. Liu, T. Chen, C. Li, H. Zhang, J. Chen, M. Zeng, G. Ruan, F. Pan, D. Chen, L. Jie, S. Yuan, J. C. C. Wei, C. Ding, Z. Zhu
|
|
2026 POS1210
|
RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS ASSOCIATED WITH JAK INHIBITORS VERSUS TNF INHIBITORS IN ELDERLY PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES: A NATIONWIDE POPULATION-BASED COHORT STUDY,
R. Curmin, B. Fautrel, Y. de-rycke, T. Pham, C. Miceli Richard, J. Kirchgesner, F. Tubach
|
|
2026 POS1228
|
THREE-MONTH TREATMENT TARGETS FOR ACHIEVING GLUCOCORTICOID-FREE REMISSION AT 12 MONTHS IN LATE-ONSET RHEUMATOID ARTHRITIS,
T. Sugihara, M. Kojima, Y. Kawahito, T. Kojima, K. Matsui, H. Ishikawa, S. Hirata, Y. Kaneko, E. Tanaka, M. Kishimoto, A. Morinobu, M. Hashimoto, I. Matsushita, T. Hidaka, K. Nishida, H. Ito, T. Matsui, R. Harada, A. Abe, M. Ishitoku, T. Kida, S. Takanashi, K. Maeda, A. Onishi, S. Asai, T. Nanki, M. Harigai
|
|
2026 POS1293
|
ASSOCIATION BETWEEN SERUM MMP-3 LEVELS AND COGNITIVE FUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS,
M. Tada, Y. Matsumoto, T. Nakamura, H. Goto, M. Matsuura
|
|
2026 POS1326
|
TREAT-TO-TARGET STRATEGIES WITHOUT PHARMACOLOGIC RESTRICTIONS ARE FEASIBLE IN ELDERLY-ONSET RHEUMATOID ARTHRITIS DUE TO A RISK-BENEFIT PROFILE COMPARABLE TO YOUNG-ONSET RHEUMATOID ARTHRITIS,
H. H. Dag, M van Onna, R. J. E. M. Dolhain, P. H. P. de Jong
|
|
|
[51]
|
And Inclusion (DEI)
|
|
|
| 2026 |
|
2026 AB0008
|
DOES HORMONE REPLACEMENT THERAPY IN TRANSGENDER PATIENTS AFFECT THE RISK OF DEVELOPING RHEUMATOLOGIC AND AUTOIMMUNE DISEASE?,
P. Velagapudi, F. Rodriguez, A. Lau, C. Pena, I. Tan
|
|
2026 AB0062
|
MISSED, DISMISSED, AND DELAYED: CAREGIVER-REPORTED MISDIAGNOSIS AND DIAGNOSTIC DELAY IN JUVENILE IDIOPATHIC ARTHRITIS,
M. Metcalfe, S. Marett, I. Gadsby, S. Brown, M. Hollis
|
|
2026 AB0077
|
INTERVENTIONS AIMED AT ADVANCING GENDER EQUITY IN RHEUMATOLOGY: INSIGHTS FROM THE COALITION FOR HEALTH AND GENDER EQUITY (CHANGE) SURVEY,
T. Talreja, L. Minikumari Rahulan, P. V. Ovseiko, M. Sarkar, L. Gossec, J. Day, L. Traboco, A. M. Russel, S. A. Haq, C. Hill, D. Dey, N. Hassan, A. M. Babini, A. M. Arredondo-González, C. E. Toro-Gutierrez, C. Duftner, D. Alpizar-Rodriguez, H. M. Badsha, E. Nikiphorou, G. Harifi, I. Hmamouchi, J. Von Feldt, J. Boechat Farani, A. Ali Kalla, L. Andreoli, M. Peixoto, L. S. Tam, P. Esther Palominos, R. Nakashima, Y. Tanaka, W. Bautista-Molano, V. Agarwal, N. Ziade, G. Wright, L. C. Coates, L. Gupta
|
|
2026 AB0095
|
COMPARATIVE STUDY OF CONTRIBUTIONS FROM LOW-AND MIDDLE-INCOME COUNTRIES IN HIGH-IMPACT GLOBAL RHEUMATOLOGY RESEARCH,
R. Martinez-Canales, Á. B. Ruiz-García, J. E. Ruiz-García, B. R. Avalos García, D. Rodriguez-Garibay, L. Perez-Barbosa, C. M. Skinner-Taylor, D. A. Galarza-Delgado
|
|
2026 AB0096
|
AUTHORSHIP REPRESENTATION FROM LOW- AND MIDDLE-INCOME COUNTRIES (LMICS) IN HIGH IMPACT PUBLICATIONS IN RHEUMATOLOGY: A YEAR IN REVIEW,
R. Martinez-Canales, J. E. Ruiz-García, A. L. Urbina-Lievano, P. F. García-Aguirre, B. R. Avalos García, D. Rodriguez-Garibay, L. Perez-Barbosa, C. M. Skinner-Taylor, D. A. Galarza-Delgado, A. Montoya-Rosales, Á. B. Ruiz-García, N. Macias-Segura
|
|
2026 AB0097
|
SCIENTIFIC IMPACT IS NOT SHARED EQUALLY: GENDER GAPS IN RESEARCH OUTPUT AMONG RHEUMATOLOGY EDITORS,
R. Martinez-Canales, M. Montelongo Rojas, P. S. Gloria-Rojas, N. K. Martinez Lozano, L. M. Saldaña-Rodriguez, B. R. Avalos García, D. Rodriguez-Garibay, L. Perez-Barbosa, C. M. Skinner-Taylor, D. A. Galarza-Delgado
|
|
2026 AB0297
|
PERSONALIZED OUTREACH AND EQUITABLE TREATMENT IN RHEUMATOLOGY,
A. Yu, N. Saleh, D. Choudhary, G. Montesano, M. Kestler, A. Palepu, B. Ohata
|
|
2026 AB0307
|
RECOGNITION OF MENOPAUSE IN RHEUMATOLOGY CONSULTATIONS: A MULTI-SITE SERVICE EVALUATION,
Z. Syrimi, N. Padmanabhan, G. Davies, R. Hendry, Z. Mclaren
|
|
2026 AB0324
|
GENDER AND HEALTH-RELATED QUALITY OF LIFE IN AXIAL SPONDYLOARTHRITIS, PSORIATIC ARTHRITIS AND SYSTEMIC SCLEROSIS: A SCOPING REVIEW,
A. Hamamou, I. Göttgens, I. E. van der Horst-Bruinsma, M. Mulder, S. Oertelt-Prigione
|
|
2026 AB0590
|
DIGITAL SCREENING IDENTIFIES AT-RISK WOKRERS BEFORE PAIN ONSET: ACTIVITY PREDICTS FUNCTION BETTER THAN SYMPTOMS,
N. Tik
|
|
2026 AB0658
|
INCLUSION OF PATIENTS AS PARTNERS IN RHEUMATOLOGY EDUCATION AT THE BRITISH SOCIETY FOR RHEUMATOLOGY (BSR),
R. Benson, S. Ellis, G. Bishop, S. Stones, D. Southam, C. Wincup, P. Watson
|
|
2026 AB0663
|
WHO PARTICIPATES IN RHEUMATOLOGICAL CLINICAL STUDIES? REPRESENTATIVENESS BY NATIONALITY AND GENDER IN REAL-WORLD PRACTICE,
E. Grau García, P. Muñoz-Martinez, M. Simeó Vinaixa, H. Charia, B. Villanueva Mañes, D. Ramos Castro, A. M. Torrat Noves, I. Alcántara Álvarez, A. Pérez Hurtado, P. Antón Enguidanos, B. Díaz Mora, J. A. Román Ivorra
|
|
2026 AB0665
|
IMPOSTOR SYNDROME AMONG RHEUMATOLOGY PROFESSIONALS IN THE PAN AMERICAN LEAGUE OF RHEUMATOLOGY ASSOCIATIONS (PANLAR): GENDER DIFFERENCES AND ASSOCIATED FACTORS,
I. J. Colunga-Pedraza, D. B. Tovar-Bastidas, A. M. Arredondo-González, D. G. Fernández-Ávila, A. Ribeiro, M. F. Brandão de Resende Guimarães, A. C. Bardan-Inchaustegui, E. Guevara-Mejia, D. R. Gil Calderon, C. E. Toro-Gutierrez, D. Alpizar-Rodriguez
|
|
2026 AB0776
|
AI-SUPPORTED PATIENT-FRIENDLY RHEUMATOLOGY LETTERS: TRANSFORMING COMPLEX MEDICAL LANGUAGE INTO ACCESSIBLE COMMUNICATION,
I. Hoffman, K. Vevey, C. Cuigniez, V. De Pourcq, A. Willems, S. Reinenbergh, M. Helbert
|
|
2026 AB1069
|
PATIENT-FOCUSED DRUG DEVELOPMENT IN PRACTICE: HOW PATIENTS WERE INVOLVED IN THE DEVELOPMENT OF THE TREATMENT RESPONSE MEASURE FOR SYSTEMIC LUPUS ERYTHEMATOSUS CLINICAL OUTCOME ASSESSMENT,
R. Koelmeyer, A. Cornet, A. Somers, A. Sluijmers, B. Rubio, C. Hjelmeset, D. Tremarias, D. Kalla, F. Marchiori, G. Tobar, I. Adisa, J. Mills, K. Dantata, N. Yun, S. Nagamori, S. Komati, N. Black, S. Scoggins, S. Gydesen, T. Grimes, V. Haroun, Z. Karakikla Mitsakou, K. Connelly, E. Morand, D. Ayton, K. Liao, J. Buie, J. Andersen
|
|
2026 AB1087
|
EDUCATION STATUS’ ASSOCIATION WITH THE RISK OF EARLY DEATH WITH LUPUS,
L. Hernandez, R. R. Singh
|
|
2026 AB1247
|
SOCIOECONOMIC STATUS APPEARS NOT TO INFLUENCE LONG TERM DISEASE OUTCOME IN A VERY LOW-INCOME SYSTEMIC SCLEROSIS COHORT,
V. Alcantara, A. C. Matias Dinelly Pinto, A. da Rocha, B. Holanda, V. Fonseca, M. Montenegro, F. A. Castro Rocha
|
|
2026 AB1383-HPR
|
THE ASSOCIATION BETWEEN SOCIOECONOMIC STATUS AND DELAYED FIRST CONTACT WITH A GENERAL PRACTITIONER IN RHEUMATOID ARTHRITIS: EVIDENCE FROM LINKED SELF-REPORTED AND NATIONAL REGISTRY DATA,
P. Alsing, E. M. Hauge, S. Daugaard Pedersen, A. de Thurah
|
|
2026 AB1401-HPR
|
USING CO-DESIGN TO DEVELOP INTERVENTIONS TO ADDRESS HEALTH LITERACY NEEDS OF PATIENTS WITH MIGRANT BACKGROUNDS AND INFLAMMATORY RHEUMATIC DISEASES,
L. Treacy, L. M. Alpers, M. Azimi, S. Hakim, B. A. Esbensen, J. Primdahl, H. A. Zangi
|
|
2026 AB1427-HPR
|
ANALYSIS OF SEXUAL DYSFUNCTION IN PRE- AND POSTMENOPAUSAL WOMEN WITH RHEUMATIC DISEASES,
J. P. González-Morales, J. A. Alvarez-Meza, G. Garcia-Arellano, H. T. Rios-Bazaldua, F. Alexandra Medina, S. D. De Jesus Martinez Romero, J. L. Guerrero-Rodriguez, M. E. Corral-Trujillo, M. A. Villarreal-Alarcon, J. A. Cardenas-de la Garza, D. A. Galarza-Delgado
|
|
2026 AB1436-HPR
|
IDENTIFYING SUPPORT NEEDS OF PEOPLE WITH RARE AUTOIMMUNE RHEUMATIC DISEASES (RAIRDS): QUALITATIVE RESEARCH WITH PEOPLE FROM DIVERSE AND UNDERSERVED GROUPS,
S. Janjua, M. Griffiths, J. Orme, I. Berrou, Z. Anastasa, D. Tremarius, A. Hunt, S. Baig, S. Boughan, A. Berry, M. Ndosi, M. Y. Md Yusof, J. C. Robson
|
|
2026 AB1449-PARE
|
WEIGHT STIGMA AMONG PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES,
M. Grammatikopoulou, E. Pardali, A. Gkouvi, N. M. Liapis, D. Poulimeneas, C. Katsiari, D. G. Goulis, D. Bogdanos
|
|
2026 AB1456-PARE
|
SEEING IS UNDERSTANDING! A CO-CREATION APPROACH TO ACCESSIBLE RMD CARDS,
P. Pennings, P. Borsje, H. Koning, N. Krikhaar, L. Couwenberg, F. Eekelen, J. Otker, A. Vossen, P. H. P. de Jong, B. van den Bemt, J. Postma, R. Klaassen, G. Willemsen- de Mey
|
|
2026 AB1464-PARE
|
INFLAMMATORY ARTHRITIS UK A NEW PATIENT-LED CHARITY BRIDGING THE GAP BETWEEN CLINICAL CARE AND LIVED EXPERIENCE,
D. Wilson
|
|
2026 AB1475-PARE
|
BREAKING BARRIERS: UNDERSTANDING OBSTACLES TO CLINICAL TRIAL PARTICIPATION IN PSORIATIC DISEASE AND SHAPING SOLUTIONS FOR INCLUSIVE RESEARCH,
R. Vaz
|
|
2026 AB1476-PARE
|
THE ROLE OF PATIENT PARTNERS IN MAKING DIGITAL HEALTH RESEARCH MORE INCLUSIVE: EXPERIENCES FROM THE REmote MOnitoring OF RHEUMATOID ARTHRITIS (REMORA) RESEARCH PROGRAMME,
M. Al-Attar, K. Staniland, P. Amlani-Hatcher, J. Paton, J. Behan-Devlin, C. Sharp, C. Sanders, W. Dixon, S. van der Veer
|
|
2026 OP0132-HPR
|
HOW THE CONVERSATIONAL HEALTH LITERACY ASSESSMENT TOOL FOR INFLAMMATORY RHEUMATIC DISEASES (CHAT-iRD) CAN HELP TO ADDRESS HEALTH LITERACY IN PRACTICE: A QUALITATIVE STUDY,
J. Pergens, M. M. Bakker, I. Andreica, M. Dey, O. Gershuni, U. Kiltz, S. Makri, E. Nikiphorou, A. de Thurah, M. de Wit, A. Boonen
|
|
2026 OP0133-HPR
|
HEALTH LITERACY NEEDS OF PATIENTS WITH MIGRANT BACKGROUNDS AND INFLAMMATORY RHEUMATIC DISEASES - A QUALITATIVE EXPLORATION,
L. Treacy, L. M. Alpers, M. Azimi, S. Hakim, H. A. Zangi
|
|
2026 OP0136-HPR
|
SEXUAL HEALTH, PLEASURE, JUSTICE, AND WELL-BEING IN PEOPLE WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES: A SYSTEMATIC SCOPING REVIEW,
B. Giardulli, Y. Prior, G. Bumin, G. I. Kinikli, J. Prior, S. Stones, C. Flurey, G. Bertoni, A. Lavender, M. Testa, S. Battista
|
|
2026 OP0156
|
OFF-THE-SHELF DUAL-CAR T-CELL THERAPY: TARGETING B AND T CELLS IN AUTOIMMUNE DISEASE WITHOUT PRECONDITIONING,
N. J. Shiff, M. Jelcic, S. Chandra, S. Shirinbak, B. Groff, A. Williams, A. Gutierrez, M. Meza, B. Gaertner, K. Palomares, L. Campanati, C. Dege, P. F. Tsai, T. Lee, R. Clarke, K. J. Malmberg, M. Mamonkin, B. Valamehr, V. Sandhu, A. Garcia, J. Goodridge, M. Hosking
|
|
2026 OP0246
|
PERIMENOPAUSE IS ASSOCIATED WITH INCREASED DISEASE ACTIVITY IN PSORIATIC ARTHRITIS,
L. Eder, X. Li, S. Koppikar, I. Lega, D. Gladman, V. Chandran, R. Cook
|
|
2026 OP0252-PARE
|
CHRONIC COMPETENCE - SEE THE RESOURCES, NOT THE RESTRICTIONS,
I. Dybvig, A. K. Bakke
|
|
2026 OP029
|
INEQUITIES IN GLOBAL REPRESENTATION AND TRANSPARENCY IN TRANSCRIPTOMIC STUDIES OF SYSTEMIC LUPUS ERYTHEMATOSUS: A SYSTEMATIC ASSESSMENT OF PUBLIC DATASETS,
R. Martinez-Canales, M. Montelongo Rojas, L. Perez-Barbosa, D. Rodriguez-Garibay, B. R. Avalos García, C. M. Skinner-Taylor, D. A. Galarza-Delgado, M. C. Salinas-Carmona, N. Macias-Segura
|
|
2026 POS0017
|
DISTINCT HLA RISK LANDSCAPES IN FEMALE AND MALE PATIENTS WITH SYSTEMIC SCLEROSIS,
I. Rodriguez-Martin, M. Kerick, C. Rangel-Peláez, C. Rosa-Baez, G. Borrego-Yaniz, L. Ortiz-Fernández, A. Guillen-Del-Castillo, C. P. Simeón-Aznar, J. L. Callejas, O. Distler, I. S Sc Group, P. Clinical Consortium, S. M. Proudman, M. Nikpour, A. Scleroderma Interest Group (ASIG), N. Hunzelmann, J. K. de Vries-Bouwstra, A. L. Herrick, Y. Allanore, M. Alarcon-Riquelme, L. Beretta, S. Assassi, C. P. Denton, M. D. Mayes, J. Martin, M. Acosta-Herrera
|
|
2026 POS0105-PARE
|
HEALTH LITERACY PROFILES OF PEOPLE LIVING WITH INFLAMMATORY ARTHRITIS: APPLICATION OF THE OPHELIA PROCESS IN A UK COHORT,
M. Dey, C. Cheng, R. Osborne, A. Bosworth, S. Norton, J. Galloway, E. Nikiphorou
|
|
2026 POS0185
|
GAP IN THE COLLECTION OF SOCIAL DETERMINANTS OF HEALTH IN IMMUNE-MEDIATED INFLAMMATORY DISEASES: A CROSS-NETWORK COLLABORATION OF REGISTRIES,
A. Triguero-Martinez, L. Comino-Maroto, J. Molina-Collada, M. Uriarte-Ecenarro, S. Llorente-González, A. Chas, I. González-Álvaro, I. Castrejon
|
|
2026 POS0243-PARE
|
GIRASOLES EN CAMINO. THE SANTIAGO’S WAY FOR PEOPLE WITH SCLERODERMA,
M. Piñero Vegas, A. Sánchez Lorite, B. García Criado, I. Martín Ramos, C. Robledano, D. Gómez, J. Soler Bonany, V. Martinez, E. J. Castro
|
|
2026 POS0250-PARE
|
CO-DESIGNED RESOURCES TO SUPPORT RHEUMATOLOGY HEALTHCARE PROFESSIONALS TO WRITE CLINIC LETTERS DIRECTLY TO PATIENTS: OUTPUTS FROM A UK MIXED-METHODS STUDY,
R. Goulding, W. Dixon, K. Staniland, J. Firth, E. Macphie, B. McMillan, W. Gregory, R. S. Rahman, C. Sharp
|
|
2026 POS0297-HPR
|
SOCIODEMOGRAPHIC AND CLINICAL FACTORS ASSOCIATED WITH NON-ATTENDANCE AT RHEUMATOLOGY OUTPATIENT APPOINTMENTS,
M. I. Alarcon-Jarquin, E. C. Garza-Gonzalez, A. M. Ortiz-Rios, I. C. Cantu-Zapata, K. Palomo-Arnaud, S. Hervert-Bulbarella, J. C. Riega-Torres, D. A. Galarza-Delgado, D. E. Flores-Alvarado
|
|
2026 POS0302-HPR
|
HEALTH LITERACY PERCEPTIONS AND PRACTICES AMONG EUROPEAN HEALTHCARE PROVIDERS IN RHEUMATOLOGY: A CROSS-SECTIONAL MIXED METHODS SURVEY-BASED STUDY,
J. Pergens, E. De Meyst, I. Andreica, C. Boström, L. Carmona, M. Dey, F. Guillemin, U. Kiltz, K. Kumar, S. Makri, E. Nikiphorou, A. de Thurah, M. de Wit, A. Boonen, R. Westhovens, M. M. Bakker
|
|
2026 POS0716
|
HEALTH INEQUALITIES IN SYSTEMIC LUPUS ERYTHEMATOSUS: COMORBIDITIES, INFECTIONS, AND TREATMENT PATTERNS IN A MULTI-ETHNIC UK POPULATION,
S. Dyball, M. Rodziewicz, I. Bruce, B. Parker
|
|
2026 POS0802
|
IMPACT OF GENDER ON TREATMENT RESPONSE AND IMMUNOGENICITY OF TUMOR NECROSIS FACTOR INHIBITORS IN ARTHRITIS: A PROSPECTIVE OBSERVATIONAL STUDY,
K. B. Lauridsen, L. W. Dreyer, K. R. Nielsen, A. V. Olesen, A. Linauskas, C. H. Nielsen, S. Kristensen
|
|
2026 POS0816-PARE
|
PATIENT- AND PUBLIC-LED RESEARCH: A SCOPING REVIEW WITH IMPLICATIONS FOR RHEUMATIC AND MUSCULOSKELETAL DISEASE RESEARCH,
E. Wang, L. Truong, N. Hassen, E. Qureshi, M. Lin, T. Lowthian, K. Merry, H. Gainforth, N. Oelke, J. Curran, L. Li
|
|
2026 POS0825
|
GLOBAL DIVERSITY AMONG EDITORIAL JOURNAL BOARDS IN RHEUMATOLOGY PUBLISHING: A CALL FOR EQUITABLE REPRESENTATION,
R. Martinez-Canales, M. Montelongo Rojas, A. Y. Romo-Moreno, D. A. Lugo-Gutiérrez, J. S. Suárez-Cabrera, B. R. Avalos García, D. Rodriguez-Garibay, L. Perez-Barbosa, C. M. Skinner-Taylor, D. A. Galarza-Delgado
|
|
2026 POS0863
|
SEX DIFFERENCES IN MEDICATION USE AND HEALTHCARE COSTS IN RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: A NATIONWIDE CLAIMS STUDY,
Y. S. Jung, S. R. Choi, E. Nam, Y. Kim, S. K. Cho, S. Y. Jung, Y. K. Sung
|
|
2026 POS1025
|
WHEN TREATMENT STALLS: CAREGIVER-RELATED BARRIERS TO OPTIMAL MANAGEMENT OF JUVENILE IDIOPATHIC ARTHRITIS,
M. Metcalfe, S. Marett, I. Gadsby, S. Brown, M. Hollis
|
|
2026 POS1027
|
DISEASE OUTCOMES AND QUALITY OF LIFE OVER THE FIRST 12 MONTHS FOLLOWING DIAGNOSIS IN CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS: ASSOCIATION WITH ETHNICITY AND SOCIOECONOMIC POSITION,
R. Beesley, A. Chieng, C. Ciurtin, G. Cleary, F. McErlane, S. Shoop-Worrall, L. Wedderburn, K. Hyrich, J. Humphreys, L. Kearsley-Fleet
|
|
2026 POS1151
|
HEALTH LITERACY AS THE MISSING LINK BETWEEN SOCIO-ECONOMIC VULNERABILITY AND POOR HEALTH OUTCOMES,
A. Mufudza, M. M. Bakker, S. Ramiro, A. Agten, A. Boonen
|
|
2026 POS1366
|
WOMEN AND MEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS REPORT A WIDE RANGE OF DISEASE BURDEN: OBSERVATIONAL DATA FROM THE GERMAN NATIONAL DATABASE OF THE COLLABORATIVE ARTHRITIS CENTERS,
K. Albrecht, K. Thiele, T. Alexander, M. Aringer, G. Chehab, J. Mucke, J. Richter, S. Spaethling-Mestekemper, J. Callhoff
|
|
2026 POS1383-HPR
|
COMMUNICATION GAPS ON SEXUAL HEALTH IN PATIENTS WITH RHEUMATIC DISEASES,
J. P. González-Morales, J. A. Alvarez-Meza, G. Garcia-Arellano, H. Rios Bazaldua, P. F. Martínez Valencia, D. M. Miranda Velázquez, P. E. Meza Lugo, M. E. Corral-Trujillo, M. A. Villarreal-Alarcon, J. A. Cardenas-de la Garza, D. A. Galarza-Delgado
|
|
2026 POS1385-PARE
|
INVOLVING PEOPLE WITH ARTHRITIS IN THE DECISION-MAKING OF A RESEARCH FUNDING PATIENT ORGANISATION, ARTHRITIS UK,
G. Winsor, S. Yorke, S. Rudkin
|
|
|
[70]
|
And Physical Activity
|
|
|
| 2026 |
|
2026 AB0517
|
CARDIAC HEALTH IN INDIVIDUALS WITH STABLE MYOSITIS AFTER 16 WEEKS OF HIGH-INTENSITY RESISTANCE TRAINING,
K. Y. Jensen, S. J. Rahbek, S. B. Christensen, A. B. Diederichsen, L. P. Diederichsen
|
|
2026 AB0641
|
REPORTING QUALITY OF ABSTRACTS OF RANDOMIZED CONTROLLED TRIALS INCLUDING PHYSICAL THERAPY PRESENTED AT THE 2025 EUROPEAN ALLIANCE OF ASSOCIATIONS FOR RHEUMATOLOGY (EULAR) CONGRESS: AN EVALUATION BASED ON THE CONSORT GUIDELINE,
B. Unver, Ö. Bulduk, T. Yildirim
|
|
2026 AB0676
|
IMPACT OF FIBROMYALGIA ON QUALITY OF LIFE: THE INFLUENCE OF CLINICAL AND PSYCHOLOGICAL OUTCOMES AND PHYSICAL EXERCISE,
L. De Souza, L. Barni, G. Vilarino, A. Andrade
|
|
2026 AB0684
|
AI-BASED FRACTAL ANALYSIS OF ULTRASOUND-GUIDED DRY NEEDLING IN LOW BACK PAIN: 3D MULTIPLANAR EVALUATION OF LUMBAR MUSCLES AND FASCIA,
R. Bubnov, L. Kalika
|
|
2026 AB0795
|
FEASIBILITY, USABILITY, AND DIGITAL BIOMARKER PATTERNS OF A WEARABLE-INTEGRATED EXERCISE APP (RHEUMA-FIT) IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS: A PILOT CLINICAL STUDY,
E. Tabaga, A. Temiz, M. Nissen, M. Flaucher, G. Schett, H. Morf
|
|
2026 AB0808
|
RHEUMATOID SARCOPENIA DRIVES FUNCTIONAL FRAILTY DESPITE REMISSION IN RHEUMATOID ARTHRITIS: A ONE-YEAR PROSPECTIVE COHORT STUDY,
Y. Saito, M. Suzuki, K. Terabe, H. Yamamoto, Y. Saito, T. Sato, S. Asai, S. Imagama
|
|
2026 AB0812
|
ACCELEROMETER-DERIVED ‘WEEKEND WARRIOR’ PHYSICAL ACTIVITY, GENETIC SUSCEPTIBILITY, AND INCIDENT RHEUMATOID ARTHRITIS: A PROSPECTIVE COHORT STUDY,
Z. Xu, Z. Li
|
|
2026 AB0816
|
EFFECTS OF AEROBIC EXERCISE ON PATIENT-REPORTED OUTCOMES IN RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW,
E. Egberink, M. Martinez Claros, J. Primdahl, L. F. Perez
|
|
2026 AB0995
|
TOWARDS THE STANDARDIZATION OF PHYSICAL ACTIVITY ASSESSMENT IN AXIAL SPONDYLOARTHRITIS: TRANSLATION AND CROSS-CULTURAL ADAPTATION OF THE MSQUASH IN 11 LANGUAGES ACROSS 14 COUNTRIES,
Y. M. van der Kraan, J. P. L. Spoorenberg, D. Paap, D. Benavent, V. Navarro-Compán, C. López-Medina, A. Molto, D. Kiefer, X. Baraliakos, G. Ayan, L. Kiliç, A. Sepriano, A. C. Moniz, M. S. Chimenti, L. Fiannacca, M. Konsta, M. de Vries, S. Brolin, H. Maldonado Ficco, R. Perez Alamino, S. Ibáñez, D. García, W. Bautista-Molano, B. Meghnathi, P. Patel, T. Kim, S. C. Shim, W. Fong, Y. H. Kwan, L. S. Gensler, U. Kiltz, S. Ramiro, S. Arends
|
|
2026 AB1012
|
DISTINCT DRIVERS OF PHYSICAL ACTIVITY AVOIDANCE IN AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS: INSIGHTS FROM A CROSS-SECTIONAL STUDY,
F. Saracino, D. Currado, M. Minerba, F. De Vincenzo, F. Trunfio, E. Corberi, L. Frascà, L. Lamberti, M. Vomero, M. Gatti, L. Kun, A. Orlando, G. Giannini, S. Lorusso, O. Berardicurti, A. Marino, R. Giacomelli, L. Navarini
|
|
2026 AB1044
|
WHEN FEELING ACTIVE IS NOT ENOUGH: DISCORDANCE BETWEEN PERCEIVED AND OBJECTIVELY MEASURED PHYSICAL ACTIVITY IN AXIAL SPONDYLOARTHRITIS,
S. Lukovic, N. Tomonjic, M. Vujovic Sestakov, K. Lauševic, I. Smiljanic, A. Neskovic, I. Pavlovic, J. Mihailovic Durdevic, K. Vagic, V. Štulić, A. Radivcev, M. Zlatanovic, T. Zivanovic Radnic, B. Barac, P. Ostojic
|
|
2026 AB1148
|
ActiLup - HIGH INTENSITY INTERVAL TRAINING AND FATIGUE IN SYSTEMIC LUPUS ERYTHEMATOSUS,
M. Dreher, S. Engelhardt, L. Geselle, S. Petros, T. Wicke, J. Babb, A. Schwarting
|
|
2026 AB1172
|
PHYSICAL ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: VALIDATION OF THE mSQUASH, ADHERENCE TO WHO RECOMMENDATIONS AND IMPACT ON HEALTH-RELATED QUALITY OF LIFE,
D. Harmsen, H. Kokol, D. Paap, J. P. L. Spoorenberg, K. de Leeuw, S. Arends
|
|
2026 AB1218
|
EFFECTS OF A 12-WEEK BRISK WALKING–BASED EXERCISE INTERVENTION ON MUSCLE MASS, STRENGTH, AND POWER IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS: THE EJERCITA-LES STUDY,
B. Gavilán-Carrera, J. A. Vargas-Hitos, A. Hernández-Martínez, E. Martínez-Rosales, M. J. Martín-Jáimez, A. Soriano-Maldonado
|
|
2026 AB1225
|
A COMPREHENSIVE INVESTIGATION OF THE RELATIONSHIP BETWEEN COGNITIVE PERFORMANCE, PHYSICAL PERFORMANCE AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC SCLEROSIS,
C. Susam, H. Yakut Ozdemir, Z. Koç, H. Yarkan Tugsal, E. Manci
|
|
2026 AB1271
|
EFFECTS OF MODERATE-INTENSITY RESISTANCE TRAINING AND HOME-BASED TRAINING IN LOWER-LIMB MUSCLE STRENGTH AND MUSCLE THICKNESS IN WOMEN WITH SYSTEMIC SCLEROSIS: A BLINDED RANDOMIZED CLINICAL TRIAL,
A. L. Mallmann, L. Denardi Dória, S. Pilotti, L. dos Santos, D. Moraes, P. Manzke Glanzel, R. Silva, G. Freitas, E. Caroline Lopes, H. Beheregaray, R. Araújo, D. Silva, A. Francisco, A. de Queiroz Rivera Palmeira, V. Hax, J. Boechat Farani, R. Cavalheiro do Espírito Santo, M. Bredemeier, E. Berlet, T. Muniz Fighra, P. M. Spritzer, C. Malcorra dos Santos, R. M. Xavier, R. Mendonça da Silva Chakr
|
|
2026 AB1393-HPR
|
REPORTING AND METHODOLOGICAL QUALITY OF RESISTANCE EXERCISE INTERVENTIONS FOR RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS,
E. C. Atasoy, B. Ünver, M. Bayrak
|
|
2026 AB1396-HPR
|
GUIDELINE IMPLEMENTATION FOR LOW BACK PAIN IN GERMAN HEALTHCARE: A TALE OF OVER- AND UNDERUSE,
N. Arora, B. Bühring, S. Vickery, R. Schäfer, L. Butry, G. Armbrecht, C. Bahns, L. Danneels, L. Donath, K. Ehrenbrusthoff, C. Kopkow, C. Miller, P. Owen, D. Peschke, B. Scheffler, T. Schleimer, F. Teichert, T. Willems, D. Belavy
|
|
2026 AB1404-HPR
|
PHYSICAL FUNCTION AND PATIENT-REPORTED OUTCOMES FOLLOWING A 16-WEEK EXERCISE INTERVENTION IN PATIENTS WITH INCLUSION BODY MYOSITIS: RESULTS FROM A FEASIBILITY STUDY,
M. Skattør, U. Nilsson, H. Alexanderson, T. Brovold, H. Andersson, K. Risum
|
|
2026 AB1406-HPR
|
GREATER INTEROCEPTIVE AWARENESS IS ASSOCIATED WITH ENGAGEMENT IN VIGOROUS EXERCISE IN AXIAL SPONDYLOARTHRITIS PATIENTS,
T. Gudu, M. Klabunde, S. Orbell
|
|
2026 AB1407-HPR
|
ARE SHORT-TERM BENEFITS OF PLATELET-RICH PLASMA DISTINCT FROM TOPICAL DICLOFENAC IN KNEE OSTEOARTHRITIS? RESULTS FROM A PILOT COMPARATIVE STUDY,
S. Karabörklü Argut, A. Erekdağ, D. Çelik, O. Ergin
|
|
2026 AB1408-HPR
|
HOME-BASED STRATEGIES FOR KNEE OSTEOARTHRITIS: COMPARATIVE EFFECTIVENESS OF EXERCISE VERSUS TOPICAL THERAPY IN A RANDOMIZED CONTROLLED TRIAL,
S. Karabörklü Argut
|
|
2026 AB1416-HPR
|
VALIDITY AND RESPONSIVENESS OF THE ANIMATED ACTIVITY QUESTIONNAIRE FOR ASSESSING ACTIVITY LIMITATIONS IN PATIENTS AFTER TOTAL HIP OR TOTAL KNEE REPLACEMENT,
L. Groot, W. Peter, T. P. M. Vliet Vlieland, M. Reijman, C. Terwee, M. G. J. Gademan
|
|
2026 AB1418-HPR
|
MORPHOLOGICAL AND MECHANICAL PROPERTIES OF CERVICAL MUSCLES AND RELATION TO PAIN, HAND GRIP STRENGTH AND DISABILITY IN PATIENTS WITH RHEUMATOID ARTHRITIS,
Y. Mirza, E. Cihan, P. D. Yilmaz, C. Kadiyoran, A. Kucuk
|
|
2026 AB1422-HPR
|
ASSESSMENT OF PHYSICAL FITNESS, FUNCTIONAL PERFORMANCE AND GAIT DYNAMICS IN JUVENILE BEHÇET’S DISEASE: A COMPARATIVE STUDY,
A. Yekdaneh, O. Akgun, N. Arman, A. Albayrak, S. D. Arik, N. Aktay Ayaz
|
|
2026 AB1431-HPR
|
EQUITY, SAFETY AND PERCEIVED QUALITY OF PHYSIOTHERAPY AMONG ITALIAN LGBTQIA+ PEOPLE WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES: PRELIMINARY QUANTITATIVE DATA,
G. Bertoni, M. Bisconti, B. Giardulli, S. Ghezzi, M. Esposto, L. Sant’Ambrogio, V. Vallon, D. Cali, A. Vassallo, A. Agostini, V. Donisi, Y. Prior, S. Stefano, R. Ostelo, L. Schaap, S. Battista
|
|
2026 AB1433-HPR
|
INFLAMMATORY ARTHRITIS FACILITATORS AND BARRIERS (IFAB) QUESTIONNAIRE FOR PHYSICAL ACTIVITY: CROSS-CULTURAL ADAPTATION INTO GERMAN FOLLOWED BY A RELIABILITY STUDY,
J. Ketteler, A. K. Rausch
|
|
2026 AB1434-HPR
|
LIFE SATISFACTION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS UNDER TREAT-TO-TARGET STRATEGIES IS ASSOCIATED WITH PSYCHOSOCIAL FACTORS BEYOND INFLAMMATORY DISEASE ACTIVITY: A CROSS-GENERATIONAL ANALYSIS,
N. Shimahara, N. Hishikawa, S. Sato, S. Toyama, K. Nishida, N. Sawada, Y. Okuda, M. Onishi
|
|
2026 AB1446-HPR
|
FROM EDUCATION TO CLINICAL PRACTICE: RECOGNITION AND CLINICAL DECISION-MAKING IN INFLAMMATORY AND NON-INFLAMMATORY LOW BACK PAIN AMONG PHYSIOTHERAPY STUDENTS AND CLINICIANS,
G. Soylu, Ö. Ülger
|
|
2026 AB1450-PARE
|
FROM MOTIVATION TO ACTION! CLOSING THE LIFESTYLE GAP IN RMDs WITH PATIENT-CENTERED RHEUMATOLOGY CARE,
P. Pennings, P. Borsje, H. Koning, L. Couwenberg, G. Willemsen-de Mey
|
|
2026 AB1481-PARE
|
ACTIVE TOGETHER: A TEAM-BASED PHYSICAL ACTIVITY COMPETITION PROMOTING SOCIAL PARTICIPATION AMONG PEOPLE WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES,
J. Hillesland
|
|
2026 AB1484-PARE
|
PEOPLE WITH HIP OR KNEE OSTEOARTHRITIS’ EXPECTATIONS OF PHYSIOTHERAPY: A QUALITATIVE STUDY,
A. Konings-Pijnappels, M. van der Steen, E. Schols, T. P. M. Vliet Vlieland, R. P. A. Janssen
|
|
2026 OP021-PARE
|
“FALL PREVENTION FOR BETTER AGEING” PROJECT FOR ADULTS OVER 65 WHO HAVE RHEUMATIC AND MUSCULOSKELETAL CONDITIONS. PRINCIPAL AUTHOR: MACHI SALAMALIKI-SPANOU,HELLENIC LEAGUE AGAINST RHEUMATISM,
M. Spanou Salamaliki
|
|
2026 OP0220
|
THE ASSOCIATION OF PHYSICAL FUNCTION WITH PATIENT-REPORTED OUTCOMES IN PEOPLE WITH SYSTEMIC LUPUS ERYTHEMATOSUS,
M. Dey, J. Fitzpatrick, M. Dall’Era, C. Dunlop-Thomas, C. Hoge, S. S. Lim, P. Katz, J. Yazdany, L. Plantinga
|
|
2026 OP0250-PARE
|
INCREASING ACCESS IN GENERAL HEALTH SYSTEM FOR PHYSIOTHERAPY TREATMENTS FOR PEOPLE WITH RMDS,
S. Papamichael
|
|
2026 OP033-HPR
|
EFFECTIVENESS OF A 3-MONTH, MULTICOMPONENT, PEDOMETER-DRIVEN PHYSICAL ACTIVITY BEHAVIOUR CHANGE INTERVENTION INITIATED AFTER TOTAL HIP ARTHROPLASTY FOR HIP OSTEOARTHRITIS ON DAILY STEP COUNTS - A RANDOMISED CONTROLLED TRIAL,
T. Bieler, C. Dall, V. Siersma, P. Magnusson, M. T. Kristensen, M. Rinaldo, M. Schmiegelow, A. Krifa, S. Overgaard, B. Kjær, H. Palm, J. Midtgaard
|
|
2026 POS0103-PARE
|
OSTEOPOROSIS IN NORWAY: INCREASING ACCESS TO SAFE AND EVIDENCE-BASED EXERCISE PROGRAM,
J. Hillesland, B. Stanghelle
|
|
2026 POS0199
|
THE DIGITAL THERAPEUTIC AXIA IMPROVES SPINAL MOBILITY AND STRENGTH, IMPAIRMENT OF INSOMNIA, AND DISEASE RELATED SEXUAL DYSFUNCTION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS OF A 24-WEEK PRE-POST INTERVENTIONAL TRIAL (BECHTEREW-APP TRIAL II),
P. P. Strunz, A. Wüst, P. Possler, M. le Maire, T. Heusinger, A. Fleischer, K. S. Luetkens, M. Gernert, H. Labinsky, O. Gadeholt, R. Leppich, A. Schmieder, L. Hammel, B. Sperlich, H. Einsele, M. Fröhlich, M. Schmalzing
|
|
2026 POS0243-PARE
|
GIRASOLES EN CAMINO. THE SANTIAGO’S WAY FOR PEOPLE WITH SCLERODERMA,
M. Piñero Vegas, A. Sánchez Lorite, B. García Criado, I. Martín Ramos, C. Robledano, D. Gómez, J. Soler Bonany, V. Martinez, E. J. Castro
|
|
2026 POS0339-HPR
|
PROMOTING HEALTHY LIFESTYLE HABITS IN INDIVIDUALS WITH EARLY KNEE OSTEOARTHRITIS: A SCOPING REVIEW,
E. Wiking, E. Haglund, I. Larsson, M. Andersson
|
|
2026 POS0340-HPR
|
HIGHER PATIENT EXPECTATIONS ARE ASSOCIATED WITH BETTER OUTCOMES AFTER EXERCISE THERAPY FOR KNEE OSTEOARTHRITIS, RESULTS OF THE GLA:D PROGRAM IN THE NETHERLANDS,
A. Konings-Pijnappels, M. van der Steen, F van Bekkum, C. van Doesburg, W. den Boer, J. Young, T. P. M. Vliet Vlieland, R. P. A. Janssen
|
|
2026 POS0346-HPR
|
IMPROVING ADHERENCE TO FALL PREVENTION EXERCISE IN OLDER ADULTS WITH A HISTORY OF FALLS: A CLUSTER RANDOMISED TRIAL OF BRIEF ACTION PLANNING TRAINING AND DIGITAL SUPPORT FOR PHYSIOTHERAPISTS,
L. Li, H. Xie, N. Lu, J. Davis, M. Oakey, D. Bayraktar, J. Xu, S. Therrien, Y. S. Seo, E. Wang, C. Primeau, J. Ma, J. Mollins, C. Shaw, D. Jehu, T. Liu-Ambrose
|
|
2026 POS0444
|
EXERCISE-INDUCED CYTOKINE MODULATION IN PSORIATIC ARTHRITIS: RESULTS FROM A RANDOMIZED CONTROLLED TRIAL ON BLOOD FLOW RESTRICTION TRAINING,
C. J. Bauer, M. Sturhahn, S. M. Petzinna, C. Wilhelm, T. McCulloch, M. Schmid, P. Karakostas, L. Hatzmann, M. S. Adamson, R. Gheitasi, J. Schäfer, P. Preuss, V. S. Schäfer
|
|
2026 POS0451
|
ASSOCIATIONS BETWEEN PHYSICAL ACTIVITY AND BODY COMPOSITION IN INDIVIDUALS WITH PSORIATIC ARTHRITIS - LONGITUDINAL OBSERVATIONS IN THE TRØNDELAG HEALTH STUDY,
A. A. Osman, M. Hoff, V. Videm
|
|
2026 POS0642-HPR
|
HEALTHY SENIORS WITH RMDS AND STRONGER BRIDGE BUILDING WITH DANISH MUNICIPALITIES,
M. Jelsbak Raundahl
|
|
2026 POS0646-HPR
|
COMPARISON OF MOBILE-BASED AND SUPERVISED ARTIFICIAL INTELLIGENCE PERSONALIZED EXERCISE PROGRAMS IN JUVENILE IDIOPATHIC ARTHRITIS: A RANDOMIZED CONTROLLED TRIAL,
A. Yekdaneh, N. Arman, N. Aktay Ayaz
|
|
2026 POS0647-HPR
|
DIGITAL ACTIVITY PATTERNS MEASURED BY WEARABLE DEVICES IN ADULTS WITH AND WITHOUT OSTEOARTHRITIS: ASSOCIATIONS WITH FUNCTIONAL IMPAIRMENT IN THE US NHANES DATABASE,
V. Ritschl, V. Schmolik, L. Dorfer, F. Eibensteiner, T. Stamm
|
|
2026 POS0648-HPR
|
PREVALENCE AND PREDICTORS OF DYSPHAGIA IN IDIOPATHIC INFLAMMATORY MYOPATHIES: A CROSS-SECTIONAL STUDY,
F. Sari, I. Gerhardson, M. Holmqvist, H. Alexanderson
|
|
2026 POS0651-HPR
|
EFFECTS OF STRUCTURED VERSUS EXERGAMING-BASED CORE STABILIZATION TRAINING ON PAIN AND PHYSICAL FUNCTION IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: A RANDOMIZED CONTROLLED TRIAL,
I. Donmez, N. Arman, F. Çakmak, N. Aktay Ayaz
|
|
2026 POS0652-HPR
|
REPORTING OF EXERCISE INTERVENTIONS IN SPONDYLOARTHRITIS RESEARCH: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS,
K. Norden, H. Solveig Dagfinrud, G. Smedslund
|
|
2026 POS0735-HPR
|
PHYSIOTHERAPY AS A MULTIMODAL INTERVENTION IS EFFECTIVE TO TREAT ADULTS WITH RECURRENT OR CHRONIC LOW BACK PAIN: A SYSTEMATIC REVIEW WITH META-ANALYSIS,
S. Le Cam, M. Rospabe, B. Granger, B. Fautrel, F. Bailly
|
|
2026 POS0740-HPR
|
ADVANCED PRACTICE PHYSIOTHERAPY-LED INFLAMMATORY BACK PAIN PATHWAY - DIAGNOSTIC YIELD, REFERRAL SOURCE OUTCOMES AND CONSULTANT TIME SAVINGS IN AXIAL SPONDYLOARTHRITIS,
K. Rigler, I. MedinaMarchant, A. Chan
|
|
2026 POS0743-HPR
|
DYSPHAGIA IN PATIENTS WITH SYSTEMIC SCLEROSIS: CLINICAL CHARACTERISTICS, PATIENT-REPORTED OUTCOMES, AND ASSOCIATED FACTORS,
F. Sari, I. Gerhardson, M. Holmqvist, H. Alexanderson
|
|
2026 POS0747-HPR
|
EXPERIENCES WITH HIGH-INTENSITY TRAINING AMONG PATIENTS WITH INFLAMMATORY DISEASE,
C. Hestevik, K. Norden, A. T. Tveter, H. Eik
|
|
2026 POS0758
|
MACHINE LEARNING–BASED IDENTIFICATION OF KEY PATIENT-REPORTED DOMAINS IN INFLAMMATORY ARTHRITIS,
S. N. Aydogdu, B. Coppers, S. Heinrich, K. Tascilar, S. Bayat, M. Sadeghi, A. Kleyer, I. Minopoulou, D. Simon, G. Corte, F. Fagni, V. Schönau, S. Leyendecker, G. Schett, A. M. Liphardt
|
|
2026 POS0819-PARE
|
REHABILITATION AND PHYSICAL ACTIVITY IN RHEUMATOLOGICAL DISEASES,
A. Celano, M. D. Antonio
|
|
2026 POS0853
|
MULTICOMPONENT NON-PHARMACOLOGICAL INTERVENTIONS DEMONSTRATE SUPERIOR EFFICACY FOR PAIN AND FUNCTION IN FIBROMYALGIA: SYSTEMATIC REVIEW OF 40 RANDOMIZED CONTROLLED TRIALS (2020–2025),
J. S. Theran Leon, W. OTERO, A. Felipe, C. E. arenas, L. A. Dulcey Sarmiento, J. Gomez Ayala
|
|
2026 POS0858
|
SUSTAINED AND CONSISTENT IMPROVEMENTS IN DISEASE ACTIVITY, FUNCTIONAL STATUS, AND QUALITY OF LIFE WITH THE DIGITAL THERAPEUTIC AXIA IN AXIAL SPONDYLOARTHRITIS: RESULTS OF A 26-WEEK RANDOMISED CONTROLLED CROSSOVER TRIAL (BECHTEREW-APP TRIAL),
P. P. Strunz, M. le Maire, T. Heusinger, A. Fleischer, K. S. Luetkens, P. Possler, M. Gernert, H. Labinsky, O. Gadeholt, R. Leppich, A. Schmieder, L. Hammel, B. Sperlich, H. Einsele, M. Schmalzing, M. Fröhlich
|
|
2026 POS0911
|
THE EFFECTIVENESS OF LUMBAR BELTS FOR NON-SPECIFIC LOW BACK PAIN: A MULTI-CENTRE RANDOMIZED CLINICAL TRIAL,
L. Grange, P. Calmels, Y. M. Pers, G. Laustriat, V. Wieczorek, N. Saih, M. De-Seze, C. Nguyen, C. Daste, I. Fayolle-Minon, E. Coudeyre, F. Rannou
|
|
2026 POS0953
|
COMBINED INTENSIVE RESISTANCE AND ENDURANCE EXERCISE IN LOW-DISEASE ACTIVITY INFLAMMATORY MYOPATHIES: A HOSPITAL VS. COMMUNITY-BASED PROSPECTIVE STUDY,
Q. Toumazeau, L. Debrut, P. Silverstrin, A. Heit, A. L. Charles, B. Geny, M. Giannini, A. Meyer
|
|
2026 POS0957
|
FATTY ACID BINDING PROTEIN 3 (FABP-3) IS A POTENTIAL MEDIATOR OF MUSCLE DAMAGE IN INFLAMMATORY MYOPATHIES AND ITS SERUM LEVEL DECREASE IN RESPONSE TO AN INTENSIVE COMBINED EXERCISE PROGRAM,
L. Debrut, Q. Toumazeau, G. Quiring, P. Silverstrin, A. Heit, A. L. Charles, B. Geny, A. Meyer, M. Giannini
|
|
2026 POS1095-HPR
|
THREE MONTHS OF REMOTE MONITORING UPON DISCHARGE VS USUAL CARE IN PATIENTS WITH SUBACUTE OR CHRONIC LOW BACK PAIN (AVA-PREPA): A RANDOMISED, OPEN-LABEL, PHASE 3, MULTICENTRE, SUPERIORITY TRIAL,
V. Wieczorek, A. Homs, J. T. Houedakor, A. Thevenon, E. Chaleat, M. De-Seze, P. Carson-Jouzel, G. Delaruelle, T. Davergne
|
|
2026 POS1096-HPR
|
EFFECTS OF EXERCISE-BASED INTERVENTIONS ON CLINICAL OUTCOMES IN PRE-CLINICAL AND EARLY RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS,
J. Courel Ibáñez, Á. Buendía Romero, T. Vetrovsky
|
|
2026 POS1100-HPR
|
EFFECTS OF CLINICAL PILATES TRAINING ON PHYSICAL, FUNCTIONAL AND PSYCHOSOCIAL OUTCOMES IN INDIVIDUALS WITH RHEUMATOID ARTHRITIS: A RANDOMIZED CONTROLLED TRIAL,
S. Bayram, D. Oskay, M. A. Oztürk
|
|
2026 POS1101-PARE
|
EMOTIONS, IDENTITY AND SITUATED AGENCY IN SYSTEMIC LUPUS ERYTHEMATOSUS: PATIENT-REPORTED OUTCOMES FROM AN ADAPTED AQUATIC INTERVENTION,
L. Athié, E. Calleja Macedo
|
|
2026 POS1240
|
EXPLORING THE ROLE OF CENTRALLY AUGMENTED PAIN PROCESSING ON DISABILITY IN RHEUMATOID ARTHRITIS: DATA FROM THE CENTRAL ASPECTS OF PAIN IN RHEUMATOID ARTHRITIS (CAP-RA) STUDY,
C. Ainsworth, D. McWilliams, D. Walsh, V. Georgopoulos, S. Smith
|
|
2026 POS1380-HPR
|
PREDICTING FUNCTIONAL PERFORMANCE IN KNEE OSTEOARTHRITIS: THE RELATIVE CONTRIBUTION OF STRENGTH AND ULTRASOUND-BASED MORPHOLOGY AND QUALITY OF QUADRICEPS AND HAMSTRING MUSCLES,
B. Tayfur, S. Karaçam, F. Tuncay, A. Tayfur
|
|
2026 POS1384-HPR
|
SUPPORT NEEDS AND NON-PHARMACOLOGICAL INTERVENTIONS FOR PEOPLE WITH HAND OSTEOARTHRITIS: A SYSTEMATIC REVIEW,
J. K. Karstensen, C. M. T. Madsen, A. Damgaard
|
|
2026 POS1387-PARE
|
IDENTIFYING UNMET INFORMATIONAL AND SUPPORT NEEDS AMONG PEOPLE LIVING WITH SJÖGREN’S DISEASE: A PATIENT PERSPECTIVE STUDY,
S. Venkatachalam, E. Stone, I. Carroll, S. Ginsberg, A. Degrassi, D. Curtis, S. Fritz
|
|
2026 POS1389-PARE
|
BLUE SOLER THERAPEUTIC PADDLEBOARDING (SUP) SPORTS PROGRAM: A PATIENT-LED CLINICAL TRIAL TO IMPROVE QoL IN ADULTS WITH RMDs,
C. Navalon-Martinez, M. S. García Rodríguez, E. Ferrer Vidal-Barraquer, M. Leon-Garcia
|
|
|
[95]
|
And genetics
|
|
|
| 2026 |
|
2026 AB0030
|
IMPACT OF IMMUNOSUPPRESSIVE STRATEGIES AND UBA1 MUTATION GENOTYPES ON DISTRIBUTION AND TRANSCRIPTIONAL LANDSCAPE OF HEMATOPOIETIC CELLS IN VEXAS SYNDROME,
C. Campochiaro, M. Fiumara, L. Alessandrini, G. Bergonzi, E. Cozzo, A. Tomelleri, E. Diral, P. Quaranta, L. Bassoricci, R. Molteni, S. Cenci, A. Aiuti, F. Ciceri, L. Dagna, M. Matucci-Cerinic, S. Scala, L. Naldini, S. Ferrari
|
|
2026 AB0032
|
IDENTIFICATION OF MRTFA VARIANTS IN THREE FAMILIES WITH BEHÇET-LIKE AUTOINFLAMMATORY PHENOTYPES,
G. Zucca, M. Di Rosa, E. De Martino, M. Girardelli, A. Zabotti, E. Marrani, A. Kumar Singh, G. Simonini, G. Posern, G. Emmi, A. Tommasini
|
|
2026 AB0048
|
TISSUE RESIDENT MONOCYTIC CELLS NAVIGATE ENTRY OF IMMUNE CELLS TO THE SYNOVIUM DURING INFLAMMATORY ARTHRITIS,
H. Perlman, Y. Wang, D. Winter
|
|
2026 AB0064
|
CHIMERIC NOD SCID MODEL OF MYOSITIS USING PERIPHERAL BLOOD MONONUCLEAR CELLS FROM A PATIENT WITH MDA5+ DERMATOMYOSITIS RECAPITULATES DISEASE FEATURES,
P. Gonzalez Manrique, S. Coss, N. Weisleder, W. Jarjour
|
|
2026 AB0070
|
GENETIC INTEGRATION OF MITOCHONDRIAL AND NUCLEAR VARIANTS IMPROVES PREDICTION OF METABOLIC SYNDROME–RELATED KNEE OSTEOARTHRITIS,
J. Vázquez-García, A. Morano Torres, L. Martínez-Sotodosos, D. Noriega, S. Relaño-Fernandez, N. Oreiro, F. J. Blanco, I. Rego-Perez
|
|
2026 AB0092
|
UNRAVELING SEX-SPECIFIC WEIGHTED GENETIC MARKERS AND PATHWAYS IN PSORIATIC ARTHRITIS,
K. Healey, Q. Li, I. Jurisica, D. Gladman, V. Chandran, L. Eder, P. Rahman
|
|
2026 AB0101
|
TRANSCRIPTOMIC AND CHROMATIN ACCESSIBILITY PROFILING OF PERIPHERAL BLOOD MONOCYTES IN RHEUMATOID ARTHRITIS FLARE AND REMISSION,
A. Melville, K. Woolcock, F. Rayner, A. McGucken, A. E. Anderson, A. Filer, I. B. McInnes, K. Raza, A. Pratt, K. F. Baker, J. Isaacs, S. Siebert, C. S. Goodyear
|
|
2026 AB0145
|
PARTITIONING RHEUMATOID ARTHRITIS GENETIC ARCHITECTURE USING SHARED GENETIC OVERLAP WITH BMI, CRP, AND OSTEOARTHRITIS,
B. Sedaghati-Khayat, S. Honda, N. Steinz, T. D. Maarseveen, S. A. Sytske Anne, T. Huizinga, M. Kloppenburg, E. B van den Akker, R. Knevel
|
|
2026 AB0156
|
STATUS OF RA SUSCEPTIBILITY LOCUS RS4409785 (SESN3) ASSOCIATES WITH OLIGO- VERSUS HAND-JOINT INVOLVEMENT IN EARLY RHEUMATOID ARTHRITIS,
S. Honda, B. Sedaghati-Khayat, T. D. Maarseveen, T. Huizinga, R. Knevel, E. B van den Akker
|
|
2026 AB0192
|
DISSECTING THE IMMUNE GENETIC ARCHITECTURE OF SJÖGREN’S SYNDROME USING A SINGLE-CELL CAUSAL FRAMEWORK,
Y. Jin, L. S. Tam
|
|
2026 AB0193
|
GENE EXPRESSION SIGNATURES FROM SINGLE-CELL TRANSCRIPTOMICS PREDICT SJÖGREN’S DISEASE,
S. M. Cheng, Y. Q. Mo, B. H. Huang
|
|
2026 AB0198
|
DECIPHERING THE ROLE OF RUNX3 IN HUMAN γδ CELLS,
M. Melchior, D. Venturoli, E. Donckier De Donceel, A. Pedron, M. Nguyen, S. Thomas, V. Acolty, A. Azouz, F. Szymczak, A. Detavernier, K. Venken, D. Elewaut, S. Goriely
|
|
2026 AB0199
|
EXPLORING THE CAUSAL RELATIONSHIP BETWEEN METABOLIC TRAITS AND ANKYLOSING SPONDYLITIS: A BIDIRECTIONAL MENDELIAN RANDOMISATION STUDY,
J. Hou, P. Peng, A. Shi, H. Ji, Y. Bai, H. Cheng, H. Wen
|
|
2026 AB0243
|
TRANSCRIPTOME-BASED MOLECULAR STRATIFICATION TO GUIDE THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH INSUFFICIENT TREATMENT RESPONSE,
A. Ainatzoglou, L. Beretta, S. C. W. Chan, G. S. Moysidou, D. M. Nöthling, S. Katechis, A. Fanouriakis, P. Sidiropoulos, C. Bergmann, D. Boumpas, G. Schett, G. Bertsias, P. Garantziotis
|
|
2026 AB0251
|
TYPE I INTERFERON GENE SIGNATURE IN SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM A PILOT STUDY INCLUDING DNASE1L3-DEFICIENT PATIENTS,
N. Aljaberi, A. Abdul Khalam, H. Alblooshi
|
|
2026 AB0258
|
MOBILE GENES (TRANSPOSONS) EXPRESSION IN FIBROBLASTS FROM SKIN BIOPSIES OF PATIENTS WITH SYSTEMIC SCLEROSIS,
D. Bleck, T. Filla, K. Drechsel, P. Li, M. V. Napoli, P. Bearzi, E. Pachera, O. Distler, A. Pezone, E. V. Avvedimento, N. Del Papa, R. De Angelis, J. Distler, A. Gabrielli
|
|
2026 AB0266
|
GENOME-WIDE ASSOCIATION STUDY IDENTIFIES GENETIC RISK LOCI ASSOCIATED WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE,
C. Rosa-Baez, C. Rangel-Peláez, I. Rodriguez-Martin, G. Borrego-Yaniz, M. Kerick, A. Guillen-Del-Castillo, C. P. Simeón-Aznar, J. L. Callejas, A. Voskuyl, A. Kreuter, O. Distler, I. SSc Group, S. M. Proudman, M. Nikpour, A. Scleroderma Interest Group (ASIG), N. Hunzelmann, G. Moroncini, A. Gabrielli, M. Dapas, J. K. de Vries-Bouwstra, A. L. Herrick, Y. Allanore, L. Beretta, M. D. Mayes, C. Denton, S. Assassi, J. Martin, M. Acosta-Herrera
|
|
2026 AB0299
|
COMPARATIVE ANALYSIS OF C1Q GENETIC CLUSTER SNPs IN PATIENTS WITH SLE AND RA,
M. Kosturkova, G. Mihaylova, V. Vasilev, M. Radanova
|
|
2026 AB0378
|
VEXAS SYNDROME DETECTION THROUGH TARGETED SCREENING: EPIDEMIOLOGICAL INSIGHTS FROM A NORTHERN ITALIAN POPULATION,
C. Marvisi, P. Mancuso, V. Y. Cusenza, O. Bonanno, C. Ricordi, I. Capodanno, E. Lugli, P. Zaldini, E. Farnetti, R. Longo, D. Nicoli, P. Giorgi Rossi, F. Muratore, C. Salvarani
|
|
2026 AB0391
|
NEXT-GENERATION SEQUENCING UNLOCKS DIAGNOSIS OF AUTOINFLAMMATORY DISEASES IN NORTH AFRICAN PATIENTS,
R. Bourguiba, S. Bellakhal, T. Laarbi, I. Ksontini, R. Ben Amor, V. Geromel, H. Jilani
|
|
2026 AB0397
|
CLASSIFICATION OF CLINICAL PHENOTYPES RELATED TO MEFV GENE OTHER THAN CLASSICAL FAMILIAL MEDITERRANEAN FEVER,
B. Ç. Yalçin Dulundu
|
|
2026 AB0401
|
A STUDY OF ATHEROGENIC INDICES AND FIBRINOGEN-TO-ALBUMIN RATIO IN JUVENILE FAMILIAL MEDITERRANEAN FEVER,
S. Machaly, S. El-Sayed, D. Abd-Elghafar, A. Sobh
|
|
2026 AB0427
|
ASSOCIATION BETWEEN GCKR POLYMORPHISMS AND COMORBIDITIES IN HYPERURICEMIA PATIENTS – A NATIONWIDE TAIWAN BIOBANK STUDY,
Y. Mai, T. H. Li, M. H. Chen, H. T. Liao, C. C. Chuang, C. Y. Tsai, H. I. Yang, Y. Y. Yang
|
|
2026 AB0659
|
APPLYING PHARMACOGENOMICS IN REAL-WORLD RHEUMATOLOGY PRACTICE: EMR-INTEGRATED AND STANDALONE SOLUTIONS,
B. Ghang, J. C. Choi, N. Han
|
|
2026 AB0890
|
FTO rs7195994 IS ASSOCIATED WITH TNF INHIBITOR RESPONSE IN LEAN RHEUMATOID ARTHRITIS PATIENTS: A BMI-STRATIFIED PHARMACOGENETIC ANALYSIS,
W. Huang, C. M. Kao, Y. J. Chen, Y. M. Chen
|
|
2026 AB0931
|
THE INFLUENCE OF THE SHARED EPITOPE ON THE EFFECTIVENESS OF BIOLOGIC ANTIRHEUMATIC AGENTS IN EUROPEAN PATIENTS WITH RHEUMATOID ARTHRITIS,
A. Finckh, R. Aymon, D. Mongin, S. Saevarsdottir, I. Jonsdottir, K. Stefansson, M. Lund Hetland, B. Moeller, J. Villard, D. S. Courvoisier, K. Lauper, B. Glintborg
|
|
2026 AB1098
|
ASSOCIATION OF STAT4 GENETIC VARIANTS WITH RENAL RESPONSE AND DAMAGE IN PROLIFERATIVE LUPUS NEPHRITIS: A MULTI-ETHNIC COHORT STUDY,
S. S. Shaharir, N. Ramli, R. Mohd, E. A. Azizan, N. Abdullah@Muda
|
|
2026 OP0120
|
MOSAIC LOSS OF THE Y CHROMOSOME DIFFERENTIATES GIANT CELL ARTERITIS FROM POLYMYALGIA RHEUMATICA ACROSS THE GCA–PMR SPECTRUM,
S. M. Petzinna, S. M. Kirch, M. S. Adamson, C. J. Bauer, S. Zimmer, R. N. Jamin, V. S. Schäfer
|
|
2026 OP0161
|
ACCUMULATION OF MITOCHONDRIAL dsRNA DUE TO DEFECTIVE m6A-DEPENDENT RNA REGULATION IN EPITHELIAL CELLS MAY EXPLAIN THE INTERFERON SIGNATURE IN SJÖGREN’S DISEASE,
A. Arco-Hierves, K. Pamboukas, L. Mutala, L. S. Borowski, C. Mayet, P. Mazet, S. E Silva-Saffar, L. Askenatzis, J. Pascaud, P. Labrot, C. Lasgi, A. Navickas, T. Naninck, N. Seddiki, R. Szczęsny, G. Nocturne, X. Mariette, R. Bechara
|
|
2026 OP0165
|
INTEGRATED GENOMICS AND CROSS-TISSUE SINGLE-CELL TRANSCRIPTOMICS DEFINE MONOCYTE-DRIVEN TISSUE INJURY IN MYOSITIS,
S. Izuka, T. Komai, I. Ueda, M. Fujimoto, H. Fukui, M. Takeshita, N. Umezawa, S. Yasuda, Y. Kondo, I. Matsumoto, M. Yasuda, Y. Fujieda, T. Iwasaki, A. Morinobu, T. Kawamoto, M. Matsushita, N. Tamura, H. Nakajima, K. Yoshida, T. Isozaki, N. Yajima, A. Yoshida, T. Gono, M. Kuwana, M. Ueno, Y. Tanaka, K. Sakurai, K. Kawahata, Y. Kamata, K. Sato, T. Mimura, A. Suzuki, Y. Kochi, K. Yamamoto, H. Yuki, T. Itamiya, M. Ota, T. Okamura, K. Fujio
|
|
2026 OP0169
|
MOSAIC CHROMOSOMAL ALTERATIONS IN SEX CHROMOSOMES IN INCLUSION BODY MYOSITIS,
L. Tomlinson, D. Scannali, J. Eales, N. Routledge, A. Khan, I. Skorupinska, C. Bettencourt, J. Vandrovcova, S. Nagy, M. Sinnreich, Q. Gang, C. Liang, J. Coudert, M. Needham, J. De Bleecker, B. De Paepe, W. De Paepe, J. Baets, E. Zanoteli, D. Amelin, C. Chrysovitsanou, M. Zulai, M. Mora, A. Corrado, M. Ripolone, D. Lopergolo, A. Oldfors, A. Tariq, A. Radunovic, K. Walker, S. Brady, J. B. Lilleker, D. Caraballo, A. Amato, T. Llyod, P. Shieh, B. Blume, M. P. Wicklund, R. J. Barohn, J. Guptill, L. Carter, E. Naddaf, A. Shaibani, H. Runk, M. Dimachkie, A. Bartlett, J. Kissel, M. Dalakas, T. Mozaffar, N. A. Goyal, O. Carbunar, C. C. Weihl, A. B. Singleton, M. G. Hanna, H. Houlden, P. M. Machado, H. Chinoy, J. Lamb, G. Papadimas, C. Papadopoulos
|
|
2026 OP017
|
INSULIN INHIBITS INFLAMMATION AND EPIGENETICALLY SUPPORTS T CELL PHENOTYPE TRANSITION IN RHEUMATOID ARTHRITIS,
V. Chandrasekaran, M. Erlandsson, D. Svensson, E. Malmhäll-Bah, G. Katona, R. Pullerits, M. I. Bokarewa
|
|
2026 OP0196
|
A GENETIC MIMIC IN RHEUMATOLOGY: TYPE II COLLAGENOPATHY MASQUERADING AS TREATMENT-RESISTANT SERONEGATIVE ARTHRITIS,
Z. Yagbasan, B. Yagiz, B. N. Coskun, A. Topak, E. Dalkilic, Y. Pehlivan
|
|
2026 OP0200
|
BILE ACID–ASSOCIATED SYSTEMIC INFLAMMATORY SYNDROME (BASIS): A NOVEL AUTOINFLAMMATORY DISORDER LINKED TO IMPAIRED BILE ACID ABSORPTION,
E. Sahin, Y. Akbal, M. Senkal, B. Ince, Y. Yalçinkaya, B. Artim Esen, M. Inanc, A. Gül
|
|
2026 OP0272
|
NSD1, H3K36me1/2 METHYLTRANSFERASE AS A POTENTIAL THERAPEUTIC TARGET IN TH17 CELL-MEDIATED AUTOINFLAMMATORY DISEASE,
S. E. Wang, D. T. Kim, J. S. Joo, S. H. Lee, J. Chin, S. Jo, J. Y. Hong, T. H. Kim
|
|
2026 OP0279
|
GENETIC RISK VARIANTS REVEAL CYTOKINE-RESPONSIVE MODULES DRIVING PATHOGENIC PROGRAMS IN RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLASTS,
E. Ezen, A. Khmelevskaia, M. Lugar, C. Ospelt
|
|
2026 OP0321
|
RECURRENT SOMATIC MUTATIONS IN KRAS DRIVE A SPECIFIC AUTOINFLAMMATORY PHENOTYPE ASSOCIATED WITH MYELOID NEOPLASMS,
P. Chen, O. Debeaupuis, A. Le Pogam, L. P. Zhao, F. Castellan, E. Lazaro, S. Dimicoli-Salazar, C. Etienne, E. Clappier, H. Dupuy, C. Dussiau, A. Bidet, F. Chasset, M. Ruyer Thompson, R. Stammler, R. Itzykon, O. Fain, T. Comont, P. Hirsch, P. Fenaux, A. Mekinian, J. Rossignol, V. Jachiet, D. B. Beck, E. Solary, F. Rieux-Laucat, D. Selimoglu-Buet, J. Hadjadj
|
|
2026 OP0325
|
ASSOCIATION OF NOD2 VARIANTS WITH CLINICAL PHENOTYPES IN AUTOINFLAMMATORY DISEASE: INSIGHTS FROM A COHORT THROUGH A VALIDATED NEXT-GENERATION SEQUENCING PANEL,
M. Schermi, M. T. Perez-Cartier Beingolea, S. Rizzo, A. Fu, S. Moz, P. Galozzi, R. Ramonda, P. Sfriso, S. Bindoli
|
|
2026 OP0326
|
BONE MARROW SINGLE-CELL MULTIOMICS SHEDS LIGHT ON THE ETIOLOGY OF SCHNITZLER SYNDROME,
S. Riescher, Y. Le Bris, E. Douillard, M. Devic, M. Cherkaoui, S. Barbarot, F. Magrangeas, S. Minvielle, E. Letouze, A. Néel
|
|
2026 OP0328
|
EXPLORING GENETIC VARIANTS ASSOCIATED WITH MONOGENIC AUTOINFLAMMATORY DISEASES USING NEXT-GENERATION SEQUENCING WITH A TARGETED GENE PANEL IN STILL’S DISEASE,
E. Bektas, P. Ercoskun, A. Yilmaz, A. Islamova, A. Gezdirici, C. Bes
|
|
2026 OP064
|
ASAP2 FACILITATES OSTEOARTHRITIS PROGRESSION BY PROMOTING MACROPHAGE M1 POLARIZATION VIA HNRNPA1-MEDIATED STABILIZATION OF NFKB3 MRNA,
T. Meng, M. Lu
|
|
2026 OP087
|
CANCER POLYGENIC SCORES AND CANCER RISK IN RHEUMATOID ARTHRITIS,
V. Kuusi, A. Kerola, E. Ikdahl, F. FinnGen, N. Mars
|
|
2026 OP088
|
CONTRIBUTION OF RARE DELETERIOUS VARIANTS IN TELOMERE-RELATED GENES TO THE RISK OF RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE,
P. A. Juge, L. Kawano-Dourado, A. Stockwell, J. S. Lee, R. Blumhagen, S. Gazal, P. Brocard, G. McDermott, K. Hayashi, J. Cui, J. Solomon, P. J. Wolters, B. Granger, C. Kannengiesser, R. Borie, I. Ba, L. Wemeau Stervinou, M. P. Debray, S. Marchand-Adam, C. Richez, H. Nunez, P. Froguel, J. Avouac, R. M. Flipo, V. Cottin, M. C. Boissier, T. Schaeverbeke, N. Saidenberg Kermanac’h, B. Crestani, T. Doyle, S. Raychaudhuri, E. Karlson, B. L. Yaspan, D. Schwartz, J. A. Sparks, P. Dieudé
|
|
2026 OP096
|
GENOME-WIDE METHYLATION PROFILING IDENTIFIES EPIGENETIC SIGNATURES OF PAIN, FATIGUE, AND HEALTH SCORES IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS,
A. Camponeschi, A. Ravaei, T. Fatima, C. Wincup, A. Rudin, J. Bjersing, C. Maglio
|
|
2026 POS0017
|
DISTINCT HLA RISK LANDSCAPES IN FEMALE AND MALE PATIENTS WITH SYSTEMIC SCLEROSIS,
I. Rodriguez-Martin, M. Kerick, C. Rangel-Peláez, C. Rosa-Baez, G. Borrego-Yaniz, L. Ortiz-Fernández, A. Guillen-Del-Castillo, C. P. Simeón-Aznar, J. L. Callejas, O. Distler, I. S Sc Group, P. Clinical Consortium, S. M. Proudman, M. Nikpour, A. Scleroderma Interest Group (ASIG), N. Hunzelmann, J. K. de Vries-Bouwstra, A. L. Herrick, Y. Allanore, M. Alarcon-Riquelme, L. Beretta, S. Assassi, C. P. Denton, M. D. Mayes, J. Martin, M. Acosta-Herrera
|
|
2026 POS0040
|
LESS PRONOUNCED INTERFERON SIGNATURE IN PRIMARY ANTIPHOSPHOLIPID SYNDROME COMPARED WITH OTHER AUTOIMMUNE DISEASES,
D. Nikolopoulos, K. Charitidis, L. Beretta, J. Lindblom, G. Barturen, M. Alarcon-Riquelme, I. Parodis
|
|
2026 POS0087
|
A GENOME-WIDE ASSOCIATION STUDY OF TREATMENT RESPONSE TO TUMOUR-NECROSIS FACTOR INHIBITOR (TNFi) IN PSORIATIC ARTHRITIS PATIENTS,
M. R. Khasru, M. Stadler, H. Chinoy, M. Jani, P. Ho, J. Bowes, N. Nair, A. Barton, J. Bluett
|
|
2026 POS0088
|
GENETIC DETERMINANTS AND POLYGENIC RISK SCORES FOR PREDICTING PSORIATIC ARTHRITIS ONSET IN PATIENTS WITH PSORIASIS,
K. Dyer, Q. Li, V. Chandran, D. Gladman, P. Rahman
|
|
2026 POS0111
|
DIAGNOSTIC YIELD AND CLINICAL IMPACT OF MULTIGENE AUTOINFLAMMATORY PANELS IN ADULT ROUTINE CARE (2018–2025): THE ROLE OF PRE-TEST CLINICAL SUSPICION,
J. Manzaneque Sánchez, L. Álvarez Ortiz, M. Camacho Halcón, P. Figueras González, C. Aguilera Cros, M. A. Montes Cano, L. Mendez Diaz, R. J. Gil Vélez
|
|
2026 POS0117
|
SOMATIC NLRP3 MOSAICISM IDENTIFIED AFTER 44 YEARS OF UNEXPLAINED INFLAMMATION,
G. Khatu, S. Chander
|
|
2026 POS0130
|
CHIDAMIDE REPROGRAMS THE GATA1-HES1 DYSREGULATION TO RESTORE MEGAKARYOPOIESIS IN SLE-ASSOCIATED IMMUNE THROMBOCYTOPENIA,
Y. Hou, Z. Yang, M. Zhou, X. Tang, X. Feng, L. Sun
|
|
2026 POS0273
|
GENETIC BIOMARKERS OF CLINICAL MANIFESTATIONS OF GIANT CELL ARTERITIS DEFINE FOUR CLINICALLY-RELEVANT GENETIC SUBGROUPS,
G. Borrego-Yaniz, V. Fuentes-Moreno, L. Ortiz-Fernández, J. Hernández-Rodríguez, S. Mackie, A. Vaglio, S. Castañeda, R. Solans-Laqué, J. Mestre Torres, N. Khalidi, C. Langford, S. R. Ytterberg, L. Beretta, M. Govoni, G. Emmi, M. A. Cimmino, T. Witte, T. Neumann, J. Holle, V. Schönau, G. Pugnet, T. Papo, J. Haroche, A. Mahr, L. Mouthon, Ø. Molberg, A. Diamantopoulos, A. Voskuyl, T. Daikeler, C. Berger, E. Molloy, Y. van Sleen, L. Sorensen, R. Luqmani, S. GCA Group, U. G. Consortium, V. C. Research Consortium, N. Ortego-Centeno, E. Brouwer, P. Lamprecht, S. Klapa, C. Salvarani, P. Merkel, M. C. Cid, M. Iles, M. Á. González-Gay, A. Morgan, J. Martin, A. Márquez
|
|
2026 POS0317
|
PERIPHERAL BLOOD GENE EXPRESSION AS A BIOMARKER OF SUSTAINED RESPONSE TO B-CELL THERAPY IN SJÖGREN’S DISEASE,
A. Ibrahim, J. Peng, B. Tian, G. Robinson, L. Martin-Gutierrez, J. Casement, K. Thompson, W. F. Ng, A. van Maurik, E. Jury, C. Ciurtin
|
|
2026 POS0319
|
CELLULAR AND TRANSCRIPTIONAL DIFFERENCES ACROSS EARLY SJÖGREN’S DISEASE SUBPHENOTYPES,
M. Radziszewski, J. Li, S. Yao, C. Pritchett Frazee, M. M. Wiley, K. L. Tessneer, M. C. Marlin, M. Smith, K. Wei, S. Raychaudhuri, M. Brenner, L. Tsoi, J. E. Gudjonsson, N. Hacohen, U. Deshmukh, S. Kovats, J. A. James, R. H. Scofield, A. Rasmussen, S. Shiboski, B. Khatri, A. Baer, A. D. Farris, C. Shiboski, J. M. Guthridge, B. M. Warner, C. J. Lessard
|
|
2026 POS0320
|
MOLECULAR CHARACTERIZATION OF ANTI-Ro POSITIVE AND NEGATIVE SJÖGREN’S DISEASE WITH SINGLE CELL RNA SEQUENCING OF PERIPHERAL BLOOD,
J. Li, B. Khatri, S. Yao, M. Radziszewski, C. Pritchett Frazee, M. M. Wiley, K. L. Tessneer, C. Lawrence, H. Christakos, C. Lopez-Davis, T. C. Taylor, M. L. Joachims, A. Rasmussen, R. H. Scofield, B. M. Warner, J. A. James, J. M. Guthridge, A. D. Farris, C. J. Lessard
|
|
2026 POS0333
|
GENETIC ARCHITECTURE OF JUVENILE IDIOPATHIC ARTHRITIS FROM A LARGE-SCALE GENOME-WIDE ASSOCIATION STUDY META-ANALYSIS,
S. Bastakoti, A. Shadrin, H. Khoshfekr Rudsari, P. Jaholkowski, V. Fominykh, K. Løkås Haftorn, B. A. Lie, O. A. Andreassen, H. Sanner
|
|
2026 POS0347
|
INTEGRATING RARE VARIANT BURDEN AND POLYGENIC RISK SCORES REVEALS A COMPLEX GENETIC ARCHITECTURE AMONG SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES,
A. Madenidou, G. I. Rice, S. Dyball, B. Parker, A. Stevens, T. Briggs, A. Morris, I. N. Bruce
|
|
2026 POS0370
|
GENETIC VARIANTS IN IDIOPATHIC OSTEOPOROSIS IN MEN,
J. Peñafiel-Sam, E. González, C. Arango Silva, A. Monegal, H. Florez, P. Peris
|
|
2026 POS0384
|
A NOVEL PATHOGENIC MECHANISM IN ANTIPHOSPHOLIPID SYNDROME INVOLVING HEPATIC, AUTOIMMUNE AND METABOLIC PATHWAYS,
B. Vellón-García, S. Corrales-Díaz Flores, G. D. García-Delgado, M. Á. Aguirre-Zamorano, I. Sanchez-Pareja, L. Muñoz-Barrera, T. Cerdó, P. Seguí Azpilcueta, C. Merlo, M. D. C. Abalos-Aguilera, N. Barbarroja, R. Ortega-Castro, J. A. González-Reyes, A. Escudero-Contreras, C. Lopez-Pedrera, J. M. Villalba, C. Perez-Sanchez
|
|
2026 POS0394
|
NOVEL GENETIC RISK FACTORS FOR SYSTEMIC SCLEROSIS-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION,
C. Rangel-Peláez, C. Rosa-Baez, I. Rodriguez-Martin, M. Kerick, A. Guillen-Del-Castillo, C. P. Simeón-Aznar, J. L. Callejas, A. Voskuyl, A. Kreuter, O. Distler I. SSc Group, S. M. Proudman, M. Nikpour A. Scleroderma Interest Group (ASIG), N. Hunzelmann, G. Moroncini, A. Gabrielli, J. Distler, J. K. de Vries-Bouwstra, A. L. Herrick, Y. Allanore, L. Beretta, B. Skaug, S. Assassi, C. P. Denton, J. Martin, L. Ortiz-Fernández, M. Acosta-Herrera
|
|
2026 POS0484
|
HLA-CW6 IN PSORIATIC ARTHRITIS: CLINICAL PHENOTYPE AND THERAPEUTIC IMPACT,
C. Macia-Villa, J. I. Fernandez Velasco, M. Ferre-Sanfrancisco, D. A. Mendoza Bravo, A. M. Ruiz Bejerano, C. Ferrez Hernandez, J. L. Morell Hita
|
|
2026 POS0623
|
CLINICAL MANIFESTATIONS AND LONG-TERM PROGNOSIS OF JUVENILE- AND ADULT-ONSET TAKAYASU ARTERITIS,
H. Tsuji, H. Yoshifuji, T. Sasai, M. Shirakashi, R. Hiwa, S. Akizuki, R. Nakashima, A. Onishi, M. Tanaka, A. Morinobu
|
|
2026 POS0665
|
INFLAMMASOME-RELATED POLYMORPHISMS AS BIOMARKERS TO ACCURATELY DIAGNOSE INTERSTITIAL LUNG DISEASE ASSOCIATED WITH AUTOIMMUNE DISEASES?,
V. Pulito-Cueto, J. C. Batista-Liz, B. Atienza-Mateo, D. Iturbe Fernández, V. M. Mora-Cuesta, M. Sebastián Mora-Gil, C. Aguirre Portilla, J. M. Cifrián-Martínez, R. Blanco, R. López-Mejías
|
|
2026 POS0734-HPR
|
EVALUATING THE CAUSAL ASSOCIATIONS BETWEEN CLONAL HEMATOPOIESIS AND ITS SUBTYPES AND RHEUMATOID ARTHRITIS: A BIDIRECTIONAL MENDELIAN RANDOMIZATION STUDY,
N. Li, R. Wu, Q. Feng, Y. Mu, C. Wang
|
|
2026 POS0751
|
MITOCHONDRIAL ALTERATIONS IN STILL DISEASE: INSIGHTS FROM MTDNA COPY NUMBER AND TFAM EXPRESSION,
L. Manisera, F. Giansanti, A. Latini, F. Lo Tito, S. Colafrancesco, A. Gattamelata, C. Ciccacci, F. Conti, R. Priori
|
|
2026 POS0757
|
NON-HLA SUSCEPTIBILITY POLYGENIC RISK SCORE IS ASSOCIATED WITH EARLIER DISEASE ONSET AND LONGITUDINAL JOINT DAMAGE IN RHEUMATOID ARTHRITIS,
S. Sharma, R. Hum, N. Nair, L. Marshall, J. Bowes, A. MacGregor, M. Yates, A. Morris, S. Verstappen, A. Barton, S. Viatte
|
|
2026 POS0760
|
IMPACT OF MEFV MUTATIONS ON THE EFFICACY AND SAFETY OF COLCHICINE AND INTERLEUKIN-1 INHIBITORS IN FAMILIAL MEDITERRANEAN FEVER: A REAL-WORLD COHORT STUDY,
R. Deniz, M. Günaydin, H. K. Yerisenoglu Demir, A. Gül, C. Bes
|
|
2026 POS0771
|
BEYOND NLRP3: EXPANDING THE SPECTRUM OF NLR-ASSOCIATED AUTOINFLAMMATORY DISEASES,
R. Deniz, C. Tansu Yavuz, A. Aydin Gümüş, L. Yilmaz Çelik, P. Ercoşkun, A. Gul, C. Bes
|
|
2026 POS0772
|
CLINICAL AND PHENOTYPIC DIFFERENCES BETWEEN MEFV-POSITIVE AND MEFV-NEGATIVE FAMILIAL MEDITERRANEAN FEVER: ARE THEY REALLY THE SAME?,
R. Deniz, H. K. Yerisenoglu Demir, M. Günaydin, A. Gül, C. Bes
|
|
2026 POS0809
|
M6A EPITRANSCRIPTOMIC ANALYSIS IN TREATED INFLAMMATORY RHEUMATIC PATIENTS: GLOBAL RNA METHYLATION AND REGULATORY GENE EXPRESSION,
A. D’Antonio, G. De Benedittis, C. Morgante, A. Latini, E. Cela, C. Ciccacci, P. Conigliaro, P. Borgiani, M. S. Chimenti
|
|
2026 POS0824
|
SAFETY OF IL-6 RECEPTOR INHIBITION IN PREGNANCY: A MENDELIAN RANDOMIZATION STUDY,
B. Zuckerman, K. Powell, C. Moezinia
|
|
2026 POS0827
|
DISENTANGLING CAUSALITY AND PLEIOTROPY BETWEEN OSTEOPOROSIS AND ANKYLOSING SPONDYLITIS USING GENOME-WIDE GENETIC ANALYSES,
S. S. Zhao, N. Harvey, B. Nam, Z. Li, L. A. Bradbury, L. S. Gensler, P. B. Wordsworth, M. Ward, M. H. Weisman, T. Learch, J. D. Reveille, T. H. Kim, M. Brown
|
|
2026 POS0887
|
NASAL EPITHELIAL PADI EXPRESSION DRIVEN BY AIRBORNE POLLUTANTS: IMPLICATIONS FOR LOCAL CITRULLINATION IN RHEUMATOID ARTHRITIS,
J. Sarnik, A. Opinc-Rosiak, O. Brzezinska, A. Lewandowska-Polak, J. Makowska
|
|
2026 POS0898
|
TARGETING NAD+ METABOLISM IN INFLAMMATORY RHEUMATIC DISEASES: IMPACT OF ANTI-TNF THERAPY AND NAD+ SUPPLEMENTATION,
B. Vellón-García, A. Escudero-Contreras, G. D. García-Delgado, A. Llamas-Urbano, Y. Hanaee, P. Ortiz-Buitrago, C. Merlo, L. Romero-Zurita, M. D. C. Abalos-Aguilera, D. Ruiz-Vilchez, M. Á. Puche-Larrubia, I. Arias-de la Rosa, M. D. López Montilla, E. Collantes-Estevez, C. Aranda-Valera, I. Gómez-García, R. Ortega-Castro, J. Calvo-Gutiérrez, M. L. Ladehesa-Pineda, C. López-Medina, N. Barbarroja, C. Lopez-Pedrera, J. M. Villalba, C. Perez-Sanchez
|
|
2026 POS0908
|
MONOCYTE EPIGENETIC SIGNATURE IN SARCOIDOSIS,
M. Robert, N. Yatim, S. Culina, T. Dott, V. Saint-Andre, S. Schmutz, E. Villain, R. Borie, T. Goulenok, P. A. Juge, A. Mageau, N. Peiffer Smadja, N. Charles, D. Duffy, K. Sacre
|
|
2026 POS0909
|
MULTI-ANCESTRY GWAS OF RADIOGRAPHIC PROGRESSION IN AXIAL SPONDYLOARTHRITIS,
S. S. Zhao, N. Harvey, B. Nam, Z. Li, L. A. Bradbury, L. S. Gensler, P. B. Wordsworth, M. Ward, M. H. Weisman, T. Learch, J. D. Reveille, T. H. Kim, M. Brown
|
|
2026 POS0939
|
LONG-TERM OR RECURRENT ANTIBIOTIC USE IN CHILDHOOD IS ASSOCIATED WITH DOUBLED RISK OF AXIAL SPONDYLOARTHRITIS AMONG HLA-B27-POSITIVE INDIVIDUALS,
S. S. Zhao
|
|
2026 POS0948
|
THE INTERACTION OF HLA-B27 AND OTHER HEREDITARY RISK FACTORS ON ANKYLOSING SPONDYLITIS RISK AMONG FINNISH BIOBANK PARTICIPANTS,
J. Paltta, E. Sliz, E. Lahtela, V. Salo, J. Kettunen, F. FinnGen, A. Palomäki
|
|
2026 POS0964
|
ESCO2-DEPENDENT HISTONE LACTYLATION MEDIATES NEUTROPHIL EXTRACELLULAR TRAP-INDUCED ACTIVATION OF SYNOVIAL FIBROBLASTS IN RHEUMATOID ARTHRITIS,
H. Qi
|
|
2026 POS0969
|
CAUSAL NETWORKS OFFER INSIGHTS INTO PATHOBIOLOGICAL PATHWAYS TO FLARE IN RHEUMATOID ARTHRITIS: ANALYSIS OF THE BIOLOGICAL FACTORS THAT LIMIT SUSTAINED REMISSION (BIO-FLARE) STUDY,
K. Patasova, J. Sim, G. Smith, F. Rayner, N. Naamane, B. Dyke, A. Melville, S. Kerrigan, A. McGucken, C. D. Buckley, A. Filer, I. B. McInnes, K. Raza, S. Siebert, W. F. Ng, K. F. Baker, A. E. Anderson, J. Isaacs, H. Cordell, A. Pratt
|
|
2026 POS0970
|
EVALUATION OF HLA ALLELES AND POLYGENIC SCORES IN PREDICTING CLINICAL PROGRESSION AMONG INDIVIDUALS AT-RISK FOR RHEUMATOID ARTHRITIS,
T. Yamaguchi, Y. Okamoto, T. Hosoya, K. Ikari, C. Terao, S. Yasuda, Y. Kochi
|
|
2026 POS0974
|
MULTI-ANCESTRY GENOME-WIDE ASSOCIATION ANALYSIS OF SJÖGREN’S DISEASE IDENTIFIES NOVEL RISK LOCI,
M. Radziszewski, B. Khatri, P. E. Stuart, A. Rasmussen, K. L. Tessneer, C. Pritchett Frazee, M. T. Patrick, E. Pontarini, M. Bombardieri, M. Rischmueller, M. Kvarnström, T. Witte, H. Bootsma, G. M. Verstappen, F. G. M. Kroese, A. Vissink, S. Pringle, A. Tzioufas, C. Mavragani, A. Baer, M. Alarcon-Riquelme, J. Martin, X. Mariette, G. Nocturne, J. O. Pers, J. E. Gottenberg, W. F. Ng, E. Abner, K. Batool, B. A. Fisher, R. Gordon, G. Hernandez-Molina, A. Y. S. Lee, C. Shiboski, K. E. Taylor, L. Criswell, B. M. Warner, A. D. Farris, J. A. James, R. H. Scofield, J. M. Guthridge, D. J. Wallace M.D., S. Venuturupali, M. T. Brennan, J. Imgenberg-Kreuz, L. Ronnblom, E. Baecklund, M. L. Eloranta, S. J. A. Johnsen, R. Omdal, L. A. Aqrawi, Ø. Palm, J. G. Brun, D. Hammenfors, M. V. Jonsson, S. Appel, S. M. Bucher, H. Forsblad-d’Elia, T. Mandl, P. Eriksson, M. Wahren-Herlenius, J. E. Gudjonsson, L. Tsoi, G. Nordmark, C. J. Lessard
|
|
2026 POS0976
|
SPATIAL TRANSCRIPTOMICS REVEALS GLANDULAR CELL INVOLVMENT IN THE PATHOPHYSIOLOGY OF SJÖGREN’S DISEASE,
S. Yao, M. Radziszewski, J. Li, C. Pritchett Frazee, M. M. Wiley, K. L. Tessneer, M. C. Marlin, M. Smith, K. Wei, S. Raychaudhuri, M. Brenner, L. Tsoi, J. E. Gudjonsson, N. Hacohen, J. A. James, R. H. Scofield, A. Rasmussen, S. Shiboski, B. Khatri, A. Baer, A. D. Farris, C. Shiboski, J. M. Guthridge, B. M. Warner, C. J. Lessard
|
|
2026 POS0980
|
SEQUNCING OF HLA-A, -B,-С, -DRB1, -DQA1 GENES IN PATIENTS WITH TAKAYASU ARTERITIS IN THE KYRGYZ AND RUSSIAN POPULATIONS,
A. Bolotbekova, I. Guseva, G. Koilubaeva, O. Egorova, E. Samarkina, G. Tarasova, M. Chanyshev
|
|
2026 POS1024
|
EVIDENCE FOR SHARED GENETIC RISK BETWEEN INFERTILITY AND JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM POPULATION-BASED PREGNANCY COHORTS,
K. Løkås Haftorn, V. Ø. Dåstøl, P. P. Jaholkowski, K. Hansen Skåra, S. Valen Hestetun, S. E. Håberg, I. H. Caspersen, H. Sanner
|
|
2026 POS1026
|
BLOOD PROTEIN-WIDE ASSOCIATION STUDY REVEALS NOVEL PROTEINS IN JUVENILE IDIOPATHIC ARTHRITIS PATHOGENESIS,
K. X. Yao, L. L. Zheng, M. Chang, P. Gao
|
|
2026 POS1035
|
CONCORDANCE OF CLINICAL PHENOTYPES, HLA-B51, AND ERAP-1 VARIATIONS AMONG FIRST-DEGREE RELATIVES WITH BEHÇET SYNDROME,
M. D. Ozcan, A. Kirectepe Aydn, S. N. Esatoglu, Y. Ozguler, E. Seyahi, M. Melikoglu, E. Yilmaz, M. Dogruel, G. Hatemi
|
|
2026 POS1065
|
UNSUPERVISED CLUSTERING OF CLINICAL AND LABORATORY FEATURES OF SYSTEMIC LUPUS ERYTHEMATOSUS: INSIGHTS FROM A MULTICENTER COHORT,
Y. Hou, Y. Wang, B. Wei, Y. Chen, C. Weng, S. Wu, J. Liang, Y. Zhai, Y. Zou, G. GAO, S. Jin, P. Wang, J. Li, S. Zang, X. Li, J. Chen, H. Yao, Z. Liu, G. Wang, Z. Liu, Z. Li
|
|
2026 POS1107
|
DECIPHERING THE SHARED GENETIC ARCHITECTURE AND MOLECULAR BRIDGES BETWEEN PHYSICAL ACTIVITY AND AUTOIMMUNE DISEASES: A LARGE-SCALE MULTI-TRAIT ANALYSIS,
M. Chang, K. X. Yao, J. Qiao, Z. Li
|
|
2026 POS1125
|
CEBPA-DRIVEN ABNORMAL EXPANSION OF BONE MARROW AUTOREACTIVE CD11C+ PRO-B CELLS IN SYSTEMIC LUPUS ERYTHEMATOSUS,
Z. Yang, Y. Hou, X. Tang, X. Feng
|
|
2026 POS1126
|
CELL-FREE DNA METHYLATION AND FRAGMENTATION SIGNATURES ENABLE NON-INVASIVE DETECTION AND MONITORING OF ACTIVE LUPUS NEPHRITIS,
Q. Li, Q. Jing, C. W. S. Chan, W. Chen, F. Y. N. Choi, I. Y. K. Tang, C. S. Lau, G. S. Ling, J. W. H. Wong, P. H. Li
|
|
2026 POS1129
|
POLYGENIC BURDEN OF LUPUS ENHANCES TYPE I INTERFERON SIGNALING IN HEALTHY INDIVIDUALS,
H. Inokuchi, M. Nakano, K. Asahara, T. Arakawa, T. Kawashima, N. Takahiro, H. Takahashi, H. Hatano, M. Kono, B. Natsumoto, Y. Kaneko, K. Ishigaki
|
|
2026 POS1138
|
PATHOGENESIS AND BIOMARKER VALIDATION IN PEOPLE AT RISK OF RHEUMATIC AND MUSCULOSKELETAL DISEASES: A TRANSCRIPTOMIC AND FLOW CYTOMETRIC STUDY REVEALS A TRANSIENT INCREASE IN B CELL INTERFERON-RESPONSE AND DIFFERENTIATION PRECEDES ONSET OF RHEUMATIC AND MUSCULOSKELETAL DISEASES,
H. H. Yu, J. Arnold, Z. Wigston, L. M. Carter, M. Y. Md Yusof, E. M. Vital
|
|
2026 POS1269
|
BASELINE cfDNA ACTIVE CHROMATIN PROFILES REFLECT SYNOVIAL PATHOTYPE-ASSOCIATED PROGRAMS THAT DISTINGUISH RESPONDERS AND NON-RESPONDERS TO TNF INHIBITORS, JAK INHIBITORS, AND ABATACEPT IN RHEUMATOID ARTHRITIS,
K. Lai, J. Carlson, S. Vu, K. Lam, D. Abdueva, J. R. Curtis, P. C. Taylor
|
|
2026 POS1306
|
PD-L1 RELATED MECHANISMS DISTINGUISH CD4+ T CELLS IN THE PRE-CLINICAL AND EARLY STAGES OF RHEUMATOID ARTHRITIS,
V. Chandrasekaran, M. Erlandsson, R. Modigh, R. Pullerits, M. I. Bokarewa
|
|
|
[48]
|
And measuring health
|
|
|
| 2026 |
|
2026 AB0298
|
BATTLE OF THE BOTS: A COMPARATIVE DIAGNOSTIC PERFORMANCE EVALUATION OF PROF. VALMED, CHATGPT-5 THINKING, AND OPENEVIDENCE,
P. Kremer, E. Langballe, I. Haase, J. Bamberger, S. Kuhn, M. Krusche, J. Knitza
|
|
2026 AB0318
|
PREDICTING STABLE AND ACTIVE DISEASE IN VASCULITIS PATIENTS UNDER REMOTE CLINICAL MANAGEMENT,
P. Kresanov, T. Kolari, R. Luqmani
|
|
2026 AB0467
|
INTEGRATION OF SELF-IMAGING INTO THE SWISS NATIONAL RHEUMATOLOGY REGISTRY: A MULTICENTER FEASABILITY STUDY INCLUDING COMPUTER-VISION ASSESSMENT,
C. N. Koller, J. Maglione, M. Blanchard, A. Scherer, M. Andor, L. Brulhart Bletsas, R. Micheroli, A. Rubbert-roth, T. Manigold, C. Iking-Konert, C. Manolaraki, A. Dumusc, M. Nissen, T. Hügle
|
|
2026 AB0590
|
DIGITAL SCREENING IDENTIFIES AT-RISK WOKRERS BEFORE PAIN ONSET: ACTIVITY PREDICTS FUNCTION BETTER THAN SYMPTOMS,
N. Tik
|
|
2026 AB0640
|
PREDICT, PERSONALISE, PREVENT: A MACHINE LEARNING STRATEGY TO IMPROVE AYA RHEUMATOLOGY CLINIC ATTENDANCE,
A. Bouraoui, J. R. W. Glanville, C. Fisher, S. Mavrommatis, M. Leandro, D. Sen
|
|
2026 AB0642
|
FACTORS ASSOCIATED WITH PATIENT ACCEPTABILITY OF TELERHEUMATOLOGY,
H. Farooq, L. Jackson, R. Begum, G. Cutter, K. Saag, J. Yazdany, M. Danila
|
|
2026 AB0647
|
A BIOMARKER-BASED PREDICTIVE MODEL FOR IMMUNE-MEDIATED OBSTETRIC RISK IN AUTOIMMUNE RHEUMATIC DISEASES,
B. R. Avalos García, D. Rodriguez-Garibay, R. Martinez Canales, O. J. García Gómez, E. Galindo, D. A. Galarza-Delgado, L. Perez Barbosa, M. C. Salinas-Carmona, C. M. Skinner-Taylor, N. Macias-Segura
|
|
2026 AB0657
|
BRIDGING GAPS IN RHEUMATOLOGY: A COMPREHENSIVE, CONTINUOUSLY UPDATED, FREE DIGITAL RESOURCE FOR SUPPORTING EVIDENCE-BASED CLINICAL PRACTICE (www.rheumatologymindmap.com),
A. Papou
|
|
2026 AB0773
|
DIGITAL MATURITY OF RHEUMATOLOGY SERVICES - RESULTS OF THE GLOBAL DIGITAL RHEUMATOLOGY RADAR SURVEY,
V. Bartsch, K. Salomon-Escoto, D. De Cock, A. Ribeiro, H. Smucrova, T. Davergne, A. Fusshoeller, V. Venerito, S. Izuka, A. Rojas, N. Osteras, M. Milchert, M. Lucas Rocha, P. Studenic, D. Benavent, A. van Tubergen, A. Chan, F. Muehlensiepen, S. Kuhn, T. Hügle, L. Gupta, L. M. Verhoef, J. Knitza
|
|
2026 AB0795
|
FEASIBILITY, USABILITY, AND DIGITAL BIOMARKER PATTERNS OF A WEARABLE-INTEGRATED EXERCISE APP (RHEUMA-FIT) IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS: A PILOT CLINICAL STUDY,
E. Tabaga, A. Temiz, M. Nissen, M. Flaucher, G. Schett, H. Morf
|
|
2026 AB0815
|
HYBRID FOLLOW-UP COMPARED WITH STANDARD OF CARE IN RHEUMATOID ARTHRITIS,
J. A. Brigante, L. Ignacio, E. Dufau, G. T. Martinez Bejarano, J. P. Araque, D. Yucra Bobarin, C. Galvan, J. Denisdei, L. Vergel Orduz
|
|
2026 AB0823
|
PREDICTION AIDED TAPERING IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH BIOLOGICAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (PATIO): A RANDOMISED CONTROLLED TRIAL,
S. Fadaei, A. A. den Broeder, A. Herman, H. E. Vonkeman, J. Peeters, A. Maas, J. Spierings, J. M. van Laar, J. Tekstra, M. A. Messelink, P. Bovens, M. van der Goes, P. Welsing
|
|
2026 AB0885
|
THE IMPACT OF PROLONGED WAR-RELATED STRESS ON DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS IN A FRONTLINE UKRAINIAN CITY,
V. Kachkovska, L. Prystupa, A. Kovchun
|
|
2026 AB1044
|
WHEN FEELING ACTIVE IS NOT ENOUGH: DISCORDANCE BETWEEN PERCEIVED AND OBJECTIVELY MEASURED PHYSICAL ACTIVITY IN AXIAL SPONDYLOARTHRITIS,
S. Lukovic, N. Tomonjic, M. Vujovic Sestakov, K. Lauševic, I. Smiljanic, A. Neskovic, I. Pavlovic, J. Mihailovic Durdevic, K. Vagic, V. Štulić, A. Radivcev, M. Zlatanovic, T. Zivanovic Radnic, B. Barac, P. Ostojic
|
|
2026 AB1213
|
EasyBILAG-DIGITAL: A PRACTICE-CHANGING DIGITAL SOLUTION TO ENABLE RELIABLE BILAG-2004 SCORING IN SLE TRIALS AND ROUTINE CARE,
J. Arnold, B. Sethi, L. M. Carter, E. M. Vital
|
|
2026 AB1405-HPR
|
ADDRESSING SYNDEMICS IN MAYAN-INDIGENOUS COMMUNITIES: A MIXED-METHODS ANALYSIS OF A CARE MODEL IN MEXICO,
C. Cadena-Trejo, E. Motte-García, A. Gastelum-Strozzi, A. Loyola-Sánchez, D. Flores-Aguilar, N. Facio-Escalona, K. N. López-Herrera, M. V. Fernández-García, C. Garcia Garcia, J. F. Moctezuma, E. Alvarez Hernandez, J. Álvarez Nemegyei, P. Loeza-Magaña, M. M. Lahr, E. Buskens, I. Peláez-Ballestas
|
|
2026 AB1465-PARE
|
A BILINGUAL EDUCATIONAL PODCAST TO IMPROVE VACCINATION AWARENESS IN CHRONIC INFLAMMATORY RHEUMATIC DISEASES: A PATIENT EDUCATION INITIATIVE,
N. Chakyr, H. Rkain, F. Kronbi, C. Nouri, S. Sihida, F. Cherkaoui, H. Sefiani, A. Chaibi, L. Tahiri, R. Abouqal, N. Hajjaj-Hassouni, F. Allali
|
|
2026 AB1476-PARE
|
THE ROLE OF PATIENT PARTNERS IN MAKING DIGITAL HEALTH RESEARCH MORE INCLUSIVE: EXPERIENCES FROM THE REmote MOnitoring OF RHEUMATOID ARTHRITIS (REMORA) RESEARCH PROGRAMME,
M. Al-Attar, K. Staniland, P. Amlani-Hatcher, J. Paton, J. Behan-Devlin, C. Sharp, C. Sanders, W. Dixon, S. van der Veer
|
|
2026 OP005-HPR
|
COST-EFFECTIVENESS OF DIGITAL PATIENT EDUCATION FOR NEWLY DIAGNOSED PATIENTS WITH RHEUMATOID ARTHRITIS: AN ECONOMIC EVALUATION FROM A RANDOMISED CONTROLLED TRIAL,
L. Raunsbæk Knudsen, A. Wiben, C. Skovsgaard, M. Ndosi, E. M. Hauge, K. Lomborg, L. W. Dreyer, L. Sørensen, A. de Thurah
|
|
2026 OP014-PARE
|
MAKE RHEUM FOR YOUTH: IDENTIFYING BARRIERS TO MEDICATION ACCESS AND HEALTHCARE FOR YOUNG PEOPLE WITH RHEUMATIC DISEASES,
N. Trehan, A. Bhattal, S. Wagner
|
|
2026 OP0141-HPR
|
CO-DEVELOPING A FLEXIBLE CARE DELIVERY MODEL FOR INFLAMMATORY ARTHRITIS IN CANADA (FlexCAre): RESULTS FROM FOCUS GROUPS WITH PATIENTS AND HEALTH CARE PROVIDERS,
S. J. Bartlett, N. Deville-Stoetzel, E. McGuire, K. Raptis, D. DaCosta, D. Lacaille
|
|
2026 OP019-HPR
|
DEVELOPMENT OF THE SQUEEZE EHEALTH-FACILITATED INTEGRATED CARE MODEL TO IMPROVE DMARD ADHERENCE IN ADULTS WITH RHEUMATOID ARTHRITIS: AN IMPLEMENTATION SCIENCE-INFORMED INTERVENTION,
S. Calado, C. Wettengl, J. Ribaut, B. van den Bemt, S. Brand, L. Carmona, K. Chingov, M. L. Daly, A. Dam, C. Zabalan, E. Loza, C. Manolaraki, T. Oton, D. Kyburz, S. De Geest, A. Kocher
|
|
2026 OP023-HPR
|
OPTIMIZING IMPLEMENTATION OF DIGITAL PATIENT EDUCATION USING E-HEALTH LITERACY PROFILES IN A RHEUMATOID ARTHRITIS COHORT,
L. Raunsbæk Knudsen, S. Bech Vestergaard, M. M. Bakker, M. Ndosi, A. de Thurah
|
|
2026 OP0256-PARE
|
TURNING GUIDELINES TO ANSWERS: PATIENT EVALUATION OF AI-BASED GUIDELINE CHATBOTS IN RHEUMATOLOGY,
T. Wilhelmi, V. Bartsch, M. Weber, R. Orzanna, A. Rashid, J. Hornig, M. Krusche, A. Hueber, D. Fink, A. Pfeil, G. Dischereit, M. T. Holzer, U. Drott, P. M. Aries, M. Müller, P. Böhm, S. Kuhn, P. Klemm, J. Knitza
|
|
2026 POS0004-PARE
|
BARRIERS TO APP-BASED REMOTE MONITORING IN RHEUMATOID ARTHRITIS: FINDINGS FROM THE REMORA2 STUDY,
J. Behan-Devlin, S. Moschogianis, K. Staniland, C. Sharp, D. Dowding, S. van der Veer, W. Dixon, C. Sanders
|
|
2026 POS0007-PARE
|
MAKING SENSE OF FIBROMYALGIA: DEVELOPING AN EXPERT-LED DIGITAL LEARNING PROGRAMME FOR PATIENTS,
A. Fryxelius, N. Geetha Ravi, L. F. Lauvålien
|
|
2026 POS0152
|
USING LONGITUDINAL ePROMs TRAJECTORIES TO INFORM OUTPATIENT APPOINTMENTS PLANNING IN PATIENTS WITH RHEUMATOID ARTHRITIS,
I. Biliavska, E. Lenguerrand, A. Howell, P. Hamann
|
|
2026 POS0181
|
ON THE SIDELINES – HOW DO WE BEST SUPPORT PARTNERS OF ELDERLY PEOPLE WITH RMDS,
M. Saaby Bro
|
|
2026 POS0199
|
THE DIGITAL THERAPEUTIC AXIA IMPROVES SPINAL MOBILITY AND STRENGTH, IMPAIRMENT OF INSOMNIA, AND DISEASE RELATED SEXUAL DYSFUNCTION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS OF A 24-WEEK PRE-POST INTERVENTIONAL TRIAL (BECHTEREW-APP TRIAL II),
P. P. Strunz, A. Wüst, P. Possler, M. le Maire, T. Heusinger, A. Fleischer, K. S. Luetkens, M. Gernert, H. Labinsky, O. Gadeholt, R. Leppich, A. Schmieder, L. Hammel, B. Sperlich, H. Einsele, M. Fröhlich, M. Schmalzing
|
|
2026 POS0253
|
WEARABLE-DERIVED DATA AND MACHINE LEARNING PREDICT EQ-5D-BASED QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS,
M. Higashida-Konishi, K. Izumi, S. Saito, H. Tabata, S. Hama, T. Oshige, Y. Okano, H. Oshima, K. Suzuki, Y. Mashimo, J. Sakamoto, T. Fukami, K. Minato, N. Kajio, Y. Kondo, H. Taguchi, Y. Kaneko
|
|
2026 POS0346-HPR
|
IMPROVING ADHERENCE TO FALL PREVENTION EXERCISE IN OLDER ADULTS WITH A HISTORY OF FALLS: A CLUSTER RANDOMISED TRIAL OF BRIEF ACTION PLANNING TRAINING AND DIGITAL SUPPORT FOR PHYSIOTHERAPISTS,
L. Li, H. Xie, N. Lu, J. Davis, M. Oakey, D. Bayraktar, J. Xu, S. Therrien, Y. S. Seo, E. Wang, C. Primeau, J. Ma, J. Mollins, C. Shaw, D. Jehu, T. Liu-Ambrose
|
|
2026 POS0415
|
PRELIMINARY RECORDS FROM FMFTrackR: A PROSPECTIVE, REAL-TIME STUDY USING A PURPOSE-BUILT WEB-BASED MOBILE APPLICATION TO CAPTURE PATIENT-REPORTED FMF ATTACKS AND TRIGGERING FACTORS,
B. Menentoglu, A. Dudakli, P. Prencuva Akyürek, S. D. Arik, V. Arman, N. Arman, Ö. Akgün, N. Aktay Ayaz
|
|
2026 POS0504
|
THE Nor-SSCardioCare OPEN-LABEL CLINICAL PILOT TRIAL: HOME-BASED MONITORING OF CARDIOPULMONARY COMPLICATIONS IN SYSTEMIC SCLEROSIS,
H. J. Bjørkekjær, M. N. Carstens, P. Andel, H. Fretheim, K. Kastrati, E. Langballe, P. P. Diep, M. Mæhlen, T. Garen, C. Brunborg, M. L. T. Ramsli, H. Bitter, S. Høie, A. Andreassen, K. Broch, Ø. Molberg, A. M. Hoffmann-Vold
|
|
2026 POS0540
|
EFFICACY, SAFETY AND TOLERABILITY OF HOME-BASED ILOPROST ADMINISTRATION FOR ACRAL VASCULAR MANIFESTATIONS IN SCLERODERMA PATIENTS: A SINGLE-CENTRE REAL LIFE STUDY,
A. Dionisi, L. Verardi, A. Finucci, P. Volpe, A. C. Raspa, P. Cipriani, R. Zicolella
|
|
2026 POS0645-HPR
|
EVIDENCE-BASED FOUNDATIONS FOR MHEALTH FIBROMYALGIA SELF-MANAGEMENT: A MULTI-PHASE INVESTIGATION,
T. Lebeau Foustoukos, I. Leclercq, M. Blanchard, T. Hügle
|
|
2026 POS0646-HPR
|
COMPARISON OF MOBILE-BASED AND SUPERVISED ARTIFICIAL INTELLIGENCE PERSONALIZED EXERCISE PROGRAMS IN JUVENILE IDIOPATHIC ARTHRITIS: A RANDOMIZED CONTROLLED TRIAL,
A. Yekdaneh, N. Arman, N. Aktay Ayaz
|
|
2026 POS0741-HPR
|
DIGITAL FAST-TRACK PATHWAY FOR CONNECTIVE TISSUE DISEASES VIA ECONSULTATION IN A TERTIARY HOSPITAL: A FOUR-YEAR REAL-WORLD EVALUATION,
I. Alvarez Losada, E. Campos, M. Gómez-Cagiao, N. Gonzalez Pedrosa, J. L. Puga-Guzmán, M. Rodriguez Lopez, R. Dos-Santos, A. J. Mera-Varela, E. Pérez-Pampín
|
|
2026 POS0801
|
FROM DIGITAL CLINICAL FOOTPRINTS TO EARLY RHEUMATOLOGIC DIAGNOSIS: A REAL-WORLD MULTI-LABEL MACHINE LEARNING APPROACH,
M. Robustillo-Villarino, A. Zúñiga, M. Sanabria Hernández
|
|
2026 POS0819-PARE
|
REHABILITATION AND PHYSICAL ACTIVITY IN RHEUMATOLOGICAL DISEASES,
A. Celano, M. D. Antonio
|
|
2026 POS0858
|
SUSTAINED AND CONSISTENT IMPROVEMENTS IN DISEASE ACTIVITY, FUNCTIONAL STATUS, AND QUALITY OF LIFE WITH THE DIGITAL THERAPEUTIC AXIA IN AXIAL SPONDYLOARTHRITIS: RESULTS OF A 26-WEEK RANDOMISED CONTROLLED CROSSOVER TRIAL (BECHTEREW-APP TRIAL),
P. P. Strunz, M. le Maire, T. Heusinger, A. Fleischer, K. S. Luetkens, P. Possler, M. Gernert, H. Labinsky, O. Gadeholt, R. Leppich, A. Schmieder, L. Hammel, B. Sperlich, H. Einsele, M. Schmalzing, M. Fröhlich
|
|
2026 POS0943
|
PATIENT-INITIATED FOLLOW-UP IS MORE COST-EFFECTIVE THAN REMOTE MONITORING OR USUAL CARE IN AXIAL SPONDYLOARTHRITIS, RESULTS FROM THE REMONIT RANDOMIZED CONTROLLED TRIAL,
I. J. Berg, L. Asphaug, E. K. Kristinaslund, A. T. Tveter, L. Gossec, G. Macfarlane, S. Aarrestad Provan, E. Thomassen, A. de Thurah, E. Haavardsholm, S. Lillegraven, N. Osteras
|
|
2026 POS1095-HPR
|
THREE MONTHS OF REMOTE MONITORING UPON DISCHARGE VS USUAL CARE IN PATIENTS WITH SUBACUTE OR CHRONIC LOW BACK PAIN (AVA-PREPA): A RANDOMISED, OPEN-LABEL, PHASE 3, MULTICENTRE, SUPERIORITY TRIAL,
V. Wieczorek, A. Homs, J. T. Houedakor, A. Thevenon, E. Chaleat, M. De-Seze, P. Carson-Jouzel, G. Delaruelle, T. Davergne
|
|
2026 POS1098-HPR
|
A PATIENT EDUCATION APP AND A CLINICAL DECISION SUPPORT SYSTEM FOR PEOPLE WITH KNEE OSTEOARTHRITIS: THE OA-AID FEASIBILITY STUDY,
I. Nordmo, A. T. Tveter, T. Langset Rysstad, U. Sundin, M. Bjørndal-Mathisen, M. Flatlandsmo, H. Valland, S. B. Nyheim, T. A. Sjøvold, S. Søhus, T. Moseng
|
|
2026 POS1099-HPR
|
THE USE OF DIGITAL HEALTH INTERVENTIONS TO SUPPORT WORK ABILITY IN PEOPLE LIVING WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES: A SCOPING REVIEW,
S. Somerville, C. M. T. Madsen, D. Mockler, Y. Codd
|
|
2026 POS1173
|
UPDATE OF THE EULAR POINTS TO CONSIDER FOR THE USE OF ARTIFICAL INTELLIGENCE AND BIG DATA IN RHEUMATIC AND MUSCULOSKELETAL DISEASES,
L. Gupta, V. Venerito, L. Gossec, T. Hügle, P. Welsing, G. R. Burmester
|
|
2026 POS1295
|
SAFETY, ACCURACY AND CLINICAL UTILITY OF AI-GENERATED RHEUMATOID ARTHRITIS PATIENT EDUCATION: A BLINDED HEAD-TO-HEAD RHEUMATOLOGIST EVALUATION,
S. H. R. Gadekallu, B. G. Dharmanand, S. C. Veeravalli, S. Chandrashekara, H. Liu, T. R. Gadekallu
|
|
2026 POS1302
|
A VISION TRANSFORMER-BASED TRANSFER LEARNING MODEL TO INFER METACARPOPHALANGEAL JOINT SWELLING ON HAND PHOTOGRAPHS IN PATIENTS WITH RHEUMATOID ARTHRITIS,
A. García-Alija, L. Russo, M. Blanchard, J. Maglione, C. N. Koller, T. Hügle
|
|
2026 POS1345
|
EFFECTIVENESS OF PATIENT-INITIATED FOLLOW-UP SUPPORTED BY ASYNCHRONOUS TELEMEDICINE IN SPONDYLOARTHRITIS: PRE-SPECIFIED SUBGROUP ANALYSIS OF A RANDOMISED CONTROLLED TRIAL,
M. L. Smits, H. Salmani, A. Boonen, K. Hermans, H. E. Vonkeman, A. van Tubergen, C. Webers
|
|
|
[89]
|
Animal Models
|
|
|
| 2026 |
|
2026 AB0005
|
DISTINCT IMMUNE PROFILES AFTER IN VITRO AND IN VIVO TREATMENT WITH LLL12B, A PRE-CLINICAL SMALL MOLECULE STAT3 INHIBITOR, IN INFLAMMATORY MYOSITIS, LUPUS, AND HEALTHY CONTROLS,
S. Coss, S. Bruckner, W. Jarjour
|
|
2026 AB0007
|
PRECLINICAL CHARACTERIZATION OF A LONG-ACTING FCRN-BLOCKING BISPECIFIC ANTIBODY IN NON-HUMAN PRIMATES,
H. Su, L. Li, S. Dai, Q. Wang, B. Duplantis, P. Doonan, Y. Wang, C. V. Chin, X. He, Q. Yu, Y. Li
|
|
2026 AB0010
|
EVALUATION OF THE POTENT AND SELECTIVE DIHYDROOROTATE DEHYDROGENASE INHIBITOR PTC844 FOR USE IN IMMUNE-MEDIATED DISEASES,
M. Weetall, J. Sheedy, A. Mollin, N. Risher, L. Lee, J. Narasimhan, M. Ma, C. Delagrange, J. Karafilidis, A. Tansy, G. Bernstein, M. Johnston
|
|
2026 AB0028
|
IDENTIFICATION OF A METABOLIC-IMMUNE CROSSTALK IN ADULT-ONSET STILL’S DISEASE: MONOCYTE/MACROPHAGE-DERIVED IMMUNOMODULATORY METABOLITE ITACONATE DICTATES HEPATIC IMMUNOPATHOLOGY VIA CXCL10-CD8 T-CELL AXIS,
J. Ye
|
|
2026 AB0035
|
PUNICALAGIN INHIBITS MSU-INDUCED NLRP3 INFLAMMASOME ACTIVATION AND AMELIORATES ACUTE GOUT INFLAMMATION,
H. W. Park, A. Choi, J. Yang, H. Cho, J. J. Lee
|
|
2026 AB0048
|
TISSUE RESIDENT MONOCYTIC CELLS NAVIGATE ENTRY OF IMMUNE CELLS TO THE SYNOVIUM DURING INFLAMMATORY ARTHRITIS,
H. Perlman, Y. Wang, D. Winter
|
|
2026 AB0053
|
COMPLEMENT ACTIVATION AND M2-LIKE MACROPHAGE ACCUMULATION IN ANTI-MDA5 MONOCLONAL ANTIBODY–INDUCED HEPATIC INJURY IN MICE,
T. Koga, Y. Zaizen, H. Suzuki, S. Sugi, H. Hozumi, N. Sakamoto, T. Suda, H. Mukae, H. Kusano, A. Kawahara, J. Akiba, T. Kawaguchi, S. Kaieda, T. Hoshino
|
|
2026 AB0054
|
HISTIDYL-tRNA SYNTHETASE-INDUCED MYOSITIS IS MEDIATED BY MEMBRANOPATHY AND AMELIORATED BY REGULATORY T CELLS,
S. Coss, N. Young, S. Bruckner, B. Zeno, G. Giarrano, H. Bulgart, P. Clemens, J. Paul, C. V. Oddis, N. Weisleder, D. Ascherman, W. Jarjour
|
|
2026 AB0060
|
A NOVEL THERAPEUTIC STRATEGY WITH RASGRP4-TARGETED ANTISENSE OLIGONUCLEOTIDES FOR IDIOPATHIC INFLAMMATORY MYOPATHIES,
N. Umezawa, Y. Ueoka, T. Saito, T. Tsubata, R. Da, S. Li, Y. Hirose, Y. Hidaka, S. Yasuda
|
|
2026 AB0064
|
CHIMERIC NOD SCID MODEL OF MYOSITIS USING PERIPHERAL BLOOD MONONUCLEAR CELLS FROM A PATIENT WITH MDA5+ DERMATOMYOSITIS RECAPITULATES DISEASE FEATURES,
P. Gonzalez Manrique, S. Coss, N. Weisleder, W. Jarjour
|
|
2026 AB0076
|
ORAL ADMINISTRATION OF GERMANIUM TELLURIDE NANOSHEETS MODULATES MACROPHAGE ACTIVATION AND AMELIORATES PSORIASIS-LIKE INFLAMMATION IN MICE,
J. Han, J. W. Kim, S. M. Lee, Y. Park
|
|
2026 AB0087
|
IMIQUIMOD-INDUCED PSORIASIS TRIGGERS ARTHRITIS IN SKG MICE: A NOVEL SKIN-TO-JOINT MODEL OF PSORIATIC ARTHRITIS,
X. Romand, L. Vacher, M. H. Paclet, D. Hannani, B. Favier, A. Baillet
|
|
2026 AB0100
|
RAPAMYCIN MODULATES THE TFH/TFR AXIS TO INHIBIT GERMINAL CENTER RESPONSES IN COLLAGEN-INDUCED ARTHRITIS MICE,
B. Li, R. Wu, C. Wang
|
|
2026 AB0102
|
THERAPEUTIC SEMAPHORIN3B ADMINISTRATION REDUCES THE SEVERITY OF MURINE ARTHRITIS IN A SEX-DEPENDENT MANNER,
S. Martinez-Ramos, J. Marty, C. Rafael-Vidal, B. Malvar-Fernández, A. Rodríguez-Trillo, C. Conde, S. García
|
|
2026 AB0105
|
IRE1/P-JNK/NRF2 AXIS-MEDIATED GPX4 UPREGULATION UNDERLIES FERROPTOSIS RESISTANCE IN RHEUMATOID ARTHRITIS FIBROBLAST-LIKE SYNOVIOCYTES,
J. Liu, W. Xie, Y. Cao, L. Zhang, Y. Geng, Z. Zhang
|
|
2026 AB0107
|
THROMBOXANE A2 RECEPTOR INHIBITION REDUCES ARTICULAR EROSIONS IN AN EXPERIMENTAL MODEL OF RA VIA ACSL1 SUPPRESSION OF OXIDATIVE PHOSPHORYLATION,
L. Mei, L. Xin, S. Rao, C. Bo, Z. Chen, C. Li, C. Zhan, S. Yan, P. Zhang, M. Ma, Y. Wen, X. Guo, B. Chen, M. Chen, X. Wu, K. Gao, H. Du, H. Wang, J. Wang, T. Zhong, S. Wu, S. He, X. Chen, B. Burgering, M. Wang, R. Huang
|
|
2026 AB0112
|
INHIBITION OF BROMODOMAIN-CONTAINING PROTEIN 4 (BRD4) SUPPRESSES KEY INFLAMMATORY PATHWAYS IN DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS,
C. W. Wasson, F. Tariq, M. Segal-Salto, P. Mulipa, G. Duenstl, S. Sharrack, H. J. Sugden, A. Di Matteo, P. Emery, L. A. Bissell, A. L. Tan, F. Del Galdo, K. Schreiber, L. Rasteli, K. Mankia, R. Ross
|
|
2026 AB0121
|
HIGH DIETARY TRYPTOPHAN RESTORES IMMUNE HOMEOSTASIS AND AMELIORATES ARTHRITIS,
R. Wu, B. Li, X. Zi, C. Wang
|
|
2026 AB0125
|
THE OXYGEN SENSOR PHD1 IS A CRITICAL REGULATOR OF ARTHRITIS DEVELOPMENT AND JOINT INFLAMMATION,
T. Van der Stede, E. Gilis, K. De Wilde, J. Coudenys, D. Elewaut
|
|
2026 AB0133
|
ENHANCED MEDULLARY AND EXTRAMEDULLARY HEMATOPOIESIS ACCELERATE ATHEROSCLEROSIS IN RHEUMATOID ARTHRITIS,
E. Sevdali, G. Zakkas, M. Laskou, G. Maleza, E. Neofotistou Themeli, K. Fortounas, P. Verginis, G. Bertsias, E. Fisher, P. Sidiropoulos
|
|
2026 AB0139
|
TRANSCRANIAL DIRECT CURRENT STIMULATION (TDCS) MITIGATES HYPERNOCICEPTIVE SEVERITY IN MICE SUBJECTED TO AN ANIMAL MODEL OF RHEUMATOID ARTHRITIS IN THE EARLY STAGES OF THE DISEASE,
N. Garcia dos Santos, A Di Domico Leite, V da Silva Freitas, R. Gaia, B. de Azevedo Flor, M. L. Gasparini, G. Flores Chapacais, S. Pilotti, D. Stein, I. da Silva Torres, R. M. Xavier
|
|
2026 AB0151
|
THERAPEUTIC TARGETING OF LNCRNA ANKRD33B-2 ATTENUATES SYNOVIAL INFLAMMATION AND JOINT DAMAGE IN COLLAGEN-INDUCED ARTHRITIS,
Y. Mu, R. Wu, R. Su, X. Zi, A. Gao, C. Wang
|
|
2026 AB0163
|
BIODISTRIBUTION OF RHEUMATOID ARTHRITIS PATIENT-DERIVED ANTI-CITRULLINATED PROTEIN ANTIBODIES AT STEADY STATE AND DURING ARTHRITIS IN MICE,
M. Gomes Afonso, J. Sun, M. Filipovic, T. A. Tran, L. Lu, R. Stålesen, L. Klareskog, V. Malmström, B. Réthi
|
|
2026 AB0165
|
RADIOLABELLED ANTI-CITRULLINATED HISTONE ANTIBODY CIT-013 AS A TOOL TO VISUALIZE EXTRACELLULAR TRAP RICH INFLAMED JOINTS IN A COLLAGEN INDUCED ARTHRITIS MOUSE MODEL,
A. Kip, E. Meldrum, B. Walgreen, H. van Es, M. Helsen, D. Dorst, M. Koenders, R. Chirivi
|
|
2026 AB0171
|
LOCAL IFN-β EXPRESSION VIA NON-VIRAL GENE DELIVERY ATTENUATED CLINICAL SYMPTOMS IN COLLAGEN-INDUCED ARTHRITIS,
M. L. Gasparini, V. Monteagudo de Barros, W. da Silva Carniel, G. Flores Chapacais, N. Lumertz, R. Machado Xavier, R. Silvestri Schuh
|
|
2026 AB0172
|
WTAP-MEDIATED m6A HYPERMETHYLATION DRIVES SYNOVITIS VIA MACROPHAGE METABOLIC REPROGRAMMING IN RHEUMATOID ARTHRITIS,
W. Zhu, P. Wu, X. Meng, M. Wang, S. Zhong, Y. Jiang, Y. Liu, Y. Pan
|
|
2026 AB0180
|
COMPARED WITH USING METHOTREXATE ALONE, THE COMBINATION OF LOW-DOSE IL-2 AND METHOTREXATE IS MORE EFFECTIVE IN ALLEVIATING INFLAMMATION IN CIA RATS,
H. Yan, X. Zi, C. Gao, C. Wang
|
|
2026 AB0210
|
ACCUMULATION OF TERMINALLY EXHAUSTED T-CELLS IN KIDNEYS OF MRL/LPR MICE CORRELATES WITH SERUM LEVELS OF INTERFERON-γ-INDUCIBLE PROTEIN 10,
M. Kim, E. J. Lee, E. J. Chang, Y. E. Kim, J. S. Oh, S. M. Ahn, S. Hong, C. K. Lee, B. Yoo, Y. G. Kim
|
|
2026 AB0218
|
TARGETING MEMBRANOUS PHOSPHATIDYLETHANOLAMINE ABUNDANCE INTERFERES SPATIAL REGULATION OF IFN RESPONSE IN SYSTEMIC LUPUS ERYTHEMATOSUS,
L. Wu, N. Shen
|
|
2026 AB0226
|
TI-0032: A NOVEL CIRCULAR RNA-BASED IN VIVO CAR-T THERAPY,
C. Li, J. Deng, M. He, K. Xiang, Q. Lin, J. Zeng, L. Gao
|
|
2026 AB0231
|
IMPACT OF CHRONIC INFLAMMATION ON MESENCHYMAL STROMAL CELL CHARACTERISTICS, SENESCENCE, AND IMMUNOMODULATORY FUNCTION IN A MURINE MODEL OF EXPERIMENTAL LUPUS,
P. F. Ruiz Aparicio, S. B. Schreiber, A. L. Schäfer, R. Voll, N. Chevalier
|
|
2026 AB0238
|
ESTABLISHMENT AND PHARMACOLOGICAL EVALUATION OF TWO TEMPORAL UVB-INDUCED CLE MODELS IN TREX1 KO MICE VIA cGAS-STING/TYPE I IFN PATHWAY,
J. Liang, Y. Zhang
|
|
2026 AB0239
|
SYSTEMIC ATTENUATION OF PURINERGIC SIGNALING REDUCES DEPRESSIVE-LIKE BEHAVIOR IN A MOUSE MODEL OF LUPUS,
U. Sriram, P. Bhoj, N. Mekala, N. Togre, M. Winfield, Y. Persidsky
|
|
2026 AB0240
|
GLYCOLYTIC ENZYME PFKFB3 PROMOTES APOPTOSIS RESISTANCE OF CD4+T CELLS IN SYSTEMIC LUPUS ERYTHEMATOSUS BY REGULATING NUCKS1 LACTYLATION,
H. Dai, M. Zhang, C. Lan, F. Xiao, M. Sun, Y. Jia, J. Deng
|
|
2026 AB0248
|
COMBINED THERAPY OF BELIMUMAB AND FAP INHIBITOR FOR B CELL DEPLETION AND ANTI-FIBROSIS IN LUPUS NEPHRITIS,
H. Cao, J. Lin
|
|
2026 AB0252
|
TRIPLE-COMBINATION PROBIOTIC PROTECTS AGAINST SKIN FIBROSIS IN SYSTEMIC SCLEROSIS,
T. Huang, Y. Li, T. Wu, X. Liang, Y. Luo, H. Dai, Y. Liu
|
|
2026 OP009
|
METABOLIC REMODELING OF SALIVARY GLAND EPITHELIUM LINKS MITOCHONDRIAL DYSFUNCTION TO CHRONIC INFLAMMATION IN SJÖGREN’S DISEASE,
S. Colafrancesco, E. Pontarini, E. Simoncelli, G. Cavallaro, M. Certo, C. Mauro, S. Nayar, J. D. Turner, C. Barbati, D. Stefanoni, F. Sacco, L. Perfetto, C. Montesano, M. Sergi, F. Conti, C. F. Selmi, E. Gremese, C. Pitzalis, R. Priori, M. Bombardieri
|
|
2026 OP0149
|
CLONALLY EXPANDED DURAL CD8+ T CELLS DRIVE PATHOLOGICAL LYMPHATIC REMODELING VIA MACROPHAGE CROSSTALK IN NEUROPSYCHIATRIC SLE,
Y. Feng, Z. He, S. Li, N. Chen, C. Zhou, J. Pan, Q. Huang, L. Jie
|
|
2026 OP0153
|
12-LIPOXYGENASE REGULATES INFLAMMATORY CELL RECRUITMENT IN LUPUS NEPHRITIS,
M. Monteil, I. Allaeys, T. Lévesque, K. Greffard, I. Tsukayama, J. F. Bilodeau, P. Fortin, E. Boilard
|
|
2026 OP0154
|
OXIDATIVE STRESS–ASSOCIATED PLA2 ACTIVATION DRIVES LYSOPHOSPHOLIPID DYSREGULATION LINKED TO B CELL HYPERACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS,
J. Huang, J. Yang, X. Han
|
|
2026 OP0175
|
SPP1+ MACROPHAGES ARE SPECIFICALLY ENRICHED IN ARTHRITIC JOINTS AND ASSOCIATED WITH ABNORMAL BONE METABOLISM IN COLLAGEN-INDUCED ARTHRITIS MICE,
C. He, G. Yin, Q. Xie
|
|
2026 OP0188
|
DISTINCT ROLES OF IL-1 AND IFN-GAMMA IN RECRUITMENT OF LUNG MACROPHAGE POPULATIONS IN THE TLR9-INDUCED MODEL OF MACROPHAGE ACTIVATION SYNDROME,
R. Chhaing, N. Inoue, G. Schulert
|
|
2026 OP025
|
OPTIMISED ANTIGEN-SPECIFIC IMMUNOTHERAPY LIPOSOMES ENABLE IMMUNE REGULATION AND SUSTAINED DISEASE CONTROL IN EXPERIMENTAL ARTHRITIS,
S. Moonshi, T. Aragao Horoiwa, B. Zeng, N. Fletcher, A. Martyn, N. Pujara, R. Stone, N. Liu, S. Patel, M. Trau, M. Talekar, K. Thurecht, H. Nel, R. Thomas
|
|
2026 OP0265
|
DYNAMIC ORCHESTRATION OF Th17, TRM, AND MAIT CELLS LINKS THE GUT–JOINT AXIS DURING SPONDYLOARTHRITIS DEVELOPMENT IN THE SKG Model,
F. Verhoeven, L. Guet, B. Favier, X. Romand, C. Demougeot, D. Wendling, C. Prati, A. Baillet, D. HANNANI
|
|
2026 OP0267
|
UNCOVERING A CRITICAL ROLE FOR MALT1 IN TNF-DRIVEN ARTHRITIS AND ILEITIS,
E. Gilis, J. Coudenys, J. Staal, R. Beyaert, D. Elewaut
|
|
2026 OP0272
|
NSD1, H3K36me1/2 METHYLTRANSFERASE AS A POTENTIAL THERAPEUTIC TARGET IN TH17 CELL-MEDIATED AUTOINFLAMMATORY DISEASE,
S. E. Wang, D. T. Kim, J. S. Joo, S. H. Lee, J. Chin, S. Jo, J. Y. Hong, T. H. Kim
|
|
2026 OP0314
|
MICE ADMINISTERED IgG FROM A SUBSET OF FIBROMYALGIA PATIENTS WITH CIDP DEMONSTRATE PET/CT EVIDENCE OF WIDESPREAD IgG DEPOSITION,
X. Caro, J. Shively, S. Metyas, J. Minor, J. Pero, R. Jackson, P. Frankel, P. Wong, E. Aniogo, M. Kuhawski, L. Li, T. Hong, J. Jitender, P. Yazaki, N. Prakash
|
|
2026 OP0315
|
SEX DIFFERENCES IN CANNABINOID-MEDIATED ANALGESIA IN AN OSTEOARTHRITIS MOUSE MODEL:ROLE OF CaMKIIA NEURONS IN THE MEDIAL PREFRONTAL CORTEX,
Z. Jiang, Q. Wang, W. Wang, Z. Zheng
|
|
2026 OP0318
|
INTEGRATIVE POPULATION PROTEOGENOMICS AND CIRCUIT NEUROPHYSIOLOGY IMPLICATE CA14 AS A SHARED, DRUGGABLE AND TRANSDIAGNOSTIC BIOLOGY MARKER BETWEEN NEUROPATHIC AND NOCIPLASTIC PAIN PHENOTYPES,
L. Chen, Y. Xiong, F. Qin, X. Cen, D. Prieto-Alhambra, J. Xie
|
|
2026 OP041
|
FENESTRATED CAPILLARIES AS THE STRUCTURAL BASIS OF THE BLOOD–JOINT BARRIER,
T. Hasegawa, N. Morone
|
|
2026 OP042
|
EARLY INTERVERTEBRAL BONE FORMATION IN RECENT-ONSET ARTHRITIS REVEALED BY X-RAY PHASE-CONTRAST IMAGING: EVIDENCE FOR PARALLEL, NON-SEQUENTIAL BONE AND INFLAMMATORY PROCESSES,
F. Verhoeven, C. Olivier, S. Aubry, S. Hecquet, C. Viennet, P. Totoson, X. Romand, A. Baillet, L. Broche, D. Wendling, C. Demougeot, C. Prati, E. Brun
|
|
2026 OP061
|
INVESTIGATING THE ROLE OF TRPM8-POSITIVE NEURONS IN Δ9-TETRAHYDROCANNABINOL-MEDIATED ANALGESIA OF OSTEOARTHRITIS PAIN,
A. Maglaviceanu, J. Rockel, H. Fetter Filippini, M. Zain, E. Poduch, M. Lewis, S. Vohra, K. Hueniken, O. Espin-Garcia, C. Pastrello, P. Potla, Y. Deng, K. Delos Santos, S. Lively, N. Looby, J. Garcia, E. Pollock-Tahiri, B. Ravarian, J. Wang, M. Fehlings, R. Gandhi, N. Mahomed, T. Leroux, R. Miller, I. Jurisica, L. Kotra, R. Bonin, H. Clarke, M. Kapoor
|
|
2026 OP063
|
THE CILIA-WNT AXIS AS A THERAPEUTIC TARGET FOR SOX9 MRNA-LNP IN OSTEOARTHRITIS,
Y. Kim, S. W. Han
|
|
2026 OP066
|
SGLT2 INHIBITION IS A POTENTIAL THERAPEUTIC STRATEGY FOR TREATING OSTEOARTHRITIS,
J. Zhu, H. Li, J. Wu, Y. Zhang, W. Zhang, M. Doherty, T. Wang, X. Wu, Y. Chen, X. Ding, Y. Wang, D. Xie, N. Wang, K. Zhao, F. Yuan, C. Xie, X. Huang, C. Li, G. Lei, J. Wei, C. Zeng
|
|
2026 POS0015
|
SEMA4A NEUTRALIZATION REDUCES FIBROSIS AND INFLAMMATION IN A MOUSE MODEL OF SYSTEMIC SCLEROSIS AND A 3D MODEL OF IMMUNITY-DRIVEN FIBROSIS,
J. Marty, S. Martinez-Ramos, C. Rafael-Vidal, B. Malvar-Fernández, T. Carvalheiro, R. G. Tieland, M. I. Ramos, W. Marut, A. Pinheiro-Lopes, A. Argibay Filgueira, B. Maure, C. Vázquez Triñanes, N. Pérez Gómez, D. Fernández Fernández, S. Vila Garcia, C. Mouriño Rodríguez, R. M. Thurlings, A. van Caam, A. Rivera, J. M. Pego-Reigosa, T. Radstake, S. García
|
|
2026 POS0054
|
NICOTINAMIDE, DERIVED FROM THE GUT MICROBIOME, SUPPRESSES MECHANOFLAMMATION AND IS DISEASE MODIFYING IN MURINE OSTEOARTHRITIS,
N. Merrild, L. Zhu, J. Miotla-Zarebska, A. Chanalaris, Y. Hamdan, A. Acuna-Gonzalez, R. Kiu, E. Armitage, L. Hall, J. Swan, T. Vincent
|
|
2026 POS0057
|
MECHANISM OF ACTION OF THE NEUROTROPHIN-3 INHIBITOR, LEVI-04, A NOVEL OSTEOARTHRITIS TREATMENT: IN VITRO PHARMACOLOGY AND EFFICACY IN ANIMAL MODELS,
S. Westbrook, K. af Forselles, P. G. Conaghan
|
|
2026 POS0081
|
TL1A INHIBITION IS EFFICACIOUS IN MOUSE MODELS OF COLLAGEN-INDUCED ARTHRITIS (CIA) AND IMIQUIMOD-INDUCED (IMQ) PSORIASIS,
M. Siegel, E. Lewis, D. Giles, J. LaFountaine, J. Friedman, A. Spencer
|
|
2026 POS0089
|
LONG-TERM INEBILIZUMAB TREATMENT RESULTS IN MILD IMMUNOGLOBULIN REDUCTION BUT NO INCREASE IN INFECTION RISK,
E. Della Torre, J. H. Stone, E. L. Culver, A. Khosroshahi, W. Zhang, K. Okazaki, Y. Tanaka, M. Lohr, N. Schleinitz, L. Dong, H. Umehara, M. Lanzillotta, Z. S. Wallace, M. Ebbo, G. Webster, F. Martínez-Valle, M. Nayar, V. Rebours, C. Perugino, R. Luo, M. Osman, S. Cheng, D. Cimbora
|
|
2026 POS0097
|
THE POTENTIAL OF ALBUMIN-FUSED IL-10 AS A THERAPEUTIC AGENT FOR MACROPHAGE ACTIVATION SYNDROME,
W. Fujii, H. Sofue, E. Yuba, J. Ishihara, K. Baßler, A. Hasegawa, T. Hiyama, S. Komatsu, K. Nakamura, T. Miyao, A. Tanaka, S. Arai, R. Maezawa, M. Arima, Y. Kawahito, K. Ikeda
|
|
2026 POS0129
|
UNVEILING THE ROLE OF ABNORMAL COPPER METABOLISM IN SYSTEMIC LUPUS ERYTHEMATOSUS,
L. Peng, Z. Chen, W. Zhang, Q. Liu
|
|
2026 POS0133
|
DECIPHERING THE ALLEVIATION MECHANISM OF LUPUS NEPHRITIS BY UMBILICAL CORD BLOOD MESENCHYMAL STEM CELLS: TARGETING MiT-TFE/CCL8-MEDIATED CCL8+ MACROPHAGE-CCR5+ NEUTROPHIL CROSSTALK,
L. Sun, Q. Yang, L. Zeng
|
|
2026 POS0173
|
IMMUNOLOGICAL REPROGRAMMING: HARNESSING SMALL MOLECULES TO INDUCE RESISTANCE TO INFLAMMATION IN RHEUMATOID ARTHRITIS,
M. Kotrulev, C. Veloso de Simón, J. Codesido, A. Briones Contreras, L. Mosquera Ferreiro, S. Carreira Santos, A. Ramírez Iglesias, B. García-Pinel, R. Bernardez-Alfaya, A. Andújar-Arias, W. Li, T. Y. Chiu, A. Fuentes Iglesias, Y. Lopez-Golan, S. Trincado-Lopez, D. Guallar, O. J. Cordero, R. Varela-Calvino, C. Parker, P. Brea, M. Loza, A. J. Mera-Varela, E. Sotelo, P. Aguiar, I. Gomez-Tourino
|
|
2026 POS0174
|
Twist1-MEDIATED INDUCTION OF AEBP1 IN FIBROBLAST-LIKE SYNOVIOCYTES ACTIVATES TGF-ß SIGNALING TO DRIVE ANGIOGENESIS AND PROMOTE RHEUMATOID ARTHRITIS,
Z. Li, Z. Chen
|
|
2026 POS0207
|
TARGETING THE NETS-PPIA AXIS: A NOVEL THERAPEUTIC STRATEGY TO SUPPRESS PATHOLOGICAL SYNOVIAL ANGIOGENSIS IN RHEUMATOID ARTHRITIS,
Y. N. Wang, H. Zhang, X. Tang
|
|
2026 POS0313
|
ENDOGENOUS RETROVIRUSES ACTIVATION DRIVES EPITHELIAL NECROPTOSIS AND SALIVARY GLAND DYSFUNCTION IN SJÖGREN’S DISEASE,
X. Zhang, Y. Li, Y. Qin, G. Shi, Y. Liu
|
|
2026 POS0666
|
SEMA4A IS ELEVATED IN PATIENTS WITH PSORIATIC ARTHRITIS AND INDUCES INFLAMMATION IN VITRO AND IN VIVO,
J. Marty, C. Rafael-Vidal, S. Martinez-Ramos, B. Malvar-Fernández, T. Carvalheiro, A. Pinheiro-Lopes, J. N. Pouw, E. F. A. Leijten, S. Vila Garcia, C. Mouriño Rodríguez, N. Pérez Gómez, I. Altabás González, F. J. Maceiras-Pan, D. Fernández Fernández, C. Ventin-Rodriguez, A. Crespo-Golmar, R. Gómez, L. Santiago-Lamelas, R. Diaz-Peña, T. Radstake, J. M. Pego-Reigosa, S. García
|
|
2026 POS0679
|
3H-1,2-DITHIOLE-3-THIONE AMELIORATES LUPUS NEPHRITIS IN IMIQUIMOD-INDUCED LUPUS-PRONE MICE VIA MODULATION OF TH1 AND TH17 RESPONSES,
K. C. Wang, M. H. Tai, S. J. Yu
|
|
2026 POS0749
|
SCAVENGER RECEPTOR MSR1+ MONOCYTES TRIGGER MACROPHAGE ACTIVATION SYNDROME/HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS BY UNLEASHING MITOCHONDRIAL ROS TO ACTIVATE THE NLRP3 INFLAMMASOME,
J. Meng, Y. Xiao, C. Yang, J. Jia, Q. Hu
|
|
2026 POS0752
|
METABOLOMIC ANALYSIS REVEALED CHARACTERISTIC INFLAMMATORY AND NON-INFLAMMATORY PAIN SIGNATURES IN INFLAMMATORY ARTHRITIS,
L. Gunkl-Tóth, N. Szentes, V. Tékus, B. Fülöp, É. Borbély, Á. Horváth, K. Takács-Lovász, J. Kun, G. Karvaly, R. Farkas, G. Nagy, Z. Helyes
|
|
2026 POS0822
|
EFFECT OF MONOSODIUM URATE ON ANGIOGENESIS IN GOUTY ARTHRITIS,
Z. Chen
|
|
2026 POS0828
|
THYMIC DOWNREGULATION OF THE IFN/STAT1 PATHWAY PRECEDES TH17 POLARIZATION IN HLA-B27 TRANSGENIC RAT (B27-RAT) MODEL OF SPONDYLOARTHRITIS (SPA),
C. Bonini, E. Cela, B. Cherqaoui, M. Breban, L. M. Araujo
|
|
2026 POS0831
|
OSTEOCLAST-DERIVED DEL1 PROMOTES PATHOLOGICAL BONE FORMATION IN AS VIA REGULATING RUNX2 EXPRESSION IN OSTEOBLASTS,
S. H. Lee, S. Lee, C. Jeon, D. Kim, S. Jo, T. H. Kim
|
|
2026 POS0832
|
ENTHESITIS IN A MOUSE DISEASE MODEL: LESSONS LEARNED FROM AN INFLAMMATORY KNEE JOINT LAXITY MODEL,
D. Vegt, A. Blom, M. Helsen, B. Walgreen, E. Vitters, H. van Beuningen, E. F. A. Leijten, I. E. van der Horst-Bruinsma, M. Koenders, E. Blaney Davidson
|
|
2026 POS0900
|
DEGRADING VAV1 INHIBITS T-CELL FUNCTION AND ANTIBODY PRODUCTION IN MICE AFTER KLH CHALLENGE,
M. Liu, K. Geng, C. Zhang, B. Qu, B. Lu, F. Yang, Y. Xia, X. Wang, G. Xia, S. Wang, L. Jin
|
|
2026 POS0906
|
THE PATHOLOGICAL ROLE OF A NOVEL AUTOANTIBODY BIOMARKER IN THERAPY RESPONSE IN A MOUSE MODEL OF ARTHRITIS,
S. Fadlallah, J. Fraussen, P. Ruytinx, V. Somers
|
|
2026 POS0962
|
HGF-MSCs ALLEVIATE JOINT AND LUNG INJURY IN RA-ILD MOUSE MODEL,
M. Zhang, Y. Jin, H. Li
|
|
2026 POS1106
|
TREATMENT WITH LBL-051-S3, A CD3/CD19/BCMA TRISPECIFIC ANTIBODY, LEADS TO A COMPLETE LOSS OF PLASMA CELLS AND B CELLS WITH MINIMAL CYTOKINE RELEASE IN NON-HUMAN PRIMATES,
A. Hertz, C. Daige, S. Wong, T. Maniar, S. Truex, S. Plevy, V. Sung
|
|
2026 POS1115
|
TL1A AND TL1A-DRIVEN INFLAMMATORY PATHWAYS ARE UPREGULATED IN RA, PSA AND AXSPA,
H. Llewellyn, I. S. Jang, A. Baghela, A. Jeon, M. Sze, S. Y. Liu, L. Hegde, M. Tang, J. Woodhouse, E. Munoz
|
|
2026 POS1118
|
MESENCHYMAL STEM CELL-DERIVED MICROVESICLES CONFER PROTECTION AGAINST RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE,
X. Liang, Y. Li, Y. Luo, Y. Liu
|
|
2026 POS1123
|
INHIBITION OF INTEGRIN α5 AMELIORATES RENAL INJURY IN MRL/LPR MICE: A NOVEL THERAPEUTIC TARGET IN LUPUS NEPHRITIS,
T. Ding, Z. Zhang
|
|
2026 POS1131
|
SIX1 ACTIVATION IS INVOLVED IN GLYCOLYTIC PATHWAY AND INFLAMMATORY INJURY IN SLE MICE MODEL,
Y. Jin, M. Zhang, H. Li
|
|
2026 POS1134
|
FIRST-IN-CLASS ORAL IR5 DEGRADER, KT-579, DEMONSTRATES SELECTIVE AND POTENT IN VITRO AND IN VIVO ACTIVITY IN HUMAN CELLULAR ASSAYS AND MOUSE MODELS OF LUPUS,
V. Campbell, E. Corcoran, E. Lurier, Y. Zhang, V. Massa, J. Leedberg, C. Caroll, R. Camire, C. Ho, D. Chen, M. Lolande, R. Mehovic, Z. Zhao, C. Howarth, S. Breitkopf, S. Martinez, M. Ford, X. Fei, M. Sathappa, M. Weiss, S. Kamerkar, J. Williams, N. Mainolfi
|
|
2026 POS1135
|
A NOVEL MOUSE MODEL OF SYSTEMIC LUPUS ERYTHEMATOSUS FOR EFFICACY EVALUATION OF CD3/BCMA T CELL ENGAGERS,
J. Liang, T. Wang
|
|
2026 POS1141
|
THERAPEUTIC ROLE OF INTERLEUKIN-2 IN LUPUS-ASSOCIATED DIFFUSE ALVEOLAR HEMORRHAGE VIA MODULATING T CELL SUBSETS,
X. Zeng, X. Sun
|
|
2026 POS1143
|
PIRFENIDONE INHIBITS RENAL FIBROSIS IN MURINE LUPUS NEPHRITIS VIA DOWNREGULATING MXRA7: A POTENTIAL THERAPEUTIC STRATEGY,
X. Li, J. Bao, H. Wu, Y. Fan
|
|
2026 POS1144
|
A CD19/BCMA DUAL-TARGETING T-CELL ENGAGER ENABLES DEEP B-CELL DEPLETION WITH LOW CYTOKINE RELEASE IN PRECLINICAL MODELS,
H. Su, H. Li, Y. Zhu, Y. Sun, B. Duplantis, Y. Wang, C. V. Chin, L. Du, X. He, Q. Yu, Y. Li
|
|
2026 POS1145
|
A CIRCULAR RNA-ENCODED CD19xCD3 T-CELL ENGAGER: A NOVEL OFF-THE-SHELF STRATEGY FOR DEEP B-CELL DEPLETION THERAPY IN AUTOIMMUNE,
R. Cao, L. Cui, J. Zhao, J. Zeng, L. Gao
|
|
2026 POS1184
|
NKX019, AN ALLOGENEIC, OFF-THE-SHELF, CD19-TARGETING, CAR NK-CELL THERAPY, INDUCES DEEP CD19+ B-CELL DEPLETION IN HAEMATOLOGICAL MALIGNANCY AND MODELS OF AUTOIMMUNE DISEASE,
M. Tohme, M. Vejiga, W. Yu, E. Kang, K. Yu, J. Wei, J. Sood, M. Zhang, N. Kimura, D. Juat, I. Chan, K. Hansen, J. Trager, S. Hora, S. Rose, A. Kapoun, D. Shook, P. Gip
|
|
|
[38]
|
Anti-Inflammatory Agents
|
|
|
| 2026 |
|
2026 AB0019
|
DISCOVERY OF NOVEL SMALL-MOLECULE TL1A ANTAGONIST,
J. Chen, J. Yu, J. Du, P. Shi, X. Wang
|
|
2026 AB0060
|
A NOVEL THERAPEUTIC STRATEGY WITH RASGRP4-TARGETED ANTISENSE OLIGONUCLEOTIDES FOR IDIOPATHIC INFLAMMATORY MYOPATHIES,
N. Umezawa, Y. Ueoka, T. Saito, T. Tsubata, R. Da, S. Li, Y. Hirose, Y. Hidaka, S. Yasuda
|
|
2026 AB0076
|
ORAL ADMINISTRATION OF GERMANIUM TELLURIDE NANOSHEETS MODULATES MACROPHAGE ACTIVATION AND AMELIORATES PSORIASIS-LIKE INFLAMMATION IN MICE,
J. Han, J. W. Kim, S. M. Lee, Y. Park
|
|
2026 AB0112
|
INHIBITION OF BROMODOMAIN-CONTAINING PROTEIN 4 (BRD4) SUPPRESSES KEY INFLAMMATORY PATHWAYS IN DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS,
C. W. Wasson, F. Tariq, M. Segal-Salto, P. Mulipa, G. Duenstl, S. Sharrack, H. J. Sugden, A. Di Matteo, P. Emery, L. A. Bissell, A. L. Tan, F. Del Galdo, K. Schreiber, L. Rasteli, K. Mankia, R. Ross
|
|
2026 AB0218
|
TARGETING MEMBRANOUS PHOSPHATIDYLETHANOLAMINE ABUNDANCE INTERFERES SPATIAL REGULATION OF IFN RESPONSE IN SYSTEMIC LUPUS ERYTHEMATOSUS,
L. Wu, N. Shen
|
|
2026 AB0226
|
TI-0032: A NOVEL CIRCULAR RNA-BASED IN VIVO CAR-T THERAPY,
C. Li, J. Deng, M. He, K. Xiang, Q. Lin, J. Zeng, L. Gao
|
|
2026 AB0231
|
IMPACT OF CHRONIC INFLAMMATION ON MESENCHYMAL STROMAL CELL CHARACTERISTICS, SENESCENCE, AND IMMUNOMODULATORY FUNCTION IN A MURINE MODEL OF EXPERIMENTAL LUPUS,
P. F. Ruiz Aparicio, S. B. Schreiber, A. L. Schäfer, R. Voll, N. Chevalier
|
|
2026 AB0403
|
CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS IN SOUTH INDIAN CHILDREN: A 10-YEAR SINGLE-CENTRE COHORT ON PHENOTYPE, TREATMENT RESPONSE AND OUTCOMES,
A. Kumar, S. Balan
|
|
2026 AB0749
|
REAL-WORLD COMPARATIVE EFFECTIVENESS OF UPADACITINIB VERSUS TUMOR NECROSIS FACTOR INHIBITORS OR INTERLEUKIN-17 INHIBITORS ON SKIN SYMPTOMS IN PATIENTS WITH PSORIATIC ARTHRITIS,
P. J. Mease, W. Tillett, X. Ye, C. D. Saffore, M. Edwards, I. Truman, G. Milligan, A. Joshi, B. Parikh, L. Novelli, D. Aletaha
|
|
2026 AB0986
|
REAL-WORLD USE OF SYSTEMIC THERAPIES IN 9345 PATIENTS WITH SJÖGREN DISEASE: LONGITUDINAL TREATMENT TRANSITIONS, ESCALATION PATTERNS AND INDIVIDUAL DRUG TRAJECTORIES ACROSS THE DISEASE COURSE,
A. Flores-Chávez, I. F. Horváth, C. Baldini, R. Priori, A. Vissink, B. Armagan, L. Quartuccio, G. Hernandez-Molina, R. Pereira da Costa, A. Sebastian, N. Inanc, E. Bartoloni, M. Rischmueller, F. Reis de Oliveira, S. Pasoto, I. Sanchez-Berna, F. Carubbi, V. Fernandes Moça Trevisani, S. Melchor Díaz, B. MAURE NOIA, E. M. Fonseca-Aizpuru, H. Nakamura, L. D. Miguel, M. Vázquez, M. Akasbi Montalvo, G. Policarpo Torres, Y. Suzuki, B. De Miguel-Campo, C. Fugmann, S. Praprotnik, T. A. Gheita, N. Nardi, A. Szántó, E. G. Grilli, H. Bootsma, V. Manfrè, L. Kiliç, K. Proc, M. Bandeira, A. Shikhaliyeva, R. Gerli, C. Kirana, M. Ramos-Casals, P. Brito-Zerón
|
|
2026 AB1050
|
NOVEL TREATMENT APPROACHES IN REACTIVE ARTHRITIS: CLINICAL AND CYTOKINE RESPONSES TO IGURATIMOD 25 mg COMPARED WITH BIOLOGIC AND CONVENTIONAL THERAPIES,
J. Mullokulov, K. Akhmedov, I. Turaev
|
|
2026 AB1103
|
CUSTOMIZED THERAPY FOR SLE: HOW DISEASE SEVERITY INFLUENCES THE USE OF CORTICOSTEROIDS AND BIOLOGICS IN PATIENTS WITH SLE IN THE LUPUS FEDERATED DATA NETWORK (LupusNet) AND A US CLAIMS DATABASE,
A. Orillion, F. Zazzetti, A. Sheahan, C. Blacketer, M. van Speybroeck, S. Gasman, R. Sonmez, E. Noss, M. F. Ugarte-Gil, R. V. Gamboa-Cárdenas, V. R. Pimentel-Quiroz, K. Michaud, P. Katz, R. Kandane-Rathnayake, E. Morand, W. Louthrenoo, A. Hoi, Y. H. Chen, J. Cho, L. Hamijoyo, S. Fen Luo, S. Navarra, M. Nikpour, J. M. Pego-Reigosa, Í. J. Rúa-Figueroa, Z. Plaza, M. Galindo Izquierdo, J. Martínez-Barrio, J. Calvo Alén, A. Fernández-Nebro, R. Menor-Almagro, E. Tomero Muriel, F. J. Narváez Garcia, C. S. Karyekar
|
|
2026 AB1408-HPR
|
HOME-BASED STRATEGIES FOR KNEE OSTEOARTHRITIS: COMPARATIVE EFFECTIVENESS OF EXERCISE VERSUS TOPICAL THERAPY IN A RANDOMIZED CONTROLLED TRIAL,
S. Karabörklü Argut
|
|
2026 LB0009
|
LONG-TERM SAFETY EVALUATION OF BARICITINIB VS. TNF INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTS SELECTED FOR VENOUS THROMBO-EMBOLISM RISK,
P. C. Taylor, J. Curtis, J. T. Giles, R. Fleischmann, G. Wright, E. Perkins, D. L. Bhatt, T. Witte, M. Harigai, R. Alten, W. Deberdt, C. O’Leary, R. Rosu, L. Sanden, S. Chinchilla, J. O’Shea, B. Vardar, N. Troy, J. Gerwien, J. S. Smolen
|
|
2026 OP0166
|
RAPID, CLINICALLY MEANINGFUL IMPROVEMENT IN SKIN DISEASE WITH BREPOCITINIB IN DERMATOMYOSITIS: RESULTS FROM THE PHASE 3 VALOR TRIAL,
R. Vleugels, E. Schiopu, A. Crew, A. Maderal, S. Shaigany, J. Levin, H. Dao, J. Edminister, M. Rashighi, M. Cascino, Z. Holcomb, M. Coates, A. Allenzara
|
|
2026 OP0228
|
LENALIDOMIDE IN REFRACTORY MUCOSAL BEHÇET’S SYNDROME: A PROSPECTIVE STUDY OF EFFICACY, SAFETY, AND IMMUNOMODULATORY MECHANISMS,
J. Wu, X. Wang, Y. Liu, Y. Ao, J. Liu, W. Zheng
|
|
2026 OP0288
|
APREMILAST SUPPRESSES MONOCYTE-DRIVEN INFLAMMATION BY TARGETING BACH1 IN BEHÇET’S DISEASE,
Y. Liu, J. Wu, Y. Ao, X. Yu, J. Liu, W. Zheng
|
|
2026 OP0320
|
INCREASING METAMIZOLE PRESCRIPTION IN HIGH RISK GROUPS OF METHOTREXATE-TREATED PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: NATIONWIDE GERMAN CLAIMS DATA FROM 2006 TO 2024,
J. Callhoff, F. Hoffmann, C. Fiehn, U. Marschall, K. Albrecht
|
|
2026 OP039
|
CCR2-GUIDED TREG EXOSOME–GAS6 HYBRID SYNERGISTICALLY REPROGRAMS MACROPHAGE INFLAMMATION AND IMMUNE TOLERANCE IN GOUTY ARTHRITIS,
芳. 陈
|
|
2026 POS0123
|
SARCOIDOSIS FOLLOWING DISSEMINATED TUBERCULOSIS: A CASE OF GRANULOMATOUS RENAL INVOLVEMENT MIMICKING INFECTIOUS RECURRENCE,
J. Velasquez Ospina, S. Herrera, S. Hoyos Gutierrez, M. González
|
|
2026 POS0149
|
TRANSARTERIAL PERIARTICULAR EMBOLIZATION (TAPE) IN THE TREATMENT OF INFLAMMATORY RHEUMATIC JOINT DISEASE - CONCEPT OF PROOF STUDY,
C. Pflug, A. Pfeil, A. Barthel, G. Wolf, U. Teichgräber, R. Aschenbach
|
|
2026 POS0233
|
IS SYNOVITIS, AS MEASURED BY EFFUSION MORPHOMETRY OR HOFFA RADIOMICS, RELATED TO OSTEOARTHRITIS PROGRESSION,
F. Eckstein, K. Sheikhi Valashani, T. Winkler, J. Collins, F. Roemer, A. Guermazi, D. Hunter, W. Wirth
|
|
2026 POS0264
|
BREPOCITINIB DEMONSTRATES CONSISTENT BENEFIT ON COMBINED MEASURES OF CLINICAL RESPONSE AND SUSTAINED CORTICOSTEROID TAPERING IN DERMATOMYOSITIS PATIENTS AT ONE YEAR,
J. Paik, E. Alhassan, A. Dore, A. Menon, R. Maganti, G. Marder, M. Luggen, M. Cascino, K. DeQuattro, A. Dinu Askanase, D. R. Fernandez
|
|
2026 POS0341-HPR
|
DEMONSTRATING VALUE IN NURSE-LED CARE FOR NEWLY DIAGNOSED AXIAL SPONDYLOARTHRITIS PATIENTS IN A TERTIARY CENTRE IN IRELAND,
E. Shinners, A. Gorman
|
|
2026 POS0607
|
EFFICACY AND SAFETY OF INTERLEUKIN-6 RECEPTOR INHIBITORS IN GIANT CELL ARTERITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS,
M. H. Elkasaby, M. S. A. Ahmed, N. Hammad, M. Alayat
|
|
2026 POS0628
|
RELAPS FREE SURVIVAL IN AAV PATIENTS ON GC-FREE MAINTENANCE TREATMENT AFTER DISCONTINUATION OF AVACOPAN – A 2-YEAR PROSPECTIVE UNI-CENTER OBSERVATIONAL STUDY STRATIFIED INTO RENAL AND NON-RENAL MANIFESTATIONS,
G. Assmann, M. Schmidt, B. Alina, J. Reimers, K. Amann, R. Joerg
|
|
2026 POS0768
|
COMPLETED SUICIDE WITH COLCHICINE IN FAMILIAL MEDITERRANEAN FEVER: DEMOGRAPHIC, CLINICAL, AND POST-MORTEM FEATURES,
H. Asliyüksek, M. F. Yaman, B. Aktas, B. Acar, A. K. Ozcan, S. Ugurlu
|
|
2026 POS0773
|
IMP761, A NOVEL IMMUNOSUPPRESSIVE LAG-3 AGONIST ANTIBODY IN THE CLINIC,
F. Triebel, A. Leite Pereira, C. Brignone, S. Winckels
|
|
2026 POS0788
|
EFFICACY OF COLCHICINE IN PALINDROMIC RHEUMATISM: EVIDENCE FROM DRUG WITHDRAWAL,
R. Umesh, H. Hari, M. Mohan, C. Kavadichanda, P. Shenoy
|
|
2026 POS0830
|
ALTERED CIRCULATING B-CELL SUBSETS IN AXIAL SPONDYLOARTHRITIS AND THEIR ASSOCIATION WITH ANTI-TNF TREATMENT RESPONSE,
B. Nieto-Carvalhal, M. D. C. Uyaguari Morocho, D. Peiteado, A. Villalba, I. Monjo-Henry, S. García-Carazo, E. De Miguel, M. E. Miranda-Carus
|
|
2026 POS0880
|
REAL-WORLD EFFICACY AND SAFETY OF AVACOPAN IN ANCA-ASSOCIATED VASCULITIS: A RETROSPECTIVE COMPARATIVE STUDY,
F. Thiele, J. Schneider, E. Prager, I. Jandova, B. C. Frye, R. Voll, M. Schramm, N. Venhoff
|
|
2026 POS0900
|
DEGRADING VAV1 INHIBITS T-CELL FUNCTION AND ANTIBODY PRODUCTION IN MICE AFTER KLH CHALLENGE,
M. Liu, K. Geng, C. Zhang, B. Qu, B. Lu, F. Yang, Y. Xia, X. Wang, G. Xia, S. Wang, L. Jin
|
|
2026 POS0929
|
SARCOIDOSIS IN RHEUMATOLOGY PRACTICE: EARLY INITIATION OF IMMUNOSUPPRESSIVES MAY PREVENT RELAPSES DURING LONG TERM FOLLOW-UP,
A. Avcu, S. Aydin, R. G. Umurca Aydemir, A. Komaç, M. S. Alhouri, D. Kocakaya, A. Cefle, H. Emmungil, M. E. Tezcan, H. Direskeneli, M. Soy, F. Alibaz-Oner
|
|
2026 POS1056
|
CC312, A NOVEL CD19/CD3/CD28 TRI-SPECIFIC T CELL ENGAGER, LEADS TO RAPID AND DEEP B-CELL DEPLETION AND HAS BROAD POTENTIAL FOR DEVELOPMENT IN AUTOIMMUNE DISEASES,
J. Qi, Y. Huang, R. Zhang, J. Zhen, X. Zhang, Y. wei, M. Sun
|
|
2026 POS1113
|
HUMAN TONSIL ORGANOIDS AND IMMUNE SYNAPSE ASSAYS AS COMPLEMENTARY PLATFORMS FOR MECHANISTIC PROFILING OF AUTOIMMUNE THERAPEUTICS,
H. Leonard, D. Rocca, E. Tanase, O. Reelfs, T. Herheliuk, C. Chidomere, L. Sueiro-Ballesteros, L. Brackenbury, L. Schewitz-Bowers
|
|
2026 POS1145
|
A CIRCULAR RNA-ENCODED CD19xCD3 T-CELL ENGAGER: A NOVEL OFF-THE-SHELF STRATEGY FOR DEEP B-CELL DEPLETION THERAPY IN AUTOIMMUNE,
R. Cao, L. Cui, J. Zhao, J. Zeng, L. Gao
|
|
2026 POS1179
|
CLN-978, A BISPECIFIC CD19 x CD3 T CELL ENGAGER, INDUCES ROBUST B CELL DEPLETION IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS,
R. Grieshaber-Bouyer, A. Dinu Askanase, R. Will, N. Adi, K. Ayesu, A. Reber, Y. Zhang, S. Faison, T. Shearer, I. Shapiro, S. wax, J. Jones, M. G. Raimondo, C. Tur, S. Alivernini, G. Schett, M. A. D’ Agostino
|
|
2026 POS1350
|
CLINICAL OUTCOMES FOLLOWING WITHDRAWAL OF UPADACITINIB IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS WHO ACHIEVED REMISSION: FINDINGS FROM THE PHASE 3, PLACEBO-CONTROLLED, DOUBLE-BLIND SELECT-AXIS 2 TRIAL,
A. Deodhar, M. Kishimoto, D. Poddubnyy, W. P. Maksymowych, I. Lagunes, K. Kato, B. Parikh, K. Carter, C. Phillips, X. Baraliakos
|
|
|
[111]
|
Artificial Intelligence
|
|
|
| 2026 |
|
2026 AB0033
|
IDENTIFICATION OF NOVEL NON-SYNTHETIC XANTHINE OXIDASE INHIBITORS VIA INTEGRATED IN SILICO SCREENING AND SEMI-QUANTITATIVE IN VITRO VALIDATION,
R. Singhal
|
|
2026 AB0067
|
METABOLOMIC PROFILING OF SERUM BILE ACIDS IDENTIFIES GLCA-3S AS A MARKER OF EROSIVE HAND OSTEOARTHRITIS: DATA FROM THE DIGICOD COHORT,
M. Binvignat, A. Desmons, P. Krasniqi, C. Albalaa, A. Lefevre, A. Courties, A. Latourte, M. Kloppenburg, E. Mariotti-Ferrandiz, H. Sokol, F. Berenbaum, D. Rainteau, A. Lamaziere, J. Sellam
|
|
2026 AB0068
|
MACHINE LEARNING-BASED PLASMA PROTEOMICS IDENTIFIES TWO NOVEL ENDOTYPES IN KNEE OSTEOARTHRITIS: PLATELET-DRIVEN AND IMMUNE-DRIVEN,
P. Quaranta, P. Fernández Puente, D. Fernandez-Edreira, J. Linares-Blanco, S. Gonzalez-Carro, L. Lourido, C. Ruiz-Romero, N. Oreiro, M. Silva-Díaz, A. Soto-Gonzalez, M. Crespo, J. L. Diaz Diaz, E. Miguez-Rey, A Mena de Cea, F. J. Blanco, V. Calamia
|
|
2026 AB0085
|
FROM EXPERT ANNOTATIONS TO COMPUTER VISION-ENABLED QUANTITATIVE RADIOGRAPHIC ENDPOINTS FOR STRUCTURAL JOINT DAMAGE,
D. Kessler, Z. Gao, N. Fountoulakis, K. Wuyts, X. Tang, L. Gabriel, E. Hsia, G. O. Cula, K. Standish, T. Fuerst, J. Szechinski, M de Groot, L. Noonan, P. S. Murphy, A. Beutler, C. Watzenboeck, J. Eder, D. Aletaha, P. Mandl, T. Rooney, M. Deman, D. Govind, R. Janiczek
|
|
2026 AB0112
|
INHIBITION OF BROMODOMAIN-CONTAINING PROTEIN 4 (BRD4) SUPPRESSES KEY INFLAMMATORY PATHWAYS IN DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS,
C. W. Wasson, F. Tariq, M. Segal-Salto, P. Mulipa, G. Duenstl, S. Sharrack, H. J. Sugden, A. Di Matteo, P. Emery, L. A. Bissell, A. L. Tan, F. Del Galdo, K. Schreiber, L. Rasteli, K. Mankia, R. Ross
|
|
2026 AB0116
|
BIOINFORMATICS AND ARTIFICIAL INTELLIGENCE-INTEGRATED IDENTIFICATION AND EXPERIMENTAL VALIDATION OF RKIP AS A NOVEL THERAPEUTIC TARGET IN RHEUMATOID ARTHRITIS,
H. S. Noh, S. Kim, H. Lim, H. Lee, M. J. Pyo, H. M. Jeon, M. Kim, S. J. Buu, W. Yoon, Y. H. Cheon, S. I. Lee
|
|
2026 AB0129
|
THE CAUSAL COST OF GLUCOCORTICOIDS IN RHEUMATOID ARTHRITIS: VALIDATING AN AI-DRIVEN, INSTRUMENT-FREE APPROACH TO CORRECT FOR UNMEASURED CONFOUNDING IN OBSERVATIONAL STUDIES,
K. Zhao, A. Cheer, Y. Qian, H. Xie
|
|
2026 AB0161
|
ARTIFICIAL INTELLIGENCE-GUIDED PERSONALIZATION OF JAK INHIBITOR TREATMENT IN RHEUMATOID ARTHRITIS,
R. Barile, R. Cinzia, F. P. Cantatore, A. Corrado
|
|
2026 AB0179
|
MENDELIAN RANDOMIZATION AND MASS CYTOMETRY UNCOVER IMMUNE SIGNATURES IN SERONEGATIVE RHEUMATOID ARTHRITIS,
M. Wang, P. Zhang, R. Huang
|
|
2026 AB0205
|
TOWARDS PERSONALISED, DATA-DRIVEN DISEASE MANAGEMENT IN AXIAL SPONDYLOARTHRITIS: DEVELOPMENT OF A NOVEL CLUSTERING ALGORITHM,
D. Burrows, M. Ehrhardt, R. Barnett, R. Sengupta
|
|
2026 AB0285
|
SYNTHETIC DATA DISCRIMINATE BETWEEN SERONEGATIVE RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS WITHOUT PSORIASIS,
A. Tonutti, S. D’Amico, M. Delleani, A. Bruseghini, P. Moranding, C. Faeti, E. Barone, M. De Santis, L. Nicoletta, V. Savevski, C. F. Selmi
|
|
2026 AB0298
|
BATTLE OF THE BOTS: A COMPARATIVE DIAGNOSTIC PERFORMANCE EVALUATION OF PROF. VALMED, CHATGPT-5 THINKING, AND OPENEVIDENCE,
P. Kremer, E. Langballe, I. Haase, J. Bamberger, S. Kuhn, M. Krusche, J. Knitza
|
|
2026 AB0300
|
SINGLE CAMERA MOTION CAPTURE OF FINGER JOINT MOBILITY VIA THE MeFISTO PROMPT INFERS GRIP STRENGTH IN PATIENTS WITH INFLAMMATORY ARTHRITIS,
L. Ghika, C. N. Koller, J. Maglione, V. Venerito, T. Manigold, D. Markham, T. Hügle
|
|
2026 AB0302
|
USE OF ARTIFICIAL INTELLIGENCE IN RHEUMATIC AND MUSCULOSKELETAL DISEASES: A BRITISH SOCIETY FOR RHEUMATOLOGY AI SPECIAL INTEREST GROUP SURVEY,
H. Canagarajah, J. Tsigarides, N. Fuggle, M. Jani
|
|
2026 AB0305
|
INCIDENCE AND CLINICAL CONSEQUENCES OF METHOTREXATE-INDUCED PANCYTOPENIA: A 10-YEAR POPULATION-BASED STUDY USING NATURAL LANGUAGE PROCESSING,
B. Schultz Overgaard, L. E. Pedersen, R. Lynggaard, P. J. Vinholt, S. A. Just
|
|
2026 AB0346
|
DEVELOPMENT AND VALIDATION OF PREDICTION MODELS TO ESTIMATE THE RISK OF DIFFERENT COMBINATIONS OF MULTIPLE OPIOID RELATED ADVERSE EVENTS IN PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL CONDITIONS,
C. Diomatari, G. Martin, D. Jenkins, M. Jani
|
|
2026 AB0347
|
FINE-TUNING THE OPEN-SOURCE LARGE LANGUAGE MODEL MEDITRON SIGNIFICANTLY IMPROVES PERFORMANCE IN RHEUMATOLOGY,
T. Hügle, L. Campisi, A. Dumusc, F. J. Alromaih, P. Cuenot, C. Karatzios, E. Shevroja, M. A. Hartley, G. Carra, J. L. Raisaro
|
|
2026 AB0362
|
AI-ASSISTED NAILFOLD CAPILLAROSCOPY IN ANTIPHOSPHOLIPID SYNDROME: ASSOCIATIONS WITH aPL PROFILE, VASCULAR EVENTS AND OBSTETRIC MORBIDITY,
E. Soliman, S. Ismail, N. Ibrahim
|
|
2026 AB0389
|
MACHINE LEARNING-BASED PREDICTION OF ONE-YEAR MORTALITY IN ADULT-ONSET STILL’S DISEASE USING THE KOREAN NATIONAL HEALTH INSURANCE SERVICE DATABASE,
M. Kwon, C. I. Joung, Y. S. Song
|
|
2026 AB0426
|
AI-ASSISTED ULTRASOUND ASSESSMENT OF GOUTY NEPHROPATHY,
R. Bubnov
|
|
2026 AB0467
|
INTEGRATION OF SELF-IMAGING INTO THE SWISS NATIONAL RHEUMATOLOGY REGISTRY: A MULTICENTER FEASABILITY STUDY INCLUDING COMPUTER-VISION ASSESSMENT,
C. N. Koller, J. Maglione, M. Blanchard, A. Scherer, M. Andor, L. Brulhart Bletsas, R. Micheroli, A. Rubbert-roth, T. Manigold, C. Iking-Konert, C. Manolaraki, A. Dumusc, M. Nissen, T. Hügle
|
|
2026 AB0527
|
APPLYING SUPERVISED MACHINE LEARNING TO PREDICT ONE-YEAR DISEASE STATUS USING ONLY CLINICAL PARAMETERS IN A COHORT OF CHILDREN WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: A LONGITUDINAL SINGLE-CENTER STUDY,
S. Surendran, S. Balan, V. Kumar Raju, T. Raju, M. Pradeep
|
|
2026 AB0565
|
SYNOVITIS, MEASURED QUANTITATIVELY BY EFFUSION MORPHOMETRY OR HOFFA RADIOMICS; PREDICTS KNEE ARTHROPLASTY AS A “HARD” CLINICAL OUTCOME MEASURE,
F. Eckstein, T. Winkler, C. K. Kwoh, F. Roemer, A. Guermazi, D. Hunter, W. Wirth
|
|
2026 AB0579
|
EFFUSION-SYNOVITIS IN KNEE OSTEOARTHRITIS IS ASSOCIATED WITH 3D FEMORAL BONE SHAPE (B-SCORE) CHANGES OVER 2 YEARS,
A. Brett, P. G. Conaghan
|
|
2026 AB0590
|
DIGITAL SCREENING IDENTIFIES AT-RISK WOKRERS BEFORE PAIN ONSET: ACTIVITY PREDICTS FUNCTION BETTER THAN SYMPTOMS,
N. Tik
|
|
2026 AB0640
|
PREDICT, PERSONALISE, PREVENT: A MACHINE LEARNING STRATEGY TO IMPROVE AYA RHEUMATOLOGY CLINIC ATTENDANCE,
A. Bouraoui, J. R. W. Glanville, C. Fisher, S. Mavrommatis, M. Leandro, D. Sen
|
|
2026 AB0659
|
APPLYING PHARMACOGENOMICS IN REAL-WORLD RHEUMATOLOGY PRACTICE: EMR-INTEGRATED AND STANDALONE SOLUTIONS,
B. Ghang, J. C. Choi, N. Han
|
|
2026 AB0662
|
DERIVATION AND VALIDATION OF A TRANSFERABLE COMPOSITE INFLAMMATION INDEX FROM ROUTINE CLINICAL BIOMARKERS IN UK BIOBANK,
D. Asfaw, C. Davies, E. Kulinskaya, T. Zebin, H. Aung, A. MacGregor
|
|
2026 AB0666
|
NAILFOLD VIDEOCAPILLAROSCOPY FINDINGS IN ADULTS WITHOUT SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASE LIVING ABOVE 2,500 METERS ABOVE SEA LEVEL: A STUDY BASED ON QUANTITATIVE ASSESSMENT USING ARTIFICIAL INTELLIGENCE,
J. C. Pérez Correa, S. Bernal-Macías, J. Barahona-Correa, D. Sandoval, E. Ramos Ibáñez, A. Domínguez-Vargas, D. G. Fernández-Ávila
|
|
2026 AB0672
|
NAILFOLD VIDEOCAPILLAROSCOPY IN ROUTINE CLINICAL PRACTICE: CAN ANALYSIS TIME BE OPTIMIZED USING FEWER DIGITS OR ARTIFICIAL INTELLIGENCE?,
L. Nuño, C. Merino Argumánez, B. García Magallón, O. Rusinovich Lovgach, M. Fernández Castro, N. De La Torre Rubio, J. Sanz Sanz, L. Ramos Ortiz de Zarate, A. Martínez Rodado, H. Godoy Tundidor, C. Barbadillo, P. Mazo, C. Calvo Sparks, M. Coronado González, A. Martin Bescos, E. Ramos Ibáñez, B. Gracia Tello, J. L. Andreu Sánchez
|
|
2026 AB0703
|
AN AUTOMATED SEGMENTATION ALGORITHM TO IDENTIFY BONES OF THE HAND AND WRIST FOR LARGE SCALE STRUCTURAL DAMAGE QUANTIFICATION,
D. Henley-Marshall, N. Campbell, T. Shardlow, A. Antony, Y. Hughes-Roberts, W. Tillett
|
|
2026 AB0773
|
DIGITAL MATURITY OF RHEUMATOLOGY SERVICES - RESULTS OF THE GLOBAL DIGITAL RHEUMATOLOGY RADAR SURVEY,
V. Bartsch, K. Salomon-Escoto, D. De Cock, A. Ribeiro, H. Smucrova, T. Davergne, A. Fusshoeller, V. Venerito, S. Izuka, A. Rojas, N. Osteras, M. Milchert, M. Lucas Rocha, P. Studenic, D. Benavent, A. van Tubergen, A. Chan, F. Muehlensiepen, S. Kuhn, T. Hügle, L. Gupta, L. M. Verhoef, J. Knitza
|
|
2026 AB0776
|
AI-SUPPORTED PATIENT-FRIENDLY RHEUMATOLOGY LETTERS: TRANSFORMING COMPLEX MEDICAL LANGUAGE INTO ACCESSIBLE COMMUNICATION,
I. Hoffman, K. Vevey, C. Cuigniez, V. De Pourcq, A. Willems, S. Reinenbergh, M. Helbert
|
|
2026 AB0780
|
HIGH-DIMENSIONAL LONGITUDINAL IMMUNE PROFILING MAPS THE IMMUNE LANDSCAPE OF TNF INHIBITOR RESPONSE IN RHEUMATOID ARTHRITIS,
L. Cao, H. Zhu, R. Li, H. Ye, Z. Li
|
|
2026 AB0820
|
MANUAL ASSESSMENT OF EXPLAINABLE AI USING LARGE LANGUAGE MODELS BASED AGENTS TO DIAGNOSE RHEUMATOID ARTHRITIS,
S. Verma, A. Agarwal, P. Mruthyunjaya, U. Maharana, M. Mandal, P. Padhan, S. Ahmed
|
|
2026 AB0945
|
PREDICTION OF CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS: A MULTIMODAL DEEP LEARNING MODEL INTEGRATING CHEST COMPUTED TOMOGRAPHY AND CLINICAL DATA,
R. Shi, J. D. Ma, Y. W. Zou, H. P. Zhou, P. U. Lam, Y. Yang, Y. N. Cao, Z. H. Yang, L. Zhu, L. Dai
|
|
2026 AB0973
|
INTERPRETABLE TRANSFORMER-BASED ANALYSIS OF OSDI REVEALS DISTINCT SYMPTOM INTERACTION PATTERNS DIFFERENTIATING SJÖGREN’S SYNDROME–RELATED DRY EYE FROM NON-SJÖGREN DRY EYE,
P. H. Wu, Y. Y. Ho, H. C. Lin, W. S. Chen, C. C. Hsu, C. M. Chang
|
|
2026 AB0991
|
RADIOGRAPHIC DIFFERENTIATION OF AXIAL SPONDYLOARTHRITIS AND DEGENERATIVE SPINAL CHANGES IN PATIENTS WITH CHRONIC BACK PAIN: DEVELOPMENT AND EXTERNAL VALIDATION OF A DEEP LEARNING MODEL,
M. Jaśkowski, P. Górski, Z. Guzera, M. Podgórski
|
|
2026 AB1046
|
EARLY VERSUS DELAYED BIOLOGIC THERAPY AND RADIOGRAPHIC PROGRESSION IN AXIAL SPONDYLOARTHRITIS: SYSTEMATIC REVIEW AND META-ANALYSIS,
I. Serag
|
|
2026 AB1074
|
PRE-BASELINE SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY TRAJECTORY AND EARLY POST-BASELINE DATA IMPROVE PREDICTION OF 12-MONTH DISEASE ACTIVITY OUTCOMES,
D. Goldstaub, M. B. Urowitz, Z. Touma, G. Shoham Levin, T. Frostig, O. Machluf, K. Peri-Hanania, N. Shanwetter Levit, R. Cohen, Y. Racah, E. Berkman, R. Pryluk
|
|
2026 AB1116
|
VALIDATION OF THE SYSTEMIC LUPUS ERYTHEMATOSUS RISK PROBABILITY INDEX (SLEPRI) FOR EARLY DIAGNOSIS AND PROGNOSTIC ASSESSMENT IN A RETROSPECTIVE SLE COHORT,
A. Zoli, S. C. W. Chan, S. N. Aydogdu, M. A. D’ Agostino, P. Chasani, C. Bergmann, G. Schett, P. Garantziotis
|
|
2026 AB1171
|
PERFORMANCE OF LARGE LANGUAGE MODELS FOR CALCULATING DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS,
A. Gonzalez-Melendez, M. Gonzalez, I. C. Reynosa-Silva, D. L. Carrera-Cruz, C. J. Arequipa-Loachamin, J. A. Alvarez-Meza, D. A. Galarza-Delgado, E. P. Navarro Mendoza, M. Cuellar, M. Bautista-Vargas, G. Figueroa-Parra
|
|
2026 AB1265
|
VITAMIN B3 (NICOTINAMIDE) SUPPLEMENTATION IN PRIMARY AND SCLERODERMA-RELATED RAYNAUD PHENOMENON,
M. Govender, N. Tomson, J. Fang, M. Bakry, R. Liu, K. Morrisroe, R. Penglase, K. Dissanayake, T. Tsai
|
|
2026 AB1305
|
A DATA-DRIVEN MACHINE LEARNING MODEL FOR LONG-TERM MORTALITY PREDICTION IN TAKAYASU ARTERITIS,
A. Kante, S. Toupin, P. Cacoub, A. Mekinian, T. Mirault, D. Sene, K. Champion, S. Mouly, M. Groh, F. Ackermann, M. Samson, B. Bonnotte, P. Legendre, M. Lambert, C. Agard, A. Audemard Verger, N. Ferreira-Maldent, C. Mercuzot, C. Roubille, R. Goulabchand, Y. Benhamou, O. Espitia, H. de Boysson, D. Saadoun, T. Pezel, C. Comarmond
|
|
2026 AB1316
|
CLASSIFYING GIANT CELL ARTERITIS RISK IN POLYMYALGIA RHEUMATICA PATIENTS USING MACHINE LEARNING,
M. Clery, P. Ward, M. Carey, V. Jordan Mondragon, J. Le Moal Mouchet
|
|
2026 OP0104
|
ONE-YEAR CHANGES OF SPINAL NEW BONE FORMATION IN AXIAL SPONDYLOARTHRITIS ASSESSED BY LOW-DOSE CT AND MRI-BASED SYNTHETIC CT – A DESCRIPTIVE EVALUATION,
S. T. Willesen, J. Møllenbach Møller, K. K. Gosvig, S. J. Pedersen, S. Georgiadis, M. Østergaard
|
|
2026 OP013-PARE
|
BEYOND “DR GOOGLE”: PERFORMANCE OF LARGE LANGUAGE MODELS IN PATIENT COUNSELLING FOR CONNECTIVE TISSUE DISEASES,
P. Kremer, A. Reichard, S. Melderis, U. Schnoor, T. Xiong, I. Kötter, I. Haase, M. Krusche
|
|
2026 OP0168
|
QUANTITATIVE NAILFOLD VIDEOCAPILLAROSCOPY OUTPERFORMS MUSCLE ENZYMES FOR ASSESSING DISEASE ACTIVITY IN INFLAMMATORY MYOPATHIES,
J. Álvarez Troncoso, B. D. C. Gracia Tello, E. Martínez Robles, S. Prieto-González, E. Soliman, S. Molina-Rios, D. C. Varela, T. Santiago, L. Sáez-Comet, B. Marí-Alfonso, F. Uguna Sari, T. Georgiev, M. Martín Cascón, M. A. Mesa Navas, S. Bernal-Macias, G. J. Santamaría-Peñaloza, E. Calvo Bergueria, S. P. Pino Hernandez, J. Olas, M. Freire Dapena, J. M. Mosquera Angarita, J. Ballano Rodríguez-Solís, M. Akasbi Montalvo, I. Perales Fraile, E. García-Guijarro, L. A. Viteri Noël, E. Ramos Ibañez, G. M. Lledó-Ibáñez
|
|
2026 OP0187
|
LIGHTEN THE LOAD: ARTIFICIAL INTELLIGENCE REVEALS BODY MASS INDEX OUTRANKS TREATMENT IN ONE-YEAR PSORIATIC ARTHRITIS OUTCOMES—FINDINGS FROM THE SPEED TRIAL,
A. Garaïman, S. Massa, E. Saeedi, N. Gullick, W. Tillett, R. Hurtubise, J. G. Letarouilly, L. C. Coates
|
|
2026 OP0195
|
DISTINCT SUBGROUPS OF EARLY JUVENILE PSORIATIC ARTHRITIS IDENTIFIED USING MACHINE LEARNING: RESULTS FROM A MULTINATIONAL COLLABORATION OF INCEPTION COHORTS,
S. Shoop-Worrall, K. Hyrich, J. Guzman, K. Minden, J. Klotsche, R. Berard, R. Queiro, M. Yates, G. M. Alenius, F. McErlane, C. Ciurtin, G. Cleary, L. C. Coates, N. Geifman
|
|
2026 OP0256-PARE
|
TURNING GUIDELINES TO ANSWERS: PATIENT EVALUATION OF AI-BASED GUIDELINE CHATBOTS IN RHEUMATOLOGY,
T. Wilhelmi, V. Bartsch, M. Weber, R. Orzanna, A. Rashid, J. Hornig, M. Krusche, A. Hueber, D. Fink, A. Pfeil, G. Dischereit, M. T. Holzer, U. Drott, P. M. Aries, M. Müller, P. Böhm, S. Kuhn, P. Klemm, J. Knitza
|
|
2026 OP0261
|
STIMULATED EMISSION DEPLETION (STED) MICROSCOPY FOR ANA PATTERN IDENTIFICATION: FIRST DATASET AND MACHINE LEARNING COMPARISON WITH FLUORESCENCE MICROSCOPY,
K. Wójcik, A. Drynda, P. Kulakowski, P. Sosna, J. Wilańska, M. Sanak, O. Adamczyk, N. Pocałuń, K. Solarczyk, P. Kasprzycki, O. Szelest
|
|
2026 OP0343
|
ARTIFICIAL INTELLIGENCE-BASED THERMOGRAPHIC DETECTION OF JOINT INFLAMMATION IN RHEUMATOID ARTHRITIS,
K. Chin, A. Ang, S. J. S. Aung, J. Zhang, Y. K. Tan
|
|
2026 OP0344
|
ARTIFICIAL INTELLIGENCE-BASED ANALYSIS OF 20-YEAR RADIOGRAPHIC PROGRESSION IN THE ESPOIR RHEUMATOID ARTHRITIS INCEPTION COHORT,
H. Pensec, V. Devauchelle-Pensec, N. Foulquier, I. Brahim, S. Jousse-Joulin, F. Garrigues, Y. Le Duault, B. Quere, M. Dougados, B. Combe, N. Rincheval, B. Fautrel, A. Saraux
|
|
2026 OP0357
|
AUTOMATIC DEEP LEARNING-BASED MRI ANALYSIS OF INFLAMMATORY SIGNS IN RA (ADMIRA): A VALIDITY STUDY OF AI-BASED MRI INTERPRETATION IN EARLY ARTHRITIS,
D. A. Ton, Y. Li, D. Shamonin, M. Reijnierse, B. Stoel, A. van der Helm - van Mil
|
|
2026 POS0030
|
DISPARITIES IN SEVERE INFECTION RISK ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS: EVIDENCE FROM A CAUSAL FOREST ANALYSIS,
K. Zhao, A. Cheer, H. Xie
|
|
2026 POS0092
|
DEFINING THE IMMUNOMETABOLIC LANDSCAPE OF HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH) USING INTEGRATED MULTI-OMICS,
A. Oppong, A. Holloway, T. McDonnell, R. Wilson, B. Carpenter, G. Robinson, J. Manson, E. Jury
|
|
2026 POS0106-PARE
|
LEVERAGING ARTIFICIAL INTELLIGENCE TO EMPOWER PEOPLE WITH AXSPA IN INDIA: A MULTILINGUAL, PATIENT-LED ADVOCACY INITIATIVE,
B. Ghate, P. Bhosle
|
|
2026 POS0148
|
ROBOT-ASSISTED ARTHROSONOGRAPHY (ARTHUR) WITH AI ANALYSIS (DIANA) FOR THE INITIAL DIAGNOSIS AND FOLLOW-UP OF RHEUMATOID ARTHRITIS: REAL-WORLD DATA FROM 255 PATIENTS WITH SUSPECTED ARTHRITIS,
R. Nieberding, P. Harten, R. Zeuner, U. Schwab, G. Riemekasten, G. Fröhlich, P. Lamprecht, S. Klapa
|
|
2026 POS0151
|
A PRE-TRAINED MODEL TRAIN INCORPORATING A MILLION-SCALE MULTI-OMICS DATA MATRIX FOR COMPREHENSIVE RHEUMATOID ARTHRITIS MANAGEMENT,
Y. Zhou, M. Tang, J. Huang, C. Jian, T. Wang, J. Wu, W. Dang, F. Zeng
|
|
2026 POS0153
|
EVALUATING MACHINE LEARNING TOOLS TO ASSIST TITLE AND ABSTRACT SCREENING IN SYSTEMATIC LITERATURE REVIEWS: A REPORT FROM THE EULAR RA MANAGEMENT RECOMMENDATIONS TASK FORCE,
V. Konzett, F. Laskou, J. S. Smolen, C. J. Edwards, D. Aletaha, D. van der Heijde, K. L. Winthrop, T. Takeuchi, R. F. Caporali, P. Verschueren, J. Pope, K. Hyrich, S. de Souza, T. Stamm, J. Primdahl, J. Schoones, R. Landewé, A. Kerschbaumer
|
|
2026 POS0154
|
EULAR AI-DRIVEN SCREENING: EVALUATING ASReview FOR SYSTEMATIC LITERATURE REVIEWS INFORMING EULAR RECOMMENDATIONS AND POINTS-TO-CONSIDER,
L. Bischof, J. J. Teijema, E. Westerbeek, G. E. Fragoulis, U. Kiltz, L. Könemann, R. van de Schoot, S. Ramiro, P. Bosch
|
|
2026 POS0155
|
DIAGNOSTIC ACCURACY AND CLINICAL RELEVANCE OF AUTOMATED AI-BASED CAPILLAROSCOPY IN CONNECTIVE TISSUE DISEASES: PRELIMINARY DATA,
S. Dimitrov, S. Bogdanova-Petrova, Z. Apostolova, D. Simeonova, R. Moraliyska, G. Gerganov, S. Dimitrov, S. Hristova, T. Shivacheva, T. Georgiev
|
|
2026 POS0167
|
DEVELOPMENT AND VALIDATION OF AN ARTIFICIAL INTELLIGENCE ALGORITHM FOR THE IDENTIFICATION AND QUANTIFICATION OF CHONDROCALCINOSIS AND OSTEOARTHRITIS ON KNEE RADIOGRAPHS,
E. Cipolletta, D. Madonna, F. Ribichini, E. Conti, R. Rosati, R. Mashadi Mirza, F. Battelli, M. Carotti, M. C. Fiorentino, C. Hervas-Martínez, F. Bérchez Moreno, D. Zompa, F. Salaffi, G. Moroncini, A. Giovagnoni, E. Filippucci
|
|
2026 POS0176
|
UNSUPERVISED MULTI-OMICS ANALYSIS REVEALS DISTINCT MOLECULAR PROGRAMMES ASSOCIATED WITH PROGRESSION TO RHEUMATOID ARTHRITIS IN CCP-POSITIVE AT-RISK INDIVIDUALS,
L. Chang, F. Tariq, A. Azeem, D. Clayton, K. Flack, T. Young, A. Ibbotson, A. Martinez Rodriguez, S. Lara Reyna, A. Aman, E. Cross, L. Duquenne, A. Di Matteo, P. Emery, K. Mankia, S. Savic
|
|
2026 POS0182
|
CLOSING THE GAP BETWEEN NARRATIVE AND STRUCTURE: A WORKFLOW-INTEGRATED CLINICAL DOCUMENTATION IMPROVEMENT TOOL FOR ENHANCING SNOMED CT- CODED PROBLEM LISTS IN RHEUMATOLOGY PRACTICE.,
I. Hoffman, I. De Laet, J. Clukers, D. Ioannidou, A. Omar Khader, L. Rutsaert, G. Baldini, M. Helbert
|
|
2026 POS0198
|
PERFORMANCE OF MRI-BASED SYNTHETIC CT IN DETECTING SPINAL NEW BONE FORMATION: A COMPREHENSIVE COMPARISON WITH T1-WEIGHTED MRI, LOW-DOSE CT, AND RADIOGRAPHY,
S. T. Willesen, J. Møllenbach Møller, K. K. Gosvig, S. J. Pedersen, A. E. F. Hadsbjerg, S. Georgiadis, M. Østergaard
|
|
2026 POS0200
|
DEEP LEARNING FOR ASSESSMENT OF DISEASE ACTIVITY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS USING COMBINED SACRUM AND SPINE MRI,
S. Lee, Y. Kim, M. J. Chung, S. Kang, H. Kim, J. Lee, H. Yoo, H. S. Cha
|
|
2026 POS0209
|
DigiTREAT: A DIGITAL TWIN FRAMEWORK FOR RHEUMATOID ARTHRITIS INTEGRATING A MULTICELLULAR AGENT-BASED SYNOVIAL MODEL WITH EXPERIMENTAL AND CLINICAL DATA TO PREDICT RESPONSE TO BIOLOGICS,
E. Mages, S. Bitoun, M. A. Mendoza-Parra, A. Niarakis
|
|
2026 POS0216
|
NEUROPHYSIOLOGY OF CHRONIC WIDESPREAD PAIN: TIME-SERIES CLASSIFICATION OF RESTING-STATE EEG IN PAIN DISCORDANT TWIN PAIRS FROM TwinsUK.,
J. Tsigarides, A. Rushbrooke, M. Gyurkovics, V. Bowyer, M. Freydin, A. Bagnall, A. MacGregor, F. Williams
|
|
2026 POS0221
|
fAI-BRO: MULTIMODAL AI SENTIMENT ANALYSIS FOR FIBROMYALGIA DIAGNOSIS - A PROOF-OF-CONCEPT STUDY,
V. Venerito, G. Lopalco, S. del Vescovo, I. Agresta, A. Celano, T. Hügle, F. Iannone
|
|
2026 POS0238
|
THE RELATIONSHIP BETWEEN MENISCAL EXTRUSION AND BONE SHAPE (B-SCORE) IN KNEE OSTEOARTHRITIS,
A. Brett, P. G. Conaghan
|
|
2026 POS0253
|
WEARABLE-DERIVED DATA AND MACHINE LEARNING PREDICT EQ-5D-BASED QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS,
M. Higashida-Konishi, K. Izumi, S. Saito, H. Tabata, S. Hama, T. Oshige, Y. Okano, H. Oshima, K. Suzuki, Y. Mashimo, J. Sakamoto, T. Fukami, K. Minato, N. Kajio, Y. Kondo, H. Taguchi, Y. Kaneko
|
|
2026 POS0254
|
USING AN AI-powered Ultrasound-robot (ARTHUR) TO DETECT PATIENTS WITH INFLAMMATORY ARTHROPATHIES BY AN ASSISTANT PHYSICIAN IN A PRECLINICAL REAL WORLD TRIAGE SETTING,
P. Schulte-Terhusen, P. Sewerin, S. Tsiami, A. Ali, X. Baraliakos
|
|
2026 POS0281
|
ARTIFICIAL INTELLIGENCE-ASSISTED LYMPHOCYTIC FOCUS SCORE OF LABIAL SALIVARY GLANDS IN DIAGNOSING SJÖGREN’S SYNDROME: A MULTI-CENTER CLINICAL VALIDATION AND DEPLOYMENT STUDY,
H. Lan, Z. M. OuYang, L. Dai, Y. Q. Mo
|
|
2026 POS0306
|
LUPRED: A CLINICAL SCORE TO PREDICT COMPLETE REMISSION IN LUPUS NEPHRITIS,
C. Doutriaux, A. Chambost, M. Robert, Q. Reynaud, F. Guebre-Egziabher, P. SEVE, L. Koppe, L. Perard, M. Rabeyrin, L. Trefond, A. Hot, T. Barba
|
|
2026 POS0325
|
MULTIDIMENSIONAL APPROACH TO PREDICT DISEASE PROGRESSION AND PROGNOSIS IN PATIENTS WITH VERY EARLY DIAGNOSIS OF SYSTEMIC SCLEROSIS (MAPPing VEDOSS),
V. Venerito, F. Bonomi, M. Minerba, V. Batani, Y. Allanore, P. Airo’, R. Bevá, A. M. Gheorghiu, L. Idolazzi, P. Klemm, G. Kumánovics, V. Riccieri, T. Santiago, P. Senet Hausfater, V. Smith, U. A. Walker, D. Furst, M. Matucci-Cerinic, F. Iannone, F. Del Galdo, S. Bellando-Randone
|
|
2026 POS0338
|
MODELLING HETEROGENEITY: CHALLENGES IN LINKING INTERFERON SIGNATURES TO CLINICAL TRAJECTORIES IN JUVENILE IDIOPATHIC ARTHRITIS,
L. Scagnellato, M. Kartawinata, W. Y. Lin, S. Shoop-Worrall, R. Ramonda, C. Wallace, L. Wedderburn
|
|
2026 POS0357
|
IDENTIFICATION OF MUSCLE FUNCTIONAL VULNERABILITY PHENOTYPES IN OLDER PATIENTS WITH RHEUMATOID ARTHRITIS USING UNSUPERVISED MACHINE LEARNING,
J. M. Nolla, C. Gómez Vaquero, L. Valencia Muntalà, L. BERBEL ARCOBE, P. Vidal-Montal, L. De Daniel, M. Aguilar-Coll, M. Roig-Kim, F. J. Narváez Garcia, D. Benavent
|
|
2026 POS0396
|
CHEMOKINE-MEDIATED IMMUNE CELL TRAFFICKING CHARACTERIZES ACTIVE SYSTEMIC SCLEROSIS: INSIGHTS FROM HIGH-DIMENSIONAL IMMUNE PROFILING,
M. Noviani, A. Chia, A. Lajam, P. Kumar, V. R. Chellamuthu, K. Nay Yaung, M. Wasser, J. G. Yeo, J. Behmoaras, E. Petretto, A. Low, S. Albani
|
|
2026 POS0418
|
A MULTIMODAL ARTIFICIAL INTELLIGENCE MODEL FOR PREDICTING ACUTE GOUT FLARES: A RETROSPECTIVE STUDY INTEGRATING STRUCTURED AND UNSTRUCTURED CLINICAL DATA FROM ELECTRONIC HEALTH RECORDS,
Y. Yang, J. Chen, F. Xiao, J. Li, M. Sun, S. Liang, L. Zhou, H. Dai
|
|
2026 POS0427
|
USING MACHINE LEARNING AND ELECTRONIC HEALTH RECORDS FOR EARLY IDENTIFICATION OF ANTINUCLEAR ANTIBODY- RELATED CONNECTIVE TISSUE DISEASES,
E. Chock, Y. Ren, M. Bernabeo, M. X. Dong, D. T. Felson, H. Xu, N. Hong
|
|
2026 POS0517
|
THE USE OF ARTIFICIAL INTELLIGENCE TO RECOGNIZE FACIAL FEATURES OF SYSTEMIC SCLEROSIS (SSc),
Y. A. Suliman, J. Wu, M. Tomcik, J. Antowan, T. Winkler, E. Talaat, A. Rajan, D. Furst
|
|
2026 POS0541
|
AI-BASED QUANTITATIVE HRCT SCORING FOR PREDICTING DISEASE PROGRESSION IN SCLERODERMA-ASSOCIATED INTERSTITIAL LUNG DISEASE,
I. Vazina, E. Bercovich, L. Guralnik, K. Dolnikov, S. Giryes, Y. Tavor, A. Arraf, A. Balbir-Gurman, Y. Braun-Moscovici
|
|
2026 POS0646-HPR
|
COMPARISON OF MOBILE-BASED AND SUPERVISED ARTIFICIAL INTELLIGENCE PERSONALIZED EXERCISE PROGRAMS IN JUVENILE IDIOPATHIC ARTHRITIS: A RANDOMIZED CONTROLLED TRIAL,
A. Yekdaneh, N. Arman, N. Aktay Ayaz
|
|
2026 POS0651-HPR
|
EFFECTS OF STRUCTURED VERSUS EXERGAMING-BASED CORE STABILIZATION TRAINING ON PAIN AND PHYSICAL FUNCTION IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: A RANDOMIZED CONTROLLED TRIAL,
I. Donmez, N. Arman, F. Çakmak, N. Aktay Ayaz
|
|
2026 POS0668
|
SHARP.AI: LONGITUDINAL AI-BASED EVALUATION OF RADIOGRAPHIC PROGRESSION IN PSORIATIC ARTHRITIS,
Z. Gao, D. Govind, D. Kessler, C. Parmar, K. Broos, N. Fountoulakis, X. Tang, L. Gabriel, E. C. Hsia, G. O. Cula, L. Noonan, P. S. Murphy, A. Beutler, T. Rooney, P. Ory, M. Deman, K. Standish, R. Janiczek
|
|
2026 POS0745-HPR
|
RELIABILITY OF A NEW AUTOMATED KNEE INFLAMMATION MRI SCORING GRID PLACEMENT AND BONE MARROW LESION DETECTION ALGORITHM (“iKIMRISS”),
S. Wichuk, S. Abbasi, A. Wahd, R. Gilliland, S. McDonald, R. G. W. Lambert, W. P. Maksymowych, A. Rakkunedeth, J. L. Jaremko
|
|
2026 POS0758
|
MACHINE LEARNING–BASED IDENTIFICATION OF KEY PATIENT-REPORTED DOMAINS IN INFLAMMATORY ARTHRITIS,
S. N. Aydogdu, B. Coppers, S. Heinrich, K. Tascilar, S. Bayat, M. Sadeghi, A. Kleyer, I. Minopoulou, D. Simon, G. Corte, F. Fagni, V. Schönau, S. Leyendecker, G. Schett, A. M. Liphardt
|
|
2026 POS0765
|
PERFORMANCE OF LARGE LANGUAGE MODELS IN DIAGNOSING RARE ENDEMIC AUTOINFLAMMATORY DISEASES,
N. M. Drzeniek, F. Reis, S. D. Boie, F. Balzer, A. Pankow, D. Simon, G. Krönke, A. Kleyer
|
|
2026 POS0782
|
ARTIFICIAL INTELLIGENCE FOR IDENTIFYING AND GRADING MICROCRYSTALLINE DEPOSITS IN KNEE ULTRASOUND IMAGES: A SEMANTIC SEGMENTATION APPROACH. RESULTS OF AN OMERACT ULTRASOUND WORKING GROUP PROJECT,
M. D. Dal Fabbro, D. Cirillo, T. Bassani, A. Adinolfi, E. Cipolletta, L. Coronel, M. Diaz, R. Fabbri, E. Filippucci, H. B. Hammer, D. MacCarter, I. Möller, M. A. Mortada, E. Naredo, A. Lucia, G. Pellegrino, L. Pezzoni, F. Porta, G. Sakellariou, W. Schmidt, S. Sirotti, O. Aitisha Tabesh, G. Tamborrini, P. Todorov, O. Olivas-Vergara, S. Gitto, L. M. Sconfienza, C. Pineda, P. Mandl, M. A. D’ Agostino, L. Terslev, G. Filippou
|
|
2026 POS0823
|
AI-ASSISTED SCREENING FOR SYSTEMATIC REVIEWS IN RHEUMATOLOGY,
D. Husum, C. Moos, K. Schreiber, T. Holm-Larsen, R. Hvingelby
|
|
2026 POS0850
|
UNSUPERVISED SEGMENTATION OF JOINT ULTRASOUND IMAGES USING VISION TRANSFORMER AND SPECTRAL CLUSTERING METHODS: A SINGLE-CENTER STUDY,
V. Korendovych, J. G. Rademacher
|
|
2026 POS0860
|
SENSITIVITY TO CHANGE OF AN AUTOMATED MRI BONE MARROW OEDEMA SCORING SYSTEM FOR THE SPINE AND SACROILIAC JOINTS IN AXIAL SPONDYLOARTHRITIS: ANALYSIS OF THREE PHASE 3 TRIALS,
S. Ahmed, A. Jamaludin, T. Kadir, J. Declerck, R. Windsor, S. Ather, R. Park, A. Zisserman, J. Braun, L. S. Gensler, M. Østergaard, D. Poddubnyy, T. Coroller, B. Porter, G. Ligozio, A. Readie, P. M. Machado
|
|
2026 POS0893
|
THE USE OF ARTIFICIAL INTELLIGENCE IN RHEUMATOID ARTHRITIS DIAGNOSIS: A SCOPING REVIEW,
M. Moreira, M. Pacheco, D. Geada, N. Delgado, A. F. Águeda, M. Guerra, J. Rodrigues, R. Pinheiro Torres, M. Oliveira
|
|
2026 POS0963
|
DEEP LEARNING-BASED ASSESSMENT OF CD90+ SYNOVIAL FIBROBLAST HETEROGENEITY IN A TREATMENT-NAÏVE RHEUMATOID ARTHRITIS COHORT,
F. Abatecola, F. S. Iaquinta, C. Lynch, L. Fossati-Jimack, C. Pitzalis, F. Rivellese
|
|
2026 POS0967
|
UNSUPERVISED MACHINE LEARNING IDENTIFIES DISTINCT PHENOTYPES OF ANTI-CCP POSITIVE AT RISK INDIVIDUALS WITH DIFFERENT RISKS OF PROGRESSION TO RHEUMATOID ARTHRITIS,
E. Bolton, L. Duquenne, K. Harnden, S. Sharrack, H. J. Sugden, A. Di Matteo, J. Nam, P. Emery, G. Aivaliois, A. Bulpitt, K. Mankia
|
|
2026 POS0977
|
MULTI-OMICS PROFILING REVEALS MOLECULAR OVERLAP BETWEEN SJÖGREN’S DISEASE AND SLE AND IDENTIFIES CANDIDATE BIOMARKERS FOR SJÖGREN’S DISEASE,
H. Schebet, I. Kokundu, R. Rex, M. Barkhuizen, K. Schreiter, K. Thanamit, H. Stark, F. Rolfs, C. Kluger, I. Komarov, F. Engelke, A. Elsaghir, K. Kniesch, T. Witte, P. Skroblin, U. Andag
|
|
2026 POS1021
|
PERFORMANCE OF ARTIFICIAL INTELLIGENCE-BASED SALIVARY GLAND ULTRASOUND IN SJÖGREN DISEASE,
O. Olivas-Vergara, M. Garcia-Sevilla, L. Cubero, J. Pascau, E. Naredo
|
|
2026 POS1030
|
ARTIFICIAL INTELLIGENCE FOR EARLY DIAGNOSIS OF BEHÇET’S SYNDROME BASED ON INITIAL PATIENT’S ENCOUNTER,
F. Hassan, M. Omar, G. Aswad, A. Saab, H. Jeries, M. E. Naffaa
|
|
2026 POS1079
|
ARTIFICIAL INTELLIGENCE DRIVEN EVALUATION OF THE AIRWAYS IMPROVES PROGNOSTIC ACCURACY BEYOND STANDARD ASSESSMENT IN SYSTEMIC SCLEROSIS–ASSOCIATED INTERSTITIAL LUNG DISEASE,
E. De Lorenzis, R. D’Abronzo, G. Alonzi, V. Boni, G. D. Patti, S. Di Murro, C. T. Magnanimi, L. Lanzo, G. Natalello, P. Cerasuolo, C. Pomini, G. Cicchetti, L. Calandriello, B. Iovene, G. Sgalla, F. Varone, A. R. Larici, L. Richeldi, M. A. D’ Agostino, S. L. Bosello
|
|
2026 POS1173
|
UPDATE OF THE EULAR POINTS TO CONSIDER FOR THE USE OF ARTIFICAL INTELLIGENCE AND BIG DATA IN RHEUMATIC AND MUSCULOSKELETAL DISEASES,
L. Gupta, V. Venerito, L. Gossec, T. Hügle, P. Welsing, G. R. Burmester
|
|
2026 POS1192
|
UNDERSTANDING TRUST, AWARENESS, AND READINESS FOR ARTIFICIAL INTELLIGENCE IN ARTHRITIS CARE: RESULTS FROM A NATIONAL PATIENT SURVEY,
E. Wang, A. Chan, K. Lendvoy, C. L. Koehn
|
|
2026 POS1224
|
ARTIFICIAL INTELLIGENCE-ENABLED OPPORTUNISTIC SCREENING TO CLOSE THE CARE GAP IN OSTEOPOROSIS,
L. Jackson, S. Rothenberg, R. Begum, J. R. Curtis, J. Osborne, N. Baidwan, V. Bachiashvili, K. Saag, M. Danila
|
|
2026 POS1271
|
PATIENTS IMPROVE, PATTERNS PERSIST: TEMPORAL STABILITY OF RA SUBSETS,
T. D. Maarseveen, Y. Nagafuchi, K. Lend, A. Rudin, B. Gudbjornsson, D. Nordström, E. A. Haavardsholm, G. Grondal, J. Lampa, K. Hørslev-Petersen, M. S. Heiberg, M. Lund Hetland, M. Nurmohamed, M. Østergaard, T. Uhlig, T. Sokka-Isler, H. K. Glas, J. Veris-van Dieren, R. F. van Vollenhoven, T. Huizinga, M. J. T. Reinders, S. A. Bergstra, E. B. van den Akker, R. Knevel
|
|
2026 POS1273
|
RheumaPredict: EXTERNALLY VALIDATED ENSEMBLE MACHINE LEARNING MODEL FOR PREDICTING RHEUMATOID ARTHRITIS FLARES IN LATIN AMERICAN POPULATIONS,
J. S. Theran Leon, W. Otero, A. Felipe, C. Gutierrez, E. J. Vasquez Castro, M. A. Vivas Prada
|
|
2026 POS1279
|
MACHINE LEARNING TO PREDICT REMISSION BETWEEN SIX AND 24 MONTHS IN RHEUMATOID ARTHRITIS: INSIGHTS FROM THE JAK-pot COLLABORATION,
Z. Salis, D. Mongin, R. Aymon, D. Choquette, L. Coupal, C. Codreanu, F. Iannone, R. F. Caporali, T. K. Kvien, S. Aarrestad Provan, R. Fritsch-Stork, D. Nordström, N. Trokovic, K. Pavelka, J. Závada, A. M. Rodrigues, Z. Rotar, P. Sidiropoulos, I. Flouri, C. Lamacchia, M. Iudici, D. S. Courvoisier, K. Lauper, A. Finckh
|
|
2026 POS1295
|
SAFETY, ACCURACY AND CLINICAL UTILITY OF AI-GENERATED RHEUMATOID ARTHRITIS PATIENT EDUCATION: A BLINDED HEAD-TO-HEAD RHEUMATOLOGIST EVALUATION,
S. H. R. Gadekallu, B. G. Dharmanand, S. C. Veeravalli, S. Chandrashekara, H. Liu, T. R. Gadekallu
|
|
2026 POS1302
|
A VISION TRANSFORMER-BASED TRANSFER LEARNING MODEL TO INFER METACARPOPHALANGEAL JOINT SWELLING ON HAND PHOTOGRAPHS IN PATIENTS WITH RHEUMATOID ARTHRITIS,
A. García-Alija, L. Russo, M. Blanchard, J. Maglione, C. N. Koller, T. Hügle
|
|
2026 POS1328
|
LIMITED PREDICTABILITY OF SECOND-LINE DMARD PERSISTENCE AFTER METHOTREXATE FAILURE IN RHEUMATOID ARTHRITIS,
N. Steinz, D. Di Giuseppe, C. A. Hana, H. Lechner-Radner, J. Askling, R. Knevel
|
|
2026 POS1370
|
UNSUPERVISED PHENOTYPIC CLUSTERING OF CARDIOVASCULAR RISK PROFILES IN SYSTEMIC LUPUS ERYTHEMATOSUS,
L. D. Azoulay, N. Kachenoura, S. Boussouar, E. Charpentier, N. Pasi, L. A. Nguyen, T. Broussaud, A. Giron, J. Leite, N. Ait-Abdallah, M. Pha, M. Hié, A. Mathian, M. Pineton de Chambrun, M. Papo, F. Cohen, J. Haroche, A. Redheuil, Z. Amoura
|
|
